<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho‐pulmonary disease - Chalumeau, M - 2013 | Cochrane Library</title> <meta content="Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho‐pulmonary disease - Chalumeau, M - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003124.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho‐pulmonary disease - Chalumeau, M - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003124.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD003124.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho‐pulmonary disease" name="citation_title"/> <meta content="Martin Chalumeau" name="citation_author"/> <meta content="Necker Hospital, AP‐HP and Paris Descartes University" name="citation_author_institution"/> <meta content="martin.chalumeau@gmail.com" name="citation_author_email"/> <meta content="Yvonne CM Duijvestijn" name="citation_author"/> <meta content="Medical Centre Alkmaar" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD003124.pub4" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/05/31" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003124.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003124.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003124.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Acetylcysteine [adverse effects, *therapeutic use]; Acute Disease; Age Factors; Carbocysteine [adverse effects, *therapeutic use]; Cough [drug therapy]; Expectorants [adverse effects, *therapeutic use]; Randomized Controlled Trials as Topic; Respiratory Tract Infections [*drug therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003124.pub4&amp;doi=10.1002/14651858.CD003124.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003124.pub4&amp;doi=10.1002/14651858.CD003124.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003124.pub4&amp;doi=10.1002/14651858.CD003124.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003124.pub4&amp;doi=10.1002/14651858.CD003124.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003124.pub4&amp;doi=10.1002/14651858.CD003124.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003124.pub4&amp;doi=10.1002/14651858.CD003124.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003124.pub4&amp;doi=10.1002/14651858.CD003124.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003124.pub4&amp;doi=10.1002/14651858.CD003124.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003124.pub4&amp;doi=10.1002/14651858.CD003124.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003124.pub4&amp;doi=10.1002/14651858.CD003124.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003124.pub4&amp;doi=10.1002/14651858.CD003124.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003124.pub4&amp;doi=10.1002/14651858.CD003124.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003124.pub4&amp;doi=10.1002/14651858.CD003124.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003124.pub4&amp;doi=10.1002/14651858.CD003124.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003124.pub4&amp;doi=10.1002/14651858.CD003124.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003124.pub4&amp;doi=10.1002/14651858.CD003124.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003124.pub4&amp;doi=10.1002/14651858.CD003124.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003124.pub4&amp;doi=10.1002/14651858.CD003124.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003124.pub4&amp;doi=10.1002/14651858.CD003124.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003124.pub4&amp;doi=10.1002/14651858.CD003124.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003124.pub4&amp;doi=10.1002/14651858.CD003124.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003124.pub4&amp;doi=10.1002/14651858.CD003124.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003124.pub4&amp;doi=10.1002/14651858.CD003124.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="ZDBB8PHY";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD003124\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD003124\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003124\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003124\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","ms","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD003124.pub4",title:"Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho\\u2010pulmonary disease",firstPublishedDate:"May 31, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Acute Respiratory Infections Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ZDBB8PHY&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003124.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003124.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD003124.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD003124.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003124.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD003124.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD003124.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD003124.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD003124.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD003124.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>14904 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD003124.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003124.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003124.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003124.pub4/full#CD003124-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003124.pub4/full#CD003124-sec-0080"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003124.pub4/full#CD003124-sec-0022"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003124.pub4/full#CD003124-sec-0027"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003124.pub4/full#CD003124-sec-0028"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003124.pub4/full#CD003124-sec-0051"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003124.pub4/full#CD003124-sec-0074"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003124.pub4/appendices#CD003124-sec-0085"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/table_n/CD003124StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/table_n/CD003124StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003124.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003124.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003124.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003124.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003124.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD003124.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho‐pulmonary disease </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003124.pub4/information#CD003124-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Martin Chalumeau</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003124.pub4/information#CD003124-cr-0003">Yvonne CM Duijvestijn</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/information/en#CD003124-sec-0098">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 31 May 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD003124.pub4">https://doi.org/10.1002/14651858.CD003124.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD003124-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003124-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003124-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD003124-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD003124-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD003124-abs-0001" lang="en"> <section id="CD003124-sec-0001"> <h3 class="title" id="CD003124-sec-0001">Background</h3> <p>Acetylcysteine and carbocysteine are the most commonly prescribed mucolytic drugs in Brazil and many European and African countries. To our knowledge, no systematic review has been published on their efficacy and safety for acute upper and lower respiratory tract infections (RTIs) in children without chronic broncho‐pulmonary disease. </p> </section> <section id="CD003124-sec-0002"> <h3 class="title" id="CD003124-sec-0002">Objectives</h3> <p>The objective was to assess the efficacy and safety and to establish a benefit‐risk ratio of acetylcysteine and carbocysteine as symptomatic treatments for acute upper and lower RTIs in paediatric patients without chronic broncho‐pulmonary disease. </p> </section> <section id="CD003124-sec-0003"> <h3 class="title" id="CD003124-sec-0003">Search methods</h3> <p>We searched CENTRAL (2013, Issue 2), MEDLINE (1966 to February week 3, 2013), EMBASE (1980 to March 2013), Micromedex (2010), Pascal (1987 to 2004) and Science Citation Index (1974 to March 2013). </p> </section> <section id="CD003124-sec-0004"> <h3 class="title" id="CD003124-sec-0004">Selection criteria</h3> <p>To study efficacy, we used randomised controlled trials (RCTs) comparing the use of acetylcysteine or carbocysteine versus placebo, either alone or as an add‐on therapy. To study safety, we used trials comparing acetylcysteine or carbocysteine versus active treatment or no treatment and case reports. </p> </section> <section id="CD003124-sec-0005"> <h3 class="title" id="CD003124-sec-0005">Data collection and analysis</h3> <p>In this review update two review authors (YD, MC), with help from a colleague, extracted data and assessed trial quality. We performed a subgroup analysis of children younger than two years of age. </p> </section> <section id="CD003124-sec-0006"> <h3 class="title" id="CD003124-sec-0006">Main results</h3> <p>We included six trials involving 497 participants to study efficacy. They showed some benefit (e.g. reduction of cough at day seven) from mucolytic agents, although differences were of little clinical relevance. No conclusion was drawn about the subgroup of infants younger than two years because data were unavailable. Thirty‐four studies, including the previous six trials involving 2064 children, were eligible to study safety. Overall safety was good but very few data were available to evaluate safety in infants younger than two years. However, 59 cases of paradoxically increased bronchorrhoea observed in infants were reported to the French pharmacovigilance system. </p> </section> <section id="CD003124-sec-0007"> <h3 class="title" id="CD003124-sec-0007">Authors' conclusions</h3> <p>The results have to be interpreted with caution because they are based on a limited number of participants included in studies whose methodological quality is questionable. Acetylcysteine and carbocysteine seem to have a limited efficacy and appear to be safe in children older than two years. These results should take into consideration the fact that acetylcysteine and carbocysteine are prescribed for self limiting diseases (for example, acute cough, bronchitis). Given strong concerns about safety, these drugs should only be used for acute upper and lower RTIs in the context of a RCT with regards to children younger than two years. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD003124-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003124-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003124-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD003124-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD003124-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD003124-abs-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD003124-abs-0004">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD003124-abs-0003" lang="en"> <h3>Acetylcysteine and carbocysteine to treat acute upper and lower respiratory tract infections in children without chronic broncho‐pulmonary disease </h3> <p>Acetylcysteine and carbocysteine are the most commonly prescribed drugs which aim to change the structure of bronchial secretions. This systematic review assessed their efficacy and safety for treating acute upper and lower respiratory tract infections in children without chronic broncho‐pulmonary disease. We also looked in particular at patients younger than two years of age. </p> <p>Forty‐nine trials met the inclusion criteria. Six trials involving 497 participants were included to study efficacy, and compared acetylcysteine or carbocysteine to placebo. Thirty‐four trials (including the previous six) were eligible to study safety and involved 2064 paediatric patients. </p> <p>The results of this review suggest actual but limited efficacy of acetylcysteine and carbocysteine (e.g. reduction of cough at day seven) and good overall safety (except for rare mild gastrointestinal side effects) among children older than two years of age. However, the number of participants included was limited and the methodological quality was questionable. These results should also take into consideration the fact that acetylcysteine and carbocysteine are prescribed for self limiting diseases (for example, acute cough, bronchitis). In children younger than two years, and given strong concerns about safety (increased instead of decreased bronchial secretions), these drugs should only be used for acute upper and lower respiratory tract infections in the context of a randomised controlled trial. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD003124-sec-0080" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD003124-sec-0080"></div> <h3 class="title" id="CD003124-sec-0081">Implications for practice</h3> <section id="CD003124-sec-0081"> <p>The results of the present review have to be interpreted with caution because (i) it was based on a limited number of patients included in studies whose methodological quality was questionable, and which dated mainly from the 1970s and 1980s, (ii) these results should take into consideration the fact that acetylcysteine and carbocysteine are prescribed for self limiting diseases (for example, acute cough, bronchitis), and (iii) millions of paediatric patients are exposed to these drugs each year in many European countries (<a href="./references#CD003124-bbs2-0056" title="Cano GarcinuñoA ,  Casares AlonsoI , Rodríguez BarberoJ , Pérez GarcíaI ,  Blanco QuirósA . Prescription of systemic cold and cough drugs to children 0‐13 years old. An unresolved problem. Anales de Pediatría2013;78(1):43‐50. ">Cano Garcinuño 2013</a>; <a href="./references#CD003124-bbs2-0058" title="CazzatoT , PandolfiC , CampiR , BonatiM . Drug prescribing in out‐patient children in Southern Italy. European Journal of Clinical Pharmacology2001;57:611‐6. ">Cazzato 2001</a>; <a href="./references#CD003124-bbs2-0059" title="ChalumeauM , TreluyerJM , SalanaveB , AssathianyR , CheronG , CrochetonN , et al. Off label and unlicensed drug use among French office based paediatricians. Archives of Disease in Childhood2000;83(6):502‐5. ">Chalumeau 2000</a>; <a href="./references#CD003124-bbs2-0061" title="ColletJP , BossardN , FloretD , GilletJ , HoneggerD , BoisselJP . Drug prescription in young children: results of a survey in France. European Journal of Clinical Pharmacology1991;41:489‐91. ">Collet 1991</a>; <a href="./references#CD003124-bbs2-0064" title="DuijvestijnYC , GerritsenJ , BrandPL . Acetylcysteine in children with lung disorders prescribed by one‐third of family physicians: no support in the literature. Nederlands Tijdschrift Voor Geneeskunde1997;141:826‐30. ">Duijvestijn 1997</a>; <a href="./references#CD003124-bbs2-0070" title="HorenB , MontastrucJ‐L , Lapeyre‐MestreM . Adverse drug reactions and off‐label drug use in paediatric outpatients. Journal of Clinical Pharmacology2002;54:665‐70. ">Horen 2002</a>; <a href="./references#CD003124-bbs2-0080" title="SanzEJ , BoadaJN . Drug utilization by children in Tenerife Island. European Journal of Clinical Pharmacology1988;34:495‐9. ">Sanz 1988</a>; <a href="./references#CD003124-bbs2-0081" title="Sen EF , VerhammeKM , FelisiM , 't JongGW , GiaquintoC , PicelliG , et al. Effects of safety warnings on prescription rates of cough and cold medicines in children below 2 years of age. British Journal of Clinical Pharmacology2011;71:943‐50. ">Sen 2011</a>). These mucolytic agents seem to have some benefits on frequency, intensity and duration of symptoms, and appear to be safe in children older than two years. Regarding children younger than two years old, there are current strong concerns about the safety of acetylcysteine and carbocysteine (<a href="./references#CD003124-bbs2-0073" title="MalletP , MourdiN , DubusJ‐C , BavouxF , Boyer‐GervoiseM‐J , Jean‐PastorM‐J , et al. Respiratory paradoxical adverse drug reactions associated with acetylcysteine and carbocysteine systemic use in paediatric patients: a national survey. PLoS One2011;6:e22792. ">Mallet 2011</a>). These concerns led to the withdrawal of their licence in this age group in France and Italy in 2010 (<a href="./references#CD003124-bbs2-0075" title="MourdiN , DubusJC , BavouxF , Boyer‐GervoiseM , Jean‐PastorMJ , ChalumeauM . Mucolytic drugs: towards a contraindication in infants. Archives de Pédiatrie2010;17:735‐6. ">Mourdi 2010</a>). Therefore, these drugs should only be used for acute respiratory tract infections in neonates and infants in the context of a randomised controlled trial. </p> </section> <h3 class="title" id="CD003124-sec-0082">Implications for research</h3> <section id="CD003124-sec-0082"> <p>An adequately powered, randomised, double‐blind, placebo‐controlled trial evaluating the efficacy and safety of acetylcysteine or carbocysteine should be performed in patients under two years of age. This trial should use a main outcome which is clinically relevant (for example, cough frequency, intensity and duration). </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD003124-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD003124-sec-0022"></div> <section id="CD003124-sec-0023"> <h3 class="title" id="CD003124-sec-0023">Description of the condition</h3> <p>Acute upper and lower respiratory tract infections (RTIs) are the most frequent infections in children, occurring 7 to 10 times a year in school age children (<a href="./references#CD003124-bbs2-0060" title="ChangAB , GlombWB . Guidelines for evaluating chronic cough in pediatrics. Chest2006;129(Suppl):260‐83. ">Chang 2006</a>; <a href="./references#CD003124-bbs2-0082" title="ShieldsMD , BushA , EverardML , McKenzieS , PrimhakR , British Thoracic Society Cough Guideline Group. BTS guidelines: recommendations for the assessment and management of cough in children. Thorax2008;63(Suppl 3):iii1‐15. ">Shields 2008</a>). The main symptom is acute cough. Coughing can last more than 10 days in half of the cases and more than three weeks in about 10% of cases. Coughing can be distressing, especially in very young children and it has a major impact on the child's and other family members' sleep, and can cause parental anxiety (<a href="./references#CD003124-bbs2-0082" title="ShieldsMD , BushA , EverardML , McKenzieS , PrimhakR , British Thoracic Society Cough Guideline Group. BTS guidelines: recommendations for the assessment and management of cough in children. Thorax2008;63(Suppl 3):iii1‐15. ">Shields 2008</a>). Parents frequently seek drugs (over‐the‐counter drugs or drugs requiring a medical prescription) to treat their children's cough. </p> </section> <section id="CD003124-sec-0024"> <h3 class="title" id="CD003124-sec-0024">Description of the intervention</h3> <p>Of the mucolytic drugs available to treat acute upper and lower RTI, the cysteine derivatives (that is, acetylcysteine and carbocysteine) are the most commonly prescribed in many European (<a href="./references#CD003124-bbs2-0056" title="Cano GarcinuñoA ,  Casares AlonsoI , Rodríguez BarberoJ , Pérez GarcíaI ,  Blanco QuirósA . Prescription of systemic cold and cough drugs to children 0‐13 years old. An unresolved problem. Anales de Pediatría2013;78(1):43‐50. ">Cano Garcinuño 2013</a>; <a href="./references#CD003124-bbs2-0059" title="ChalumeauM , TreluyerJM , SalanaveB , AssathianyR , CheronG , CrochetonN , et al. Off label and unlicensed drug use among French office based paediatricians. Archives of Disease in Childhood2000;83(6):502‐5. ">Chalumeau 2000</a>; <a href="./references#CD003124-bbs2-0064" title="DuijvestijnYC , GerritsenJ , BrandPL . Acetylcysteine in children with lung disorders prescribed by one‐third of family physicians: no support in the literature. Nederlands Tijdschrift Voor Geneeskunde1997;141:826‐30. ">Duijvestijn 1997</a>; <a href="./references#CD003124-bbs2-0081" title="Sen EF , VerhammeKM , FelisiM , 't JongGW , GiaquintoC , PicelliG , et al. Effects of safety warnings on prescription rates of cough and cold medicines in children below 2 years of age. British Journal of Clinical Pharmacology2011;71:943‐50. ">Sen 2011</a>) and African countries (<a href="./references#CD003124-bbs2-0075" title="MourdiN , DubusJC , BavouxF , Boyer‐GervoiseM , Jean‐PastorMJ , ChalumeauM . Mucolytic drugs: towards a contraindication in infants. Archives de Pédiatrie2010;17:735‐6. ">Mourdi 2010</a>) and in Brazil (<a href="./references#CD003124-bbs2-0054" title="BricksLF , LeoneC . Use of medicines by children attending nursery schools. Revista de Saúde Pública1996;30:527‐35. ">Bricks 1996</a>). Various systemic (oral, intramuscular or intravenous) or inhaled forms of the drugs are available. In The Netherlands, one‐third of general practitioners prescribe acetylcysteine for asthmatic bronchitis, acute bronchitis, or for productive or dry cough (<a href="./references#CD003124-bbs2-0064" title="DuijvestijnYC , GerritsenJ , BrandPL . Acetylcysteine in children with lung disorders prescribed by one‐third of family physicians: no support in the literature. Nederlands Tijdschrift Voor Geneeskunde1997;141:826‐30. ">Duijvestijn 1997</a>; <a href="./references#CD003124-bbs2-0081" title="Sen EF , VerhammeKM , FelisiM , 't JongGW , GiaquintoC , PicelliG , et al. Effects of safety warnings on prescription rates of cough and cold medicines in children below 2 years of age. British Journal of Clinical Pharmacology2011;71:943‐50. ">Sen 2011</a>). In France, three studies have shown that acetylcysteine and carbocysteine are some of the most prescribed drugs for children, especially those younger than two years of age (<a href="./references#CD003124-bbs2-0059" title="ChalumeauM , TreluyerJM , SalanaveB , AssathianyR , CheronG , CrochetonN , et al. Off label and unlicensed drug use among French office based paediatricians. Archives of Disease in Childhood2000;83(6):502‐5. ">Chalumeau 2000</a>; <a href="./references#CD003124-bbs2-0061" title="ColletJP , BossardN , FloretD , GilletJ , HoneggerD , BoisselJP . Drug prescription in young children: results of a survey in France. European Journal of Clinical Pharmacology1991;41:489‐91. ">Collet 1991</a>; <a href="./references#CD003124-bbs2-0070" title="HorenB , MontastrucJ‐L , Lapeyre‐MestreM . Adverse drug reactions and off‐label drug use in paediatric outpatients. Journal of Clinical Pharmacology2002;54:665‐70. ">Horen 2002</a>). In one of these studies, cysteine derivatives accounted for 18% to 25% of drug prescriptions for acute rhinopharyngitis, acute cough and acute bronchitis (<a href="./references#CD003124-bbs2-0059" title="ChalumeauM , TreluyerJM , SalanaveB , AssathianyR , CheronG , CrochetonN , et al. Off label and unlicensed drug use among French office based paediatricians. Archives of Disease in Childhood2000;83(6):502‐5. ">Chalumeau 2000</a>). The high rate of prescription of cysteine derivatives for acute upper and lower RTI in paediatric patients was shown to be unchanged in the last decade in France (<a href="./references#CD003124-bbs2-0067" title="HalnaM , LeblondP , AissiE , DumonceauxA , DelepoulleF , ElKohenR , et al. Impact of the consensus conference on outpatient treatment of infant bronchiolitis. Presse Médicale2005;34:277‐81. ">Halna 2005</a>)<i>.</i> In Italy, carbocysteine is one of the 20 drugs most prescribed by family paediatricians (<a href="./references#CD003124-bbs2-0058" title="CazzatoT , PandolfiC , CampiR , BonatiM . Drug prescribing in out‐patient children in Southern Italy. European Journal of Clinical Pharmacology2001;57:611‐6. ">Cazzato 2001</a>; <a href="./references#CD003124-bbs2-0081" title="Sen EF , VerhammeKM , FelisiM , 't JongGW , GiaquintoC , PicelliG , et al. Effects of safety warnings on prescription rates of cough and cold medicines in children below 2 years of age. British Journal of Clinical Pharmacology2011;71:943‐50. ">Sen 2011</a>). In Spain, expectorants are the drugs most prescribed by paediatricians and general practitioners for the treatment of acute bronchitis, and they are the second commonest pharmacological group prescribed to children under two years of age (<a href="./references#CD003124-bbs2-0056" title="Cano GarcinuñoA ,  Casares AlonsoI , Rodríguez BarberoJ , Pérez GarcíaI ,  Blanco QuirósA . Prescription of systemic cold and cough drugs to children 0‐13 years old. An unresolved problem. Anales de Pediatría2013;78(1):43‐50. ">Cano Garcinuño 2013</a>; <a href="./references#CD003124-bbs2-0080" title="SanzEJ , BoadaJN . Drug utilization by children in Tenerife Island. European Journal of Clinical Pharmacology1988;34:495‐9. ">Sanz 1988</a>). In Germany, acetylcysteine is in the top five of drugs prescribed to paediatric patients under one year of age (<a href="./references#CD003124-bbs2-0055" title="BüchelerR , SchwabM , MörikeK , KalchthalerB , MohrH , SchröderH , et al. Off label prescribing to children in primary care in Germany: retrospective cohort study. BMJ2002;324(7349):1311‐2. ">Bücheler 2002</a>). </p> </section> <section id="CD003124-sec-0025"> <h3 class="title" id="CD003124-sec-0025">How the intervention might work</h3> <p>In vitro, cysteine derivatives act by breaking disulphide bridges between macromolecules, which leads to a reduction in mucus viscosity (<a href="./references#CD003124-bbs2-0074" title="MediciTC , RadielovicP . Effects of drugs on mucus glycoproteins and water in bronchial secretion. Journal of International Medical Research1979;7(5):434‐42. ">Medici 1979</a>). This property led physicians in the 1960s and 1970s to develop mucolytic drugs for clinical situations where sputum modification to reduce cough is sought, including cystic fibrosis and chronic and acute bronchitis. In adult patients, the use of cysteine derivatives may cause a small reduction in acute exacerbations of chronic bronchitis (<a href="./references#CD003124-bbs2-0077" title="PooleP , BlackPN , CatesCJ . Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews2012, Issue 8. [DOI: 10.1002/14651858.CD001287.pub4] ">Poole 2012</a>). In paediatric patients with cystic fibrosis, there is no evidence of effectiveness of either oral or inhaled administration of acetylcysteine (<a href="./references#CD003124-bbs2-0065" title="DuijvestijnYC , BrandPL . Systematic review of N‐acetylcysteine in cystic fibrosis. Acta Paediatrica1999;88:38‐41. ">Duijvestijn 1999</a>). In addition to being used for patients with severe chronic pulmonary disease, in some countries cysteine derivatives are also widely used to treat previously healthy paediatric patients with acute broncho‐pulmonary disease. </p> </section> <section id="CD003124-sec-0026"> <h3 class="title" id="CD003124-sec-0026">Why it is important to do this review</h3> <p>To our knowledge, no systematic review has been previously published on the efficacy and safety of acetylcysteine and carbocysteine for acute upper and lower RTIs in paediatric patients without chronic broncho‐pulmonary disease. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD003124-sec-0027" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD003124-sec-0027"></div> <p> <ol id="CD003124-list-0001"> <li> <p>To assess the efficacy of acetylcysteine and carbocysteine as symptomatic treatments for acute upper and lower RTIs in paediatric patients without chronic broncho‐pulmonary disease. </p> </li> <li> <p>To evaluate the safety of acetylcysteine and carbocysteine in the symptomatic treatment of acute upper and lower RTIs in paediatric patients without chronic broncho‐pulmonary disease. </p> </li> <li> <p>To establish a benefit‐risk ratio for the use of acetylcysteine and carbocysteine as symptomatic treatments for acute upper and lower RTIs in paediatric patients without chronic broncho‐pulmonary disease. </p> </li> </ol> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD003124-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD003124-sec-0028"></div> <section id="CD003124-sec-0029"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD003124-sec-0030"> <h4 class="title">Types of studies</h4> <p>To study efficacy, we used randomised controlled trials (RCTs) comparing the systemic or inhaled use of acetylcysteine and/or carbocysteine versus placebo, either alone or as an add‐on therapy (see <a href="#CD003124-sec-0032">Types of interventions</a>). </p> <p>To study safety, we also used trials comparing acetylcysteine and/or carbocysteine versus active treatment or no treatment and case reports. </p> </section> <section id="CD003124-sec-0031"> <h4 class="title">Types of participants</h4> <p>We included trials regardless of gender and study setting (ambulatory or hospital‐based). We included trials if the participants met all of the following criteria. </p> <p> <ol id="CD003124-list-0002"> <li> <p>Younger than 18 years (when studies involved adults and children, a minimum of 50% (arbitrary) of children were retained as a threshold to include the study). </p> </li> <li> <p>Treated in primary, secondary or tertiary care settings.</p> </li> <li> <p>Physician diagnosis of respiratory tract infection (RTI): acute pneumonia, acute bronchitis, acute bronchiolitis (secondary to respiratory syncytial virus or to another virus) or acute cough (including pertussis). </p> </li> <li> <p>Duration of symptoms less than four weeks.</p> </li> </ol> </p> <p>We excluded trials which included patients with any of the following conditions.</p> <p> <ol id="CD003124-list-0003"> <li> <p>Acetaminophen (paracetamol) intoxication.</p> </li> <li> <p>Bronchiectasis, cystic fibrosis or broncho‐pulmonary dysplasia.</p> </li> <li> <p>Underlying immunodeficiency or respiratory tract anatomical defect.</p> </li> <li> <p>Acute respiratory distress requiring mechanical ventilation.</p> </li> </ol> </p> <p>We included trials which involved patients with underlying asthma or tuberculosis (as defined by the investigators). </p> </section> <section id="CD003124-sec-0032"> <h4 class="title">Types of interventions</h4> <p>We included trials assessing the systemic use (that is, oral, intramuscular or intravenous) or inhaled use of acetylcysteine or carbocysteine, regardless of the dose regimen. </p> <p>In order to study efficacy, we included trials which allowed concurrent use of other treatments (such as antibiotics, corticosteroids, bronchodilators, antitussives, chest physiotherapy, analgesics or antipyretics), if they allowed equal access to such medications for patients in the intervention and control groups. </p> <p>We included trials comparing the use of acetylcysteine or carbocysteine in association with other treatments (such as antibiotics, corticosteroids, bronchodilators, antitussives, chest physiotherapy, analgesics or antipyretics) versus placebo, active treatment or no treatment, as well as case reports to study the safety of acetylcysteine or carbocysteine in association with other treatments. </p> </section> <section id="CD003124-sec-0033"> <h4 class="title">Types of outcome measures</h4> <p>We included trials reporting at least one of the following outcome measures.</p> <section id="CD003124-sec-0034"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD003124-list-0004"> <li> <p>Time to resolution of clinical symptoms, signs or both (where clinical symptoms and signs may include increased respiratory rate, use of accessory respiratory muscles, abnormal lung examination, cough, sputum production, fever or activity limitations). </p> </li> <li> <p>Proportions of patients with clinical symptoms, signs or both at a designated time.</p> </li> <li> <p>Global assessment of improvement by clinicians, patients or their parents at a designated time. </p> </li> </ol> </p> </section> <section id="CD003124-sec-0035"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD003124-list-0005"> <li> <p>Reduced hospitalisation rates or duration, or both, of hospitalisation stay.</p> </li> <li> <p>Adverse events reported by the investigators.</p> </li> </ol> </p> </section> </section> </section> <section id="CD003124-sec-0036"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD003124-sec-0037"> <h4 class="title">Electronic searches</h4> <p>For this update we searched the Cochrane Central Register of Controlled Trials (CENTRAL) 2013, Issue 2, part of <i>The Cochrane Library,</i> www.thecochranelibrary.com (accessed 6 March 2013), which contains the Cochrane Acute Respiratory Infections (ARI) Group's Specialised Register; MEDLINE (January 2008 to February week 3, 2013); EMBASE (January 2008 to March 2013) and Web of Science (2008 to March 2013). (See <a href="./appendices#CD003124-sec-0086">Appendix 1</a> for the MEDLINE and CENTRAL search terms). </p> <p>We combined the MEDLINE search with a filter based on the work of <a href="./references#CD003124-bbs2-0053" title="BoluytN , TjosvoldL , LefebvreC , KlassenTP , OffringaM . Usefulness of systematic review search strategies in finding child health systematic reviews in MEDLINE. Archives of Pediatrics and Adolescent Medicine2008;162(2):111‐6. ">Boluyt 2008</a> to identify child studies. We adapted the search terms to search EMBASE (see <a href="./appendices#CD003124-sec-0087">Appendix 2</a>) and Web of Science (see <a href="./appendices#CD003124-sec-0088">Appendix 3</a>). For details of previous searches see <a href="./appendices#CD003124-sec-0089">Appendix 4</a>. </p> </section> <section id="CD003124-sec-0038"> <h4 class="title">Searching other resources</h4> <p>We handsearched the references of trials obtained to identify other relevant studies. We contacted trial authors for additional information if required, and we requested information on unpublished trials from drug companies that manufacture acetylcysteine or carbocysteine in France, The Netherlands and the United States. We imposed no language or publication restrictions. </p> </section> </section> <section id="CD003124-sec-0039"> <h3 class="title" id="CD003124-sec-0039">Data collection and analysis</h3> <section id="CD003124-sec-0040"> <h4 class="title">Selection of studies</h4> <p>In the first publication of our review (<a href="./references#CD003124-bbs2-0086" title="DuijvestijnYCM , MourdiN , SmucnyJ , PonsG , ChalumeauM . Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho‐pulmonary disease. Cochrane Database of Systematic Reviews2009, Issue 1. [DOI: 10.1002/14651858.CD003124.pub3] ">Duijvestijn 2009</a>), three review authors (YD, MC, John Smucny) independently searched titles and abstracts to identify potentially relevant articles. We obtained full‐text versions of these articles and articles with ambiguous titles or abstracts. The same three review authors independently selected articles which fulfilled the inclusion criteria. We resolved discrepancies regarding inclusion criteria by discussion. In this 2012 update, two review authors (YD, MC), with help from a colleague (TA), independently searched titles and abstracts to identify potentially relevant articles. </p> </section> <section id="CD003124-sec-0041"> <h4 class="title">Data extraction and management</h4> <p>In the first published version of our review (<a href="./references#CD003124-bbs2-0086" title="DuijvestijnYCM , MourdiN , SmucnyJ , PonsG , ChalumeauM . Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho‐pulmonary disease. Cochrane Database of Systematic Reviews2009, Issue 1. [DOI: 10.1002/14651858.CD003124.pub3] ">Duijvestijn 2009</a>), three review authors (YD, MC, John Smucny) independently extracted data from each study using electronic data collection forms. We resolved disagreements through discussion. In this 2012 update, two review authors (YD, MC) independently extracted data. </p> </section> <section id="CD003124-sec-0042"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (YD, MC), with external help of a colleague (TA), independently graded the quality of each included study using The Cochrane Collaboration's tool for assessing risk of bias (<a href="./references#CD003124-bbs2-0078" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>). We resolved disagreements by discussion and consensus. The support for judgement came from a single published or unpublished study report in all cases. We incorporated the results of the 'Risk of bias' assessment into the results. </p> </section> <section id="CD003124-sec-0043"> <h4 class="title">Measures of treatment effect</h4> <p>We calculated risk ratios (RR) and risk differences (RDs) for dichotomous outcome variables of each individual study. We calculated the summary weighted RDs and their 95% confidence interval (CI) in <a href="./references#CD003124-bbs2-0078" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a> using a fixed‐effect model. We calculated the number needed to treat to benefit (NNTB) and the number needed to treat to harm (NNTH) using the RD and its CI when RDs were significant (<a href="./references#CD003124-bbs2-0057" title="CatesC . Visual Rx. Online NNT Calculator (http://www.nntonline.net/). nntonline, 2003. ">Cates 2003</a>). </p> <p>We recoded polytomous outcome variables as dichotomous variables to enable assessment. For example, an outcome assessed as 'very good, good, poor, no improvement' was recoded as 'actual improvement versus poor or no improvement'. </p> </section> <section id="CD003124-sec-0044"> <h4 class="title">Unit of analysis issues</h4> <p>We took into account differences in populations, inclusion and exclusion criteria, interventions and outcome assessment, and we undertook a qualitative comparison of the studies to determine if pooling of the results was reasonable. We chose primary endpoints as the proportion of participants presenting a relevant symptom at a common date.   </p> </section> <section id="CD003124-sec-0045"> <h4 class="title">Dealing with missing data</h4> <p>We were not able to contact the original investigators to request missing data because the studies were performed more than 22 years ago (median = 36.5 years). There were no missing data for two‐thirds of studies. For the remaining third, we analysed only the available data (i.e. ignoring the missing data). </p> </section> <section id="CD003124-sec-0046"> <h4 class="title">Assessment of heterogeneity</h4> <p>We carried out an assessment of possible heterogeneity (the studies did not evaluate the same effect) for pooled effects using a Breslow‐Day test of heterogeneity. We used the I² statistic to describe the percentage of total variation across studies that is due to heterogeneity rather than chance (<a href="./references#CD003124-bbs2-0069" title="HigginsJPT , ThompsonSG , DeeksJD , AltmanG . Measuring inconsistency in meta‐analysis. BMJ2003;327:557‐60. ">Higgins 2003</a>). A value above 50% may be considered substantial heterogeneity. In case of heterogeneity, we performed an analysis using a random‐effects model. </p> </section> <section id="CD003124-sec-0047"> <h4 class="title">Assessment of reporting biases</h4> <p>Given the number of studies for each comparison (mostly less than four), we did not perform visual and statistical tests for funnel plot asymmetry (<a href="./references#CD003124-bbs2-0078" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>). For the single comparison including the results of four studies, we used visual interpretation (<a href="./references#CD003124-bbs2-0078" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>). </p> </section> <section id="CD003124-sec-0048"> <h4 class="title">Data synthesis</h4> <p>We used meta‐analysis because the systematic review identified several eligible studies with small sample size but with closed designs. We used a random‐effects model for meta‐analysis when studies were combined to evaluate similar (but not exactly the same) endpoints. Otherwise, we used a fixed‐effect model. </p> </section> <section id="CD003124-sec-0049"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We performed a subgroup analysis of infants younger than two years of age because of different pharmacokinetics and pharmacodynamics in this age group, as recommended by the topic E 11 ("Clinical investigation of medicinal products in the paediatric population") of the International Conference on Harmonisation (<a href="./references#CD003124-bbs2-0066" title="European Agency for the Evaluation of Medicinal Products. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Clinical investigation of medicinal products in the paediatric population (ICH Topic E11). http://www.emea.europa.eu/pdfs/human/ich/271199en.pdf 2001 (accessed 15 October 2007). ">EMEA 2001</a>). </p> </section> <section id="CD003124-sec-0050"> <h4 class="title">Sensitivity analysis</h4> <p>We did not judge sensitivity analysis to be pertinent given the number of studies for each comparison (mostly less than four). </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD003124-sec-0051" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD003124-sec-0051"></div> <section id="CD003124-sec-0052"> <h3 class="title">Description of studies</h3> <section id="CD003124-sec-0053"> <h4 class="title">Results of the search</h4> <p>In July 2010 we searched CENTRAL 2010, Issue 2 and identified 165 references, but found only one potentially relevant study (<a href="./references#CD003124-bbs2-0050" title="ZuppiLJ , CroceJ . Effect of oral route acetylcysteine on the spirometric parameters in children with asthma or rhinitis [Efeito da acetilcisteina oral sobre os parametros espirometricos em criancas asmaticas ou com rinite]. Folha Médica1984;89:305‐8. ">Zuppi 1984</a>). We searched MEDLINE from 1966 to June 2010 and retrieved 294 references, including 18 potentially relevant studies (<a href="./references#CD003124-bbs2-0009" title="BaldiniG , GucciM , TaroD , MemminiC . Controlled clinical study of a new Ambroxol formula in the treatment of infantile spastic bronchitis [Studio clinico controllato sull'attivita di una nuova formulazione di Ambroxol nella bronchite asmatiforme del bambino]. Minerva Pediatrica1989;41:91‐5. ">Baldini 1989</a>; <a href="./references#CD003124-bbs2-0011" title="BanovcinP , JakusovaL , RosslerovaV , MiklerovaM , PullmanR . Carbocysteine in the treatment of recurrent bronchitis in infants [Karbocystein v liecbe recidivujucich bronchitid u dojciat]. Ceskoslovenska Pediatrie1992;47:543‐6. ">Banovcin 1992</a>; <a href="./references#CD003124-bbs2-0012" title="BellomoG , FrigerioG , TirantelloG . Controlled study on the use of intramuscular acetylcysteine in acute respiratory infections in pediatrics [Ricerche controllate sull'impiego dell'acetilcisteina per via intramuscolare nelle infezioni respiratorie acute in pediatria]. Clinica Terapeutica1967;43:437‐58. ">Bellomo 1967a</a>; <a href="./references#CD003124-bbs2-0013" title="BellomoG , TirantelloG , GiudiceS . On the use of a combination of acetylcysteine with thiamphenicol glycinate in the systemic treatment of bronchopulmonary infections in children [Sull'uso di una combinazione dell'acetilcysteina con tiamfenicolo glicato nel trattamento sistemico delle infezioni broncopolmonari in eta' pediatrica]. Clinical Pediatrics1967;49:402‐24. ">Bellomo 1967b</a>; <a href="./references#CD003124-bbs2-0016" title="BerniM , CollinaA , ZavattiniG . Ambroxol in bronchopulmonary pathology in children [Ambroxol nella patologia broncopolmonare del bambino]. Clinica Terapeutica1983;106:351‐5. ">Berni 1983</a>; <a href="./references#CD003124-bbs2-0002" title="BiscattiG , BruschelliM , DamonteG , CapozziF . Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics [Ricerca controllata sugli effetti clinici dell'acetilcisteina per via orale nelle infezioni respiratorie in pediatria]. Minerva Pediatrica1972;24:1075‐84. ">Biscatti 1972</a>; <a href="./references#CD003124-bbs2-0017" title="BonerAL , VallettaEA , StoccheroL , RichelliC , BennatiD . Combined antibiotic plus mucolytic treatment of acute or recurrent pneumonia in children. Drugs Under Experimental and Clinical Research1984;10:627‐30. ">Boner 1984</a>; <a href="./references#CD003124-bbs2-0021" title="CastelloD , CostaG , deCandussioG . Modifications in catarrhal bronchitis secretion in paediatric age following treatment with S‐carboxymethyl‐cystein (viscosimetric study) [Modificazioni dell'escreato nella bronchite catarrale in eta pediatrica dopo trattamento con S‐carbossimetilcisteina (indagine viscosimetrica)]. Minerva Pediatrica1979;31:371‐80. ">Castello 1979</a>; <a href="./references#CD003124-bbs2-0022" title="ChalumeauM , CheronG , assathianyR , MoulinF , BavouxF , BreartG , et al. Mucolytic agents for acute respiratory tract infections in infants: a pharmacoepidemiologic problem? [Fluidifiants bronchiques dans les infections respiratoires aiguës du nourrisson: un problème pharmacoépidémiologique?]. Archives de Pédiatrie2002;9:1128‐36. ">Chalumeau 2002</a>; <a href="./references#CD003124-bbs2-0028" title="HenocqA , MoreauC , MalletE , SaugerF , Menibus CHde . Changes in IgA levels in nasal mucus after upper respiratory tract diseases in infants treated with carbocysteine [Modifications du taux IgA du mucus nasal au décours des affections des voies aériennes supérieures du nourrisson traitées par la carbocistéine]. Annales d'Oto‐Laryngologie et de Chirurgie Cervico Faciale1985;102:373‐5. ">Henocq 1985</a>; <a href="./references#CD003124-bbs2-0032" title="Loscialpo RamundoD . On the use of the association of acetylcysteine and thiamphenicol glycinate in some pediatric pulmonary diseases [Sull'impiego associazone acetilcisteina‐tiamfenicolo glicinato in alcune forme di patologia polmonare pediatrica]. Clinical Pediatrics1968;50:43‐56. ">Loscialpo Ramundo 1968</a>; <a href="./references#CD003124-bbs2-0033" title="MayaudC , LentschnerC , BouchouchaS , MarsacJ . Thiamphenicol glycinate acetylcysteinate in the treatment of acute respiratory infections with mucostasis [L'acetylcysteinate de thiamphenicol glycinate dans le traitement des infections respiratoires aigues avec mucostase]. European Journal of Respiratory Diseases Supplement1980;61(111):70‐3. ">Mayaud 1980</a>; <a href="./references#CD003124-bbs2-0038" title="PlietzJ . The treatment of bronchitic syndrome using Transbronchin in the practice. Zeitschrift für Allgemeinmedizin (Stuttgart)1976;52:1832‐4. ">Plietz 1976</a>; <a href="./references#CD003124-bbs2-0041" title="RibeiroTM , CunhaLG , SantosM , FrenkielS . Treatment of bronchial diseases in pediatrics. Results of the use of oral acetylcysteine in 80 cases. European Journal of Respiratory Diseases Supplement1980;61(111):136‐8. ">Ribeiro 1980</a>; <a href="./references#CD003124-bbs2-0044" title="SantangeloG , LombardoS , GiannottiG . A combination of cefuroxime and N‐acetyl‐cysteine for the treatment of lower respiratory tract infections in children. International Journal of Clinical Pharmacology, Therapy, and Toxicology1985;23:279‐81. ">Santangelo 1985</a>; <a href="./references#CD003124-bbs2-0046" title="TrastotenojoMS , HarsoyoN , SachroAD , SoemantriAG , SaidHW . Use of acetyl cysteine in respiratory tract disease in children. Paediatrica Indonesiana1984;24:1‐10. ">Trastotenojo 1984</a>; <a href="./references#CD003124-bbs2-0047" title="VarricchioA , CapassoM , DiGiocchinoM , CiprandiG . Inhaled thiamphenicol and acetylcysteine in children with acute bacterial rhinopharyngitis. International Journal of Immunopathology &amp; Pharmacology2008;21:625‐9. ">Varricchio 2008</a>; <a href="./references#CD003124-bbs2-0048" title="VolklVKP , SchneiderB . Treatment of airway diseases with N‐acetylcystein. An open therapeutic observational study involving 2512 patients. Fortschritte der Medizin1992;110:346‐50. ">Volkl 1992</a>). We searched EMBASE from 1980 to 2010 and identified 425 references, including 12 potentially relevant studies (<a href="./references#CD003124-bbs2-0009" title="BaldiniG , GucciM , TaroD , MemminiC . Controlled clinical study of a new Ambroxol formula in the treatment of infantile spastic bronchitis [Studio clinico controllato sull'attivita di una nuova formulazione di Ambroxol nella bronchite asmatiforme del bambino]. Minerva Pediatrica1989;41:91‐5. ">Baldini 1989</a>; <a href="./references#CD003124-bbs2-0011" title="BanovcinP , JakusovaL , RosslerovaV , MiklerovaM , PullmanR . Carbocysteine in the treatment of recurrent bronchitis in infants [Karbocystein v liecbe recidivujucich bronchitid u dojciat]. Ceskoslovenska Pediatrie1992;47:543‐6. ">Banovcin 1992</a>; <a href="./references#CD003124-bbs2-0018" title="CamurriS , MarencoG . Clinical evaluation of the safety and efficacy of a new pharmaceutical formulation of bromhexine compared to N‐acetylcysteine in pediatric patients with acute bronchitis [Valutazione clinica dell'efficacia e della tollerabilita della nuova formulazione farmaceutica bromessina granulare nei confronti dell'N‐acetilcisteina granulare in piccoli pazienti affetti da bronchite acuta]. Gazzetta Medica Italiana1990;149:45‐8. ">Camurri 1990</a>; <a href="./references#CD003124-bbs2-0027" title="GusbertiC , BellazziA , LonatiC , ModestiR . Clinical evaluation of a new synthetic derivative of acetylcysteine for treating respiratory inflammations in pediatric patients [Valutazione clinica di uno nuovo derivato sintetico dell'acido acetilsalicilico nella terapia di flogosi respiratorie di pazienti pediatrici]. Archivio di Medicina Interna1985;37:123‐9. ">Gusberti 1985</a>; <a href="./references#CD003124-bbs2-0028" title="HenocqA , MoreauC , MalletE , SaugerF , Menibus CHde . Changes in IgA levels in nasal mucus after upper respiratory tract diseases in infants treated with carbocysteine [Modifications du taux IgA du mucus nasal au décours des affections des voies aériennes supérieures du nourrisson traitées par la carbocistéine]. Annales d'Oto‐Laryngologie et de Chirurgie Cervico Faciale1985;102:373‐5. ">Henocq 1985</a>; <a href="./references#CD003124-bbs2-0004" title="MalkaM , Lablache CombierB . Carbocysteine in the treatment of acute bronchitis in children [Interet d'un mucolytique, la carbocistéine, dans la bronchite aiguë de l'enfant]. Medicina Infantil1990;97:687‐92. ">Malka 1990</a>; <a href="./references#CD003124-bbs2-0034" title="MichaelP , HaaseW . Treatment of acute and chronic bronchitis. Therapeutic experience with Pulmoclase [Behandlung akuter und chronischer bronchitis. Therapeutische erfahrungen mit Pulmoclase]. Therapiewoche1986;36:4440‐5. ">Michael 1986</a>; <a href="./references#CD003124-bbs2-0036" title="NikolicP , KoracD . The influence of acetylcysteine on respiratory functions in children with recurrent bronchitis. European Journal of Respiratory Diseases Supplement1980;61(111):141. ">Nikolic 1980</a>; <a href="./references#CD003124-bbs2-0042" title="RudnikJ , GawelJ , HaluszkaJ , KurzawaR , MielnickaB , Majewska‐ZalewskaH , et al. Oral acetylcysteine treatment in children with chronic lung diseases. European Journal of Respiratory Diseases Supplement1980;61(111):140. ">Rudnik 1980</a>; <a href="./references#CD003124-bbs2-0044" title="SantangeloG , LombardoS , GiannottiG . A combination of cefuroxime and N‐acetyl‐cysteine for the treatment of lower respiratory tract infections in children. International Journal of Clinical Pharmacology, Therapy, and Toxicology1985;23:279‐81. ">Santangelo 1985</a>; <a href="./references#CD003124-bbs2-0045" title="SzekelyE , FarkasE . Treatment of chronic bronchitis with oral acetylcysteine in children. European Journal of Respiratory Diseases Supplement1980;61(111):142. ">Szekely 1980</a>; <a href="./references#CD003124-bbs2-0048" title="VolklVKP , SchneiderB . Treatment of airway diseases with N‐acetylcystein. An open therapeutic observational study involving 2512 patients. Fortschritte der Medizin1992;110:346‐50. ">Volkl 1992</a>). We searched Micromedex for acetylcysteine and carbocysteine in 2010 and identified three potentially relevant studies (<a href="./references#CD003124-bbs2-0004" title="MalkaM , Lablache CombierB . Carbocysteine in the treatment of acute bronchitis in children [Interet d'un mucolytique, la carbocistéine, dans la bronchite aiguë de l'enfant]. Medicina Infantil1990;97:687‐92. ">Malka 1990</a>; <a href="./references#CD003124-bbs2-0040" title="RamenghiM , SabayiniG , MengoniM . Combined antibiotic plus mucolytic treatment for recurrent bronchial diseases in infancy. Current Therapeutic Research1984;36:664‐7. ">Ramenghi 1984</a>; <a href="./references#CD003124-bbs2-0044" title="SantangeloG , LombardoS , GiannottiG . A combination of cefuroxime and N‐acetyl‐cysteine for the treatment of lower respiratory tract infections in children. International Journal of Clinical Pharmacology, Therapy, and Toxicology1985;23:279‐81. ">Santangelo 1985</a>). We searched Pascal from 1987 to 2004 and identified 101 references, including one potentially relevant study (<a href="./references#CD003124-bbs2-0004" title="MalkaM , Lablache CombierB . Carbocysteine in the treatment of acute bronchitis in children [Interet d'un mucolytique, la carbocistéine, dans la bronchite aiguë de l'enfant]. Medicina Infantil1990;97:687‐92. ">Malka 1990</a>). From 2005 onwards we no longer had access to Pascal. We searched Science Citation Index from 1974 to June 2010 and identified 162 references, including four potentially relevant studies (<a href="./references#CD003124-bbs2-0036" title="NikolicP , KoracD . The influence of acetylcysteine on respiratory functions in children with recurrent bronchitis. European Journal of Respiratory Diseases Supplement1980;61(111):141. ">Nikolic 1980</a>; <a href="./references#CD003124-bbs2-0042" title="RudnikJ , GawelJ , HaluszkaJ , KurzawaR , MielnickaB , Majewska‐ZalewskaH , et al. Oral acetylcysteine treatment in children with chronic lung diseases. European Journal of Respiratory Diseases Supplement1980;61(111):140. ">Rudnik 1980</a>; <a href="./references#CD003124-bbs2-0044" title="SantangeloG , LombardoS , GiannottiG . A combination of cefuroxime and N‐acetyl‐cysteine for the treatment of lower respiratory tract infections in children. International Journal of Clinical Pharmacology, Therapy, and Toxicology1985;23:279‐81. ">Santangelo 1985</a>; <a href="./references#CD003124-bbs2-0045" title="SzekelyE , FarkasE . Treatment of chronic bronchitis with oral acetylcysteine in children. European Journal of Respiratory Diseases Supplement1980;61(111):142. ">Szekely 1980</a>). </p> <p>We updated the electronic database searches in March 2013 but did not identify any new studies. </p> <p>We identified the other potentially relevant studies using the references of relevant and non‐relevant trials and the request for unpublished trials to drug companies that manufacture acetylcysteine or carbocysteine in France, The Netherlands and the United States, and from authors of relevant and non‐relevant studies (<a href="./references#CD003124-bbs2-0007" title="AmirJ , WilunskyE , ZelikovicI , ReisnerSH . Acetylcysteine for severe atelectasis in premature infants. Clinical Pharmacy1985;4:255. ">Amir 1985</a>; <a href="./references#CD003124-bbs2-0008" title="Anonymous . A study of tolerance of carbocisteine syrup in children [Etude de la tolérance clinique du sirop carbocistéine chez l'enfant]. Dossier d'autorisation de mise sur le marché, Laboratoires Alpharma, Aubervilliers, France1987. ">Anonymous 1987</a>; <a href="./references#CD003124-bbs2-0010" title="BanovcinP . Efficacy of carbocysteine in the treatment of bronchopneumonias in children. Prakticky Lekar1990;70:885‐7. ">Banovcin 1990</a>; <a href="./references#CD003124-bbs2-0001" title="BellomoG , GiudiceS . Controlled study on the efficacy of a combination &quot;thiamphenicol‐acetylcysteine&quot; in oral administration in respiratory infections in pediatrics [Studio controllata sull'efficacia della combinazione &quot;tiamfenicolo‐acetilcisteina&quot; per via orale nel trattamento delle infezioni broncopolmonari dell'infanzia]. Clinical Pediatrics1972;54:30‐51. ">Bellomo 1972</a>; <a href="./references#CD003124-bbs2-0014" title="BellomoG , GiudiceS , GanciC . Comparative study of the efficacy of acetylcysteine by the oral and intramuscular routes in acute respiratory affections in pediatrics [Studio comparativo dell'efficacia dell'acetilcisteina per via orale ed intramuscolare nelle affezioni respiratorie acute in pediatria]. Minerva Pediatrica1973;25:844‐9. ">Bellomo 1973</a>; <a href="./references#CD003124-bbs2-0015" title="Berger vonG , GottschalkB , LeupoldW . Initial experiences with ultrasonic aerosol therapy at home in children with bronchiectasis [Erste erfahrungen mit der ultraschall‐aerosolbehandlung unter heimbedingungen bei kindern mit bronchiektasen]. Kinderärztliche Praxis1978;46:523‐7. ">Berger 1978</a>; <a href="./references#CD003124-bbs2-0019" title="CaramiaG , BizzarriV , CompagnoniL , GregoriniS . Combined antibiotic plus mucolytic treatment in broncho‐pulmonary disease: cefuroxime plus acetylcysteine. Current Therapeutic Research, Clinical and Experimental1984;36:658‐63. ">Caramia 1984</a>; <a href="./references#CD003124-bbs2-0020" title="CaredduP , BernocchiD , ScottiL , ManiniG , MezzopaneA . Therapeutic activity and tolerability of a new mucoregulating drug called nesosteine in the treatment of acute diseases of the respiratory apparatus. Controlled pediatric study vs carbocysteine [Attivita terapeutica e tollerabilita di un nuovo farmaco mucoregolatore denominato nesosteina nel trattamento di affezioni acute dell'apparato respiratorio studio pediatrico controllato vs carbocisteina]. Giornale Italiano Delle Malattie Del Torace1989;43:47‐52. ">Careddu 1989</a>; <a href="./references#CD003124-bbs2-0023" title="DanoG . Bronchospasm caused by acetylcysteine in children with bronchial asthma. Acta Allergologica1971;26:181‐90. ">Dano 1971</a>; <a href="./references#CD003124-bbs2-0024" title="EgreteauL , GaillardD , JouetJB , PlotkowskiL , ZahmJM , PierrotD , et al. Effect of carbocisteine on mucus and respiratory mucosa in children with recurrent bronchitis. European Respiratory Journal1992;Suppl 5:301. ">Egreteau 1992</a>; <a href="./references#CD003124-bbs2-0003" title="FiocchiA , VignatiB , SalaM , ArancioR , BanderaliG , MarangioneP , et al. A new n‐acetylcysteine formulation in acute bronchopneumopathy in children [La n‐acetilcisteina nel trattamento delle broncopneumopatie acute in pediatria]. Giornale Italiano delle Malattie del Torace1989;43:327‐34. ">Fiocchi 1989</a>; <a href="./references#CD003124-bbs2-0025" title="GaudierB , LelongM . Carbocysteine to treat asthma in children [L'utilisation de la S‐Carboxy Methyl Cystéine (LJ 206) dans l'asthme de l'enfant]. Laboratoires Joullie, Paris1968. ">Gaudier 1968</a>; <a href="./references#CD003124-bbs2-0026" title="GinocchiG . Clinical effects of a mucolytic agent (Pol 65) in a pediatric statistical study [Effeti clinici di un mucoliyico (Pol 65) in una casistica pediatrica]. Settimana Medica1978;66:391‐408. ">Ginocchi 1978</a>; <a href="./references#CD003124-bbs2-0029" title="HofmannA . Oral acetylcystein in the treatment of bronchial asthma and chronic respiratory tract diseases [Orale anwendung von acetylcystein bei der behandlung von asthma bronchiale und chronischen erkrankungen der luftwege]. Therapiewoche1980;30:2040‐6. ">Hofmann 1980</a>; <a href="./references#CD003124-bbs2-0030" title="JeanR , GardairF . Efficacy on expectoration of acetylcysteine nebulization in pediatric patients [Utilisation du Fluimucil antibiotic 750 en aérosols chez le nourisson et l'enfant son efficacité d'expectoration]. Laboratoires Zambon, Paris1982. ">Jean 1982</a>; <a href="./references#CD003124-bbs2-0031" title="LeupoldW von . Lung function in bronchial asthma during treatment with Mucosolvin [Die lungenfunktion bei asthma bronchiale unter der behandlung mit Mucosolvia]. Das Deutsche Gesundheitswesen1970;25:1400‐2. ">Leupold 1970</a>; <a href="./references#CD003124-bbs2-0005" title="NakayamaY , MaedaK , FuanabashiS , KubagawaT , SimanugiK , TatenoK , et al. Carbocysteine syrup in pediatrics: a clinical trial [Effets cliniques de s‐carboxymethylcysteine sous forme de sirop en pédiatrie (traduction)]. Japanese Journal of Pediatrics1977;10:1823. ">Nakayama 1977</a>; <a href="./references#CD003124-bbs2-0035" title="NigamBK . S‐Carboxymethylcysteine (S‐CMC) in bronchography technique. Indian Journal of Chest Diseases and Allied Sciences1981;23:81‐4. ">Nigam 1981</a>; <a href="./references#CD003124-bbs2-0037" title="OlivieriD , PezzaA , PolistinaD , D'AgostinoF . Clinical evaluation of a new pharmacological association in the therapy of acute and chronic bronchitis [Valutazione clinica di una nuova associazione farmacologica nella terapia delle broncopneumopatie acute e croniche]. Archivio Monaldi per la Tisiologia e le Malattie dell'Apparato Respiratorio1979;34:29‐41. ">Olivieri 1979</a>; <a href="./references#CD003124-bbs2-0039" title="PoderG , PuskasJ , KelemenJ , Gegesi KissA , CserhatiE . The effect of long term treatment with N‐Acetylcysteine in infants with chronic obstructive bronchitis [Die Wirkung der Langzeitbehandlung mit N‐Acetylcystein bei chronisch‐obstruktiver Bronchitis im Sauglings‐ und Kleinkindalter]. Laboratoires Zambon (Pharmaceutical company), Paris1982. ">Poder 1982</a>; <a href="./references#CD003124-bbs2-0043" title="SamsyginaG , KazyukovaT , VykhristyukO , MotinaA , TsaregorodtsevaL , DudinaT . Acetylcysteine 100 in treatment of children with acute and chronic respiratory diseases: experience of use. Pediatriya (Moscow)1995;1:76. ">Samsygina 1995</a>; <a href="./references#CD003124-bbs2-0006" title="ZaniniA , DodesniG . Lisomucil in pediatrics [Il lisomucil in campo pediatrico]. Clinica Europea1974;13:1‐12. ">Zanini 1974</a>; <a href="./references#CD003124-bbs2-0049" title="ZensVM . Clinical trial with a mucolytic agent, acetylcysteine, in children with bronchitis [Klinische Erfahrungen mit Acetylcystein, einer mukoltytiscen Substanz, bei der Bronchitis im Kindesalter]. Fortschritte der Medizin1967;85:206‐7. ">Zens 1967</a>). </p> <p>In summary, we included 50 potentially relevant studies to evaluate the efficacy and safety of acetylcysteine and carbocysteine. </p> </section> <section id="CD003124-sec-0054"> <h4 class="title">Included studies</h4> <section id="CD003124-sec-0055"> <h5 class="title">Studies included to evaluate efficacy</h5> <p>We excluded most of the 50 potentially relevant studies from the efficacy analysis for one or more reason(s) (see <a href="./references#CD003124-sec-0102" title="">Characteristics of excluded studies</a> table). Six trials fulfilled the inclusion criteria and none of the exclusion criteria (<a href="./references#CD003124-bbs2-0001" title="BellomoG , GiudiceS . Controlled study on the efficacy of a combination &quot;thiamphenicol‐acetylcysteine&quot; in oral administration in respiratory infections in pediatrics [Studio controllata sull'efficacia della combinazione &quot;tiamfenicolo‐acetilcisteina&quot; per via orale nel trattamento delle infezioni broncopolmonari dell'infanzia]. Clinical Pediatrics1972;54:30‐51. ">Bellomo 1972</a>; <a href="./references#CD003124-bbs2-0002" title="BiscattiG , BruschelliM , DamonteG , CapozziF . Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics [Ricerca controllata sugli effetti clinici dell'acetilcisteina per via orale nelle infezioni respiratorie in pediatria]. Minerva Pediatrica1972;24:1075‐84. ">Biscatti 1972</a>; <a href="./references#CD003124-bbs2-0003" title="FiocchiA , VignatiB , SalaM , ArancioR , BanderaliG , MarangioneP , et al. A new n‐acetylcysteine formulation in acute bronchopneumopathy in children [La n‐acetilcisteina nel trattamento delle broncopneumopatie acute in pediatria]. Giornale Italiano delle Malattie del Torace1989;43:327‐34. ">Fiocchi 1989</a>; <a href="./references#CD003124-bbs2-0004" title="MalkaM , Lablache CombierB . Carbocysteine in the treatment of acute bronchitis in children [Interet d'un mucolytique, la carbocistéine, dans la bronchite aiguë de l'enfant]. Medicina Infantil1990;97:687‐92. ">Malka 1990</a>; <a href="./references#CD003124-bbs2-0005" title="NakayamaY , MaedaK , FuanabashiS , KubagawaT , SimanugiK , TatenoK , et al. Carbocysteine syrup in pediatrics: a clinical trial [Effets cliniques de s‐carboxymethylcysteine sous forme de sirop en pédiatrie (traduction)]. Japanese Journal of Pediatrics1977;10:1823. ">Nakayama 1977</a>; <a href="./references#CD003124-bbs2-0006" title="ZaniniA , DodesniG . Lisomucil in pediatrics [Il lisomucil in campo pediatrico]. Clinica Europea1974;13:1‐12. ">Zanini 1974</a>) and were eligible to study efficacy (see <a href="./references#CD003124-sec-0101" title="">Characteristics of included studies</a> table). </p> <p>Four of these six trials were written in French and two in Italian. All six studies were performed more than 17 years ago (median = 32 years). Mucolytics were administrated orally in the six studies. </p> </section> <section id="CD003124-sec-0056"> <h5 class="title">Studies included to evaluate safety</h5> <p>We excluded sixteen studies from the safety analysis because they mainly involved participants with chronic diseases (<a href="./references#CD003124-bbs2-0007" title="AmirJ , WilunskyE , ZelikovicI , ReisnerSH . Acetylcysteine for severe atelectasis in premature infants. Clinical Pharmacy1985;4:255. ">Amir 1985</a>; <a href="./references#CD003124-bbs2-0015" title="Berger vonG , GottschalkB , LeupoldW . Initial experiences with ultrasonic aerosol therapy at home in children with bronchiectasis [Erste erfahrungen mit der ultraschall‐aerosolbehandlung unter heimbedingungen bei kindern mit bronchiektasen]. Kinderärztliche Praxis1978;46:523‐7. ">Berger 1978</a>; <a href="./references#CD003124-bbs2-0024" title="EgreteauL , GaillardD , JouetJB , PlotkowskiL , ZahmJM , PierrotD , et al. Effect of carbocisteine on mucus and respiratory mucosa in children with recurrent bronchitis. European Respiratory Journal1992;Suppl 5:301. ">Egreteau 1992</a>; <a href="./references#CD003124-bbs2-0029" title="HofmannA . Oral acetylcystein in the treatment of bronchial asthma and chronic respiratory tract diseases [Orale anwendung von acetylcystein bei der behandlung von asthma bronchiale und chronischen erkrankungen der luftwege]. Therapiewoche1980;30:2040‐6. ">Hofmann 1980</a>; <a href="./references#CD003124-bbs2-0035" title="NigamBK . S‐Carboxymethylcysteine (S‐CMC) in bronchography technique. Indian Journal of Chest Diseases and Allied Sciences1981;23:81‐4. ">Nigam 1981</a>; <a href="./references#CD003124-bbs2-0037" title="OlivieriD , PezzaA , PolistinaD , D'AgostinoF . Clinical evaluation of a new pharmacological association in the therapy of acute and chronic bronchitis [Valutazione clinica di una nuova associazione farmacologica nella terapia delle broncopneumopatie acute e croniche]. Archivio Monaldi per la Tisiologia e le Malattie dell'Apparato Respiratorio1979;34:29‐41. ">Olivieri 1979</a>; <a href="./references#CD003124-bbs2-0038" title="PlietzJ . The treatment of bronchitic syndrome using Transbronchin in the practice. Zeitschrift für Allgemeinmedizin (Stuttgart)1976;52:1832‐4. ">Plietz 1976</a>; <a href="./references#CD003124-bbs2-0039" title="PoderG , PuskasJ , KelemenJ , Gegesi KissA , CserhatiE . The effect of long term treatment with N‐Acetylcysteine in infants with chronic obstructive bronchitis [Die Wirkung der Langzeitbehandlung mit N‐Acetylcystein bei chronisch‐obstruktiver Bronchitis im Sauglings‐ und Kleinkindalter]. Laboratoires Zambon (Pharmaceutical company), Paris1982. ">Poder 1982</a>; <a href="./references#CD003124-bbs2-0041" title="RibeiroTM , CunhaLG , SantosM , FrenkielS . Treatment of bronchial diseases in pediatrics. Results of the use of oral acetylcysteine in 80 cases. European Journal of Respiratory Diseases Supplement1980;61(111):136‐8. ">Ribeiro 1980</a>; <a href="./references#CD003124-bbs2-0042" title="RudnikJ , GawelJ , HaluszkaJ , KurzawaR , MielnickaB , Majewska‐ZalewskaH , et al. Oral acetylcysteine treatment in children with chronic lung diseases. European Journal of Respiratory Diseases Supplement1980;61(111):140. ">Rudnik 1980</a>; <a href="./references#CD003124-bbs2-0043" title="SamsyginaG , KazyukovaT , VykhristyukO , MotinaA , TsaregorodtsevaL , DudinaT . Acetylcysteine 100 in treatment of children with acute and chronic respiratory diseases: experience of use. Pediatriya (Moscow)1995;1:76. ">Samsygina 1995</a>; <a href="./references#CD003124-bbs2-0045" title="SzekelyE , FarkasE . Treatment of chronic bronchitis with oral acetylcysteine in children. European Journal of Respiratory Diseases Supplement1980;61(111):142. ">Szekely 1980</a>; <a href="./references#CD003124-bbs2-0048" title="VolklVKP , SchneiderB . Treatment of airway diseases with N‐acetylcystein. An open therapeutic observational study involving 2512 patients. Fortschritte der Medizin1992;110:346‐50. ">Volkl 1992</a>; <a href="./references#CD003124-bbs2-0049" title="ZensVM . Clinical trial with a mucolytic agent, acetylcysteine, in children with bronchitis [Klinische Erfahrungen mit Acetylcystein, einer mukoltytiscen Substanz, bei der Bronchitis im Kindesalter]. Fortschritte der Medizin1967;85:206‐7. ">Zens 1967</a>; <a href="./references#CD003124-bbs2-0050" title="ZuppiLJ , CroceJ . Effect of oral route acetylcysteine on the spirometric parameters in children with asthma or rhinitis [Efeito da acetilcisteina oral sobre os parametros espirometricos em criancas asmaticas ou com rinite]. Folha Médica1984;89:305‐8. ">Zuppi 1984</a>) or received additional antibiotic treatments only in the treatment group (<a href="./references#CD003124-bbs2-0047" title="VarricchioA , CapassoM , DiGiocchinoM , CiprandiG . Inhaled thiamphenicol and acetylcysteine in children with acute bacterial rhinopharyngitis. International Journal of Immunopathology &amp; Pharmacology2008;21:625‐9. ">Varricchio 2008</a>) (see <a href="./references#CD003124-sec-0102" title="">Characteristics of excluded studies</a> table). </p> <p>Twenty‐eight studies, in addition to the six trials included to study efficacy, fulfilled the inclusion criteria and none of the exclusion criteria to study safety (<a href="#CD003124-tbl-0001">Table 1</a>). </p> <div class="table" id="CD003124-tbl-0001"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Characteristics of studies included to evaluate safety</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Methods</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participants</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Notes</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Allocation concealment</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0008" title="Anonymous . A study of tolerance of carbocisteine syrup in children [Etude de la tolérance clinique du sirop carbocistéine chez l'enfant]. Dossier d'autorisation de mise sur le marché, Laboratoires Alpharma, Aubervilliers, France1987. ">Anonymous 1987</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case report</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20 children (1 to 14 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral carbocysteine <br/> 300 mg/day above 5 years <br/> 200 mg/day under 5 years <br/> 2 to 3 times daily for 6 days (except 1: 3 days) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough frequency and intensity, sputum quality and quantity</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>French</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not used</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0009" title="BaldiniG , GucciM , TaroD , MemminiC . Controlled clinical study of a new Ambroxol formula in the treatment of infantile spastic bronchitis [Studio clinico controllato sull'attivita di una nuova formulazione di Ambroxol nella bronchite asmatiforme del bambino]. Minerva Pediatrica1989;41:91‐5. ">Baldini 1989</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> Active treatment (ambroxol); <br/> participants received antibiotics if necessary </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28 children older than 2 years old</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral acetylcysteine <br/> 300 mg/day above 5 years <br/> 200 mg/day under 5 years <br/> For 10 days </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: expectoration, sputum viscosity, dyspnoea, cough, difficulty of expectoration. <br/> Biological: blood exam, monitoring of hepatic and renal function </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0010" title="BanovcinP . Efficacy of carbocysteine in the treatment of bronchopneumonias in children. Prakticky Lekar1990;70:885‐7. ">Banovcin 1990</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Controlled trial <br/> Active treatment (Ipecac syrup); <br/> antibiotics and vitamins for all participants </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18 children (6 to 15 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral carbocysteine <br/> 250 mg 3 times a day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PFT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Slovak</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0011" title="BanovcinP , JakusovaL , RosslerovaV , MiklerovaM , PullmanR . Carbocysteine in the treatment of recurrent bronchitis in infants [Karbocystein v liecbe recidivujucich bronchitid u dojciat]. Ceskoslovenska Pediatrie1992;47:543‐6. ">Banovcin 1992</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> Active treatment (Ipecac syrup); <br/> antibiotics for all participants </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51 children (6 to 24 months)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral carbocysteine <br/> 50 to 62.5 mg 3 times a day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical score: lung auscultation, fever, cough <br/> Biological: blood exam </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Slovak</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0012" title="BellomoG , FrigerioG , TirantelloG . Controlled study on the use of intramuscular acetylcysteine in acute respiratory infections in pediatrics [Ricerche controllate sull'impiego dell'acetilcisteina per via intramuscolare nelle infezioni respiratorie acute in pediatria]. Clinica Terapeutica1967;43:437‐58. ">Bellomo 1967a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Controlled trial <br/> Control participants received no treatment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81 children (&lt; 8 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intramuscular acetylcysteine <br/> 25 to 50 mg/kg/day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, thoracic semeilogic alteration, fever</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0013" title="BellomoG , TirantelloG , GiudiceS . On the use of a combination of acetylcysteine with thiamphenicol glycinate in the systemic treatment of bronchopulmonary infections in children [Sull'uso di una combinazione dell'acetilcysteina con tiamfenicolo glicato nel trattamento sistemico delle infezioni broncopolmonari in eta' pediatrica]. Clinical Pediatrics1967;49:402‐24. ">Bellomo 1967b</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial <br/> Thiamphenicol for all participants </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39 children (16: &lt; 2 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intramuscular acetylcysteine <br/> 10 to 18 mg/kg/day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, thoracic semeilogic alteration, fever <br/> Biological: blood exam; X‐ray </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0001" title="BellomoG , GiudiceS . Controlled study on the efficacy of a combination &quot;thiamphenicol‐acetylcysteine&quot; in oral administration in respiratory infections in pediatrics [Studio controllata sull'efficacia della combinazione &quot;tiamfenicolo‐acetilcisteina&quot; per via orale nel trattamento delle infezioni broncopolmonari dell'infanzia]. Clinical Pediatrics1972;54:30‐51. ">Bellomo 1972</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> All participants received thiamphenicol with or without acetylcysteine </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>59 children (22: &lt; 1 year; 28: 1 to 5 years; 9: &gt; 5 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral acetylcysteine <br/> 13.8 mg/kg/day 2 to 4 times daily for 6 to 7 days average (maximum 14 days) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: duration of febrile state, dyspnoea, thoracic semeiologic alterations, cough</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0014" title="BellomoG , GiudiceS , GanciC . Comparative study of the efficacy of acetylcysteine by the oral and intramuscular routes in acute respiratory affections in pediatrics [Studio comparativo dell'efficacia dell'acetilcisteina per via orale ed intramuscolare nelle affezioni respiratorie acute in pediatria]. Minerva Pediatrica1973;25:844‐9. ">Bellomo 1973</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> Oral and intramuscular acetylcysteine; <br/> thiamphenicol for all participants </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50 children (35: &lt; 2 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral and intramuscular acetylcysteine <br/> 300 mg/day under 2 years <br/> 600 mg/day above </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, thoracic semeilogic alteration, fever</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0016" title="BerniM , CollinaA , ZavattiniG . Ambroxol in bronchopulmonary pathology in children [Ambroxol nella patologia broncopolmonare del bambino]. Clinica Terapeutica1983;106:351‐5. ">Berni 1983</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> Antibiotics if necessary </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 children (2 to 8 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral carbocysteine <br/> 200 to 300 mg </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, expectoration</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0002" title="BiscattiG , BruschelliM , DamonteG , CapozziF . Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics [Ricerca controllata sugli effetti clinici dell'acetilcisteina per via orale nelle infezioni respiratorie in pediatria]. Minerva Pediatrica1972;24:1075‐84. ">Biscatti 1972</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> All participants received some kind of antibiotic </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50 children (29: &lt; 2 years; 21: &gt; 2 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral acetylcysteine <br/> 100 mg/day under 2 years <br/> 200 mg/day between 2 and 4 years <br/> 300 mg/day above 4 years for 6 days </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, thoracic semeilogic alteration, temperature level <br/> Biological: ESR and leucocyte count </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian <br/> Possibly not comparable treatment because various antibiotics were used </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0017" title="BonerAL , VallettaEA , StoccheroL , RichelliC , BennatiD . Combined antibiotic plus mucolytic treatment of acute or recurrent pneumonia in children. Drugs Under Experimental and Clinical Research1984;10:627‐30. ">Boner 1984</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial <br/> Cefuroxime for all participants </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60 children (4 to 12 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intramuscular acetylcysteine <br/> 15 to 30 mg/kg/day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: temperature, cough, chest and abdomen pain, dyspnoea, wheezing <br/> Bacteriological: respiratory secretion cultures <br/> X‐ray </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>English</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0018" title="CamurriS , MarencoG . Clinical evaluation of the safety and efficacy of a new pharmaceutical formulation of bromhexine compared to N‐acetylcysteine in pediatric patients with acute bronchitis [Valutazione clinica dell'efficacia e della tollerabilita della nuova formulazione farmaceutica bromessina granulare nei confronti dell'N‐acetilcisteina granulare in piccoli pazienti affetti da bronchite acuta]. Gazzetta Medica Italiana1990;149:45‐8. ">Camurri 1990</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> Active treatment (bromhexine) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32 children (2 to 11 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral acetylcysteine <br/> 300 mg/day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, expectoration (difficulty, quantity and quality)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0019" title="CaramiaG , BizzarriV , CompagnoniL , GregoriniS . Combined antibiotic plus mucolytic treatment in broncho‐pulmonary disease: cefuroxime plus acetylcysteine. Current Therapeutic Research, Clinical and Experimental1984;36:658‐63. ">Caramia 1984</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial <br/> Cefuroxime for all participants </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 children (4 months to 13 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intramuscular acetylcysteine <br/> 20 to 30 mg/kg/day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, temperature, sputum viscosity, intrinsic sputum characteristics <br/> Bacteriological: respiratory secretion cultures <br/> X‐ray </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>English</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0020" title="CaredduP , BernocchiD , ScottiL , ManiniG , MezzopaneA . Therapeutic activity and tolerability of a new mucoregulating drug called nesosteine in the treatment of acute diseases of the respiratory apparatus. Controlled pediatric study vs carbocysteine [Attivita terapeutica e tollerabilita di un nuovo farmaco mucoregolatore denominato nesosteina nel trattamento di affezioni acute dell'apparato respiratorio studio pediatrico controllato vs carbocisteina]. Giornale Italiano Delle Malattie Del Torace1989;43:47‐52. ">Careddu 1989</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> Active treatment (nesosteine) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 children (5 to12 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral carbocysteine <br/> 900 mg/day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, expectoration <br/> Biological: blood exam </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0021" title="CastelloD , CostaG , deCandussioG . Modifications in catarrhal bronchitis secretion in paediatric age following treatment with S‐carboxymethyl‐cystein (viscosimetric study) [Modificazioni dell'escreato nella bronchite catarrale in eta pediatrica dopo trattamento con S‐carbossimetilcisteina (indagine viscosimetrica)]. Minerva Pediatrica1979;31:371‐80. ">Castello 1979</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Controlled trial <br/> Antibiotics if necessary </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13 children (1 of 15 months + 12: 2 to 12 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral carbocysteine; <br/> 3 spoons/day (2% under <br/> 4 years; 5% above <br/> 4 years) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: monitoring; <br/> viscosimetry </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0022" title="ChalumeauM , CheronG , assathianyR , MoulinF , BavouxF , BreartG , et al. Mucolytic agents for acute respiratory tract infections in infants: a pharmacoepidemiologic problem? [Fluidifiants bronchiques dans les infections respiratoires aiguës du nourrisson: un problème pharmacoépidémiologique?]. Archives de Pédiatrie2002;9:1128‐36. ">Chalumeau 2002</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Targeted pharmacovigilance study</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 children (&lt; 2 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19.5 to 34.6 mg/kg/day</p> <p>3 received oral carbocysteine <br/> 3 received oral acetylcysteine </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, sputum viscosity</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>French</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not used</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0023" title="DanoG . Bronchospasm caused by acetylcysteine in children with bronchial asthma. Acta Allergologica1971;26:181‐90. ">Dano 1971</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 children (5 to 17 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inhaled acetylcysteine <br/> 2 ml 10% + 2 ml 20% </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: monitoring; <br/> PFT </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>English</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0003" title="FiocchiA , VignatiB , SalaM , ArancioR , BanderaliG , MarangioneP , et al. A new n‐acetylcysteine formulation in acute bronchopneumopathy in children [La n‐acetilcisteina nel trattamento delle broncopneumopatie acute in pediatria]. Giornale Italiano delle Malattie del Torace1989;43:327‐34. ">Fiocchi 1989</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> All participants received antibiotics if necessary </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 children (all &gt; 2 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral acetylcysteine <br/> 20 mg/kg/day 3 times a day for 28 days </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, cough productivity and thoracic semeilogic alteration <br/> PFT </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian <br/> Side effects: 2 participants vomiting in acetylcysteine group, with 1 drop‐out </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0025" title="GaudierB , LelongM . Carbocysteine to treat asthma in children [L'utilisation de la S‐Carboxy Methyl Cystéine (LJ 206) dans l'asthme de l'enfant]. Laboratoires Joullie, Paris1968. ">Gaudier 1968</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50 children (&lt; 15 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral acetylcysteine; <br/> 2 spoons 2%/day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: monitoring (evolution of asthma)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>French</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0026" title="GinocchiG . Clinical effects of a mucolytic agent (Pol 65) in a pediatric statistical study [Effeti clinici di un mucoliyico (Pol 65) in una casistica pediatrica]. Settimana Medica1978;66:391‐408. ">Ginocchi 1978</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial <br/> Antibiotics in 33 children </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44 children (2 months to 13 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral carbocysteine <br/> 2 spoons/day under 5 years; 3 spoons/day above </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, expectoration, sputum viscosity <br/> Biological: blood exam </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0027" title="GusbertiC , BellazziA , LonatiC , ModestiR . Clinical evaluation of a new synthetic derivative of acetylcysteine for treating respiratory inflammations in pediatric patients [Valutazione clinica di uno nuovo derivato sintetico dell'acido acetilsalicilico nella terapia di flogosi respiratorie di pazienti pediatrici]. Archivio di Medicina Interna1985;37:123‐9. ">Gusberti 1985</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> Active treatment (acetylsalicylate of acetylcysteine 4%, 5 ml x 3) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 children (4 months to 13 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral acetylcysteine <br/> 200 mg 3 times a day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, expectoration (difficulty, quantity and quality), temperature <br/> Biological: blood exam </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0028" title="HenocqA , MoreauC , MalletE , SaugerF , Menibus CHde . Changes in IgA levels in nasal mucus after upper respiratory tract diseases in infants treated with carbocysteine [Modifications du taux IgA du mucus nasal au décours des affections des voies aériennes supérieures du nourrisson traitées par la carbocistéine]. Annales d'Oto‐Laryngologie et de Chirurgie Cervico Faciale1985;102:373‐5. ">Henocq 1985</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> Control participants received no treatment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50 children (1 month to 4 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral carbocysteine <br/> 5 ml 2% per 5 kg/day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IgA level</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>French</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0030" title="JeanR , GardairF . Efficacy on expectoration of acetylcysteine nebulization in pediatric patients [Utilisation du Fluimucil antibiotic 750 en aérosols chez le nourisson et l'enfant son efficacité d'expectoration]. Laboratoires Zambon, Paris1982. ">Jean 1982</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial <br/> Thiamphenicol for all participants </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 children (&lt; 10 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inhaled acetylcysteine <br/> 200 mg/day under 3 months <br/> 400 mg/day above </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, expectoration, sputum viscosity, temperature <br/> Bacteriological <br/> X‐ray, PFT, bronchoscopy </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>French</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0031" title="LeupoldW von . Lung function in bronchial asthma during treatment with Mucosolvin [Die lungenfunktion bei asthma bronchiale unter der behandlung mit Mucosolvia]. Das Deutsche Gesundheitswesen1970;25:1400‐2. ">Leupold 1970</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36 children (7 to 16 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inhaled acetylcysteine <br/> 15 min: 18 participants at 20% and 18 participants at 10% </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: monitoring <br/> PFT </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>German</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0032" title="Loscialpo RamundoD . On the use of the association of acetylcysteine and thiamphenicol glycinate in some pediatric pulmonary diseases [Sull'impiego associazone acetilcisteina‐tiamfenicolo glicinato in alcune forme di patologia polmonare pediatrica]. Clinical Pediatrics1968;50:43‐56. ">Loscialpo Ramundo 1968</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial <br/> Thiamphenicol for all participants </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84 children (2 to 12 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inhaled acetylcysteine <br/> 1.5 ml 10% above 5 years <br/> 3 ml 10 % under (the first 5 days twice a day then once a day) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, fever <br/> Biological: blood exam <br/> X‐ray </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0004" title="MalkaM , Lablache CombierB . Carbocysteine in the treatment of acute bronchitis in children [Interet d'un mucolytique, la carbocistéine, dans la bronchite aiguë de l'enfant]. Medicina Infantil1990;97:687‐92. ">Malka 1990</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> All participants received antibiotics if necessary </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106 children (all &gt; 2 years); all participants received antibiotics if necessary</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral carbocysteine; <br/> 200 mg/day under 5 years <br/> 300 mg/day above for 7 days </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, expectoration, bronchial congestion, dyspnoea <br/> PFT </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>French <br/> 9 participants with side effects (in the carbocysteine group: 2 nausea, 3 diarrhoea, 1 stomach pain; in the placebo group: 1 nausea, 2 stomach pain) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0033" title="MayaudC , LentschnerC , BouchouchaS , MarsacJ . Thiamphenicol glycinate acetylcysteinate in the treatment of acute respiratory infections with mucostasis [L'acetylcysteinate de thiamphenicol glycinate dans le traitement des infections respiratoires aigues avec mucostase]. European Journal of Respiratory Diseases Supplement1980;61(111):70‐3. ">Mayaud 1980</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial <br/> Thiamphenicol for all participants </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>112 children (&lt; 8 years; 33: &lt; 1 year)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral and intramuscular acetylcysteine <br/> 50 mg/kg/day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: fever, expectoration (quality); <br/> Biological: blood exam <br/> Bacteriological: quality of sputum <br/> X‐ray </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>French</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0034" title="MichaelP , HaaseW . Treatment of acute and chronic bronchitis. Therapeutic experience with Pulmoclase [Behandlung akuter und chronischer bronchitis. Therapeutische erfahrungen mit Pulmoclase]. Therapiewoche1986;36:4440‐5. ">Michael 1986</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>374 children (mean: 5 years +/‐ 3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral carbocysteine; <br/> 500 mg/day under 4 years <br/> 750 mg/day above </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, sputum viscosity, expectoration, breathing</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>German</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0005" title="NakayamaY , MaedaK , FuanabashiS , KubagawaT , SimanugiK , TatenoK , et al. Carbocysteine syrup in pediatrics: a clinical trial [Effets cliniques de s‐carboxymethylcysteine sous forme de sirop en pédiatrie (traduction)]. Japanese Journal of Pediatrics1977;10:1823. ">Nakayama 1977</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> Patients received bronchodilators, antibiotics, antihistamine if previously treated </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152 children (0 to 18 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral carbocysteine; <br/> 30 mg/kg/day (in 3 to 4 doses a day for 7 days) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: overall assessment, cough, stridor, expectoration <br/> PFT </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>French</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adequate</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0036" title="NikolicP , KoracD . The influence of acetylcysteine on respiratory functions in children with recurrent bronchitis. European Journal of Respiratory Diseases Supplement1980;61(111):141. ">Nikolic 1980</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20 children (3 to 14 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral acetylcysteine <br/> 100 to 200 mg 3 times a day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical <br/> PFT </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>English</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0040" title="RamenghiM , SabayiniG , MengoniM . Combined antibiotic plus mucolytic treatment for recurrent bronchial diseases in infancy. Current Therapeutic Research1984;36:664‐7. ">Ramenghi 1984</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial <br/> Cefuroxim for all participants </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20 children (10 months to 2 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intramuscular acetylcysteine <br/> 15 mg/kg/day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, rale, vesicular murmur, irritability, hypo‐alimentation <br/> Biological: blood exam <br/> Bacteriological: on pharyngotracheal aspirate </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>English</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0044" title="SantangeloG , LombardoS , GiannottiG . A combination of cefuroxime and N‐acetyl‐cysteine for the treatment of lower respiratory tract infections in children. International Journal of Clinical Pharmacology, Therapy, and Toxicology1985;23:279‐81. ">Santangelo 1985</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial <br/> Cefuroxim for all participants </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>103 children (2 months to 11 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intramuscular acetylcysteine; 20 to 30 mg/kg/day</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: monitoring <br/> Bacteriological: secretion cultures; X‐ray </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>English</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0046" title="TrastotenojoMS , HarsoyoN , SachroAD , SoemantriAG , SaidHW . Use of acetyl cysteine in respiratory tract disease in children. Paediatrica Indonesiana1984;24:1‐10. ">Trastotenojo 1984</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Controlled trial <br/> Antibiotics and bronchodilator if necessary </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60 children (2 months to 13 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral acetylcysteine 100 mg 3 times a day</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, findings on auscultation; <br/> Biological: blood exam <br/> X‐ray </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>English</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0006" title="ZaniniA , DodesniG . Lisomucil in pediatrics [Il lisomucil in campo pediatrico]. Clinica Europea1974;13:1‐12. ">Zanini 1974</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> In treatment group 15 children received antibiotics + 4 inhaled acetylcysteine; in control group 8 children received antibiotics </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 children (18 &lt; 1 year; 12 &gt; 1 year)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral carbocysteine from 100 to 400 mg/day depending on age for 5 to 9 days</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, temperature level, appetite, general condition</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>RCT: randomised controlled trial <br/> PFT: pulmonary function tests <br/> ESR: erythrocyte sedimentation rate </p> </div> </div> <p>Among these 28 studies, 11 were written in Italian (<a href="./references#CD003124-bbs2-0009" title="BaldiniG , GucciM , TaroD , MemminiC . Controlled clinical study of a new Ambroxol formula in the treatment of infantile spastic bronchitis [Studio clinico controllato sull'attivita di una nuova formulazione di Ambroxol nella bronchite asmatiforme del bambino]. Minerva Pediatrica1989;41:91‐5. ">Baldini 1989</a>; <a href="./references#CD003124-bbs2-0012" title="BellomoG , FrigerioG , TirantelloG . Controlled study on the use of intramuscular acetylcysteine in acute respiratory infections in pediatrics [Ricerche controllate sull'impiego dell'acetilcisteina per via intramuscolare nelle infezioni respiratorie acute in pediatria]. Clinica Terapeutica1967;43:437‐58. ">Bellomo 1967a</a>; <a href="./references#CD003124-bbs2-0013" title="BellomoG , TirantelloG , GiudiceS . On the use of a combination of acetylcysteine with thiamphenicol glycinate in the systemic treatment of bronchopulmonary infections in children [Sull'uso di una combinazione dell'acetilcysteina con tiamfenicolo glicato nel trattamento sistemico delle infezioni broncopolmonari in eta' pediatrica]. Clinical Pediatrics1967;49:402‐24. ">Bellomo 1967b</a>; <a href="./references#CD003124-bbs2-0014" title="BellomoG , GiudiceS , GanciC . Comparative study of the efficacy of acetylcysteine by the oral and intramuscular routes in acute respiratory affections in pediatrics [Studio comparativo dell'efficacia dell'acetilcisteina per via orale ed intramuscolare nelle affezioni respiratorie acute in pediatria]. Minerva Pediatrica1973;25:844‐9. ">Bellomo 1973</a>; <a href="./references#CD003124-bbs2-0016" title="BerniM , CollinaA , ZavattiniG . Ambroxol in bronchopulmonary pathology in children [Ambroxol nella patologia broncopolmonare del bambino]. Clinica Terapeutica1983;106:351‐5. ">Berni 1983</a>; <a href="./references#CD003124-bbs2-0018" title="CamurriS , MarencoG . Clinical evaluation of the safety and efficacy of a new pharmaceutical formulation of bromhexine compared to N‐acetylcysteine in pediatric patients with acute bronchitis [Valutazione clinica dell'efficacia e della tollerabilita della nuova formulazione farmaceutica bromessina granulare nei confronti dell'N‐acetilcisteina granulare in piccoli pazienti affetti da bronchite acuta]. Gazzetta Medica Italiana1990;149:45‐8. ">Camurri 1990</a>; <a href="./references#CD003124-bbs2-0020" title="CaredduP , BernocchiD , ScottiL , ManiniG , MezzopaneA . Therapeutic activity and tolerability of a new mucoregulating drug called nesosteine in the treatment of acute diseases of the respiratory apparatus. Controlled pediatric study vs carbocysteine [Attivita terapeutica e tollerabilita di un nuovo farmaco mucoregolatore denominato nesosteina nel trattamento di affezioni acute dell'apparato respiratorio studio pediatrico controllato vs carbocisteina]. Giornale Italiano Delle Malattie Del Torace1989;43:47‐52. ">Careddu 1989</a>; <a href="./references#CD003124-bbs2-0021" title="CastelloD , CostaG , deCandussioG . Modifications in catarrhal bronchitis secretion in paediatric age following treatment with S‐carboxymethyl‐cystein (viscosimetric study) [Modificazioni dell'escreato nella bronchite catarrale in eta pediatrica dopo trattamento con S‐carbossimetilcisteina (indagine viscosimetrica)]. Minerva Pediatrica1979;31:371‐80. ">Castello 1979</a> ; <a href="./references#CD003124-bbs2-0026" title="GinocchiG . Clinical effects of a mucolytic agent (Pol 65) in a pediatric statistical study [Effeti clinici di un mucoliyico (Pol 65) in una casistica pediatrica]. Settimana Medica1978;66:391‐408. ">Ginocchi 1978</a>; <a href="./references#CD003124-bbs2-0027" title="GusbertiC , BellazziA , LonatiC , ModestiR . Clinical evaluation of a new synthetic derivative of acetylcysteine for treating respiratory inflammations in pediatric patients [Valutazione clinica di uno nuovo derivato sintetico dell'acido acetilsalicilico nella terapia di flogosi respiratorie di pazienti pediatrici]. Archivio di Medicina Interna1985;37:123‐9. ">Gusberti 1985</a>; <a href="./references#CD003124-bbs2-0032" title="Loscialpo RamundoD . On the use of the association of acetylcysteine and thiamphenicol glycinate in some pediatric pulmonary diseases [Sull'impiego associazone acetilcisteina‐tiamfenicolo glicinato in alcune forme di patologia polmonare pediatrica]. Clinical Pediatrics1968;50:43‐56. ">Loscialpo Ramundo 1968</a>), seven in English (<a href="./references#CD003124-bbs2-0017" title="BonerAL , VallettaEA , StoccheroL , RichelliC , BennatiD . Combined antibiotic plus mucolytic treatment of acute or recurrent pneumonia in children. Drugs Under Experimental and Clinical Research1984;10:627‐30. ">Boner 1984</a>; <a href="./references#CD003124-bbs2-0019" title="CaramiaG , BizzarriV , CompagnoniL , GregoriniS . Combined antibiotic plus mucolytic treatment in broncho‐pulmonary disease: cefuroxime plus acetylcysteine. Current Therapeutic Research, Clinical and Experimental1984;36:658‐63. ">Caramia 1984</a>; <a href="./references#CD003124-bbs2-0023" title="DanoG . Bronchospasm caused by acetylcysteine in children with bronchial asthma. Acta Allergologica1971;26:181‐90. ">Dano 1971</a>; <a href="./references#CD003124-bbs2-0036" title="NikolicP , KoracD . The influence of acetylcysteine on respiratory functions in children with recurrent bronchitis. European Journal of Respiratory Diseases Supplement1980;61(111):141. ">Nikolic 1980</a>; <a href="./references#CD003124-bbs2-0040" title="RamenghiM , SabayiniG , MengoniM . Combined antibiotic plus mucolytic treatment for recurrent bronchial diseases in infancy. Current Therapeutic Research1984;36:664‐7. ">Ramenghi 1984</a>; <a href="./references#CD003124-bbs2-0044" title="SantangeloG , LombardoS , GiannottiG . A combination of cefuroxime and N‐acetyl‐cysteine for the treatment of lower respiratory tract infections in children. International Journal of Clinical Pharmacology, Therapy, and Toxicology1985;23:279‐81. ">Santangelo 1985</a>; <a href="./references#CD003124-bbs2-0046" title="TrastotenojoMS , HarsoyoN , SachroAD , SoemantriAG , SaidHW . Use of acetyl cysteine in respiratory tract disease in children. Paediatrica Indonesiana1984;24:1‐10. ">Trastotenojo 1984</a>), six in French (<a href="./references#CD003124-bbs2-0008" title="Anonymous . A study of tolerance of carbocisteine syrup in children [Etude de la tolérance clinique du sirop carbocistéine chez l'enfant]. Dossier d'autorisation de mise sur le marché, Laboratoires Alpharma, Aubervilliers, France1987. ">Anonymous 1987</a>; <a href="./references#CD003124-bbs2-0022" title="ChalumeauM , CheronG , assathianyR , MoulinF , BavouxF , BreartG , et al. Mucolytic agents for acute respiratory tract infections in infants: a pharmacoepidemiologic problem? [Fluidifiants bronchiques dans les infections respiratoires aiguës du nourrisson: un problème pharmacoépidémiologique?]. Archives de Pédiatrie2002;9:1128‐36. ">Chalumeau 2002</a>; <a href="./references#CD003124-bbs2-0025" title="GaudierB , LelongM . Carbocysteine to treat asthma in children [L'utilisation de la S‐Carboxy Methyl Cystéine (LJ 206) dans l'asthme de l'enfant]. Laboratoires Joullie, Paris1968. ">Gaudier 1968</a>; <a href="./references#CD003124-bbs2-0028" title="HenocqA , MoreauC , MalletE , SaugerF , Menibus CHde . Changes in IgA levels in nasal mucus after upper respiratory tract diseases in infants treated with carbocysteine [Modifications du taux IgA du mucus nasal au décours des affections des voies aériennes supérieures du nourrisson traitées par la carbocistéine]. Annales d'Oto‐Laryngologie et de Chirurgie Cervico Faciale1985;102:373‐5. ">Henocq 1985</a>; <a href="./references#CD003124-bbs2-0030" title="JeanR , GardairF . Efficacy on expectoration of acetylcysteine nebulization in pediatric patients [Utilisation du Fluimucil antibiotic 750 en aérosols chez le nourisson et l'enfant son efficacité d'expectoration]. Laboratoires Zambon, Paris1982. ">Jean 1982</a>; <a href="./references#CD003124-bbs2-0033" title="MayaudC , LentschnerC , BouchouchaS , MarsacJ . Thiamphenicol glycinate acetylcysteinate in the treatment of acute respiratory infections with mucostasis [L'acetylcysteinate de thiamphenicol glycinate dans le traitement des infections respiratoires aigues avec mucostase]. European Journal of Respiratory Diseases Supplement1980;61(111):70‐3. ">Mayaud 1980</a>), two in German (<a href="./references#CD003124-bbs2-0031" title="LeupoldW von . Lung function in bronchial asthma during treatment with Mucosolvin [Die lungenfunktion bei asthma bronchiale unter der behandlung mit Mucosolvia]. Das Deutsche Gesundheitswesen1970;25:1400‐2. ">Leupold 1970</a>; <a href="./references#CD003124-bbs2-0034" title="MichaelP , HaaseW . Treatment of acute and chronic bronchitis. Therapeutic experience with Pulmoclase [Behandlung akuter und chronischer bronchitis. Therapeutische erfahrungen mit Pulmoclase]. Therapiewoche1986;36:4440‐5. ">Michael 1986</a>) and two in Slovak (<a href="./references#CD003124-bbs2-0010" title="BanovcinP . Efficacy of carbocysteine in the treatment of bronchopneumonias in children. Prakticky Lekar1990;70:885‐7. ">Banovcin 1990</a>; <a href="./references#CD003124-bbs2-0011" title="BanovcinP , JakusovaL , RosslerovaV , MiklerovaM , PullmanR . Carbocysteine in the treatment of recurrent bronchitis in infants [Karbocystein v liecbe recidivujucich bronchitid u dojciat]. Ceskoslovenska Pediatrie1992;47:543‐6. ">Banovcin 1992</a>). Except for a targeted pharmacovigilance study (<a href="./references#CD003124-bbs2-0022" title="ChalumeauM , CheronG , assathianyR , MoulinF , BavouxF , BreartG , et al. Mucolytic agents for acute respiratory tract infections in infants: a pharmacoepidemiologic problem? [Fluidifiants bronchiques dans les infections respiratoires aiguës du nourrisson: un problème pharmacoépidémiologique?]. Archives de Pédiatrie2002;9:1128‐36. ">Chalumeau 2002</a>), the studies were at least 15 years old (median = 23 years). The route of administration was oral in 16 studies, intramuscular in six, inhaled in four, and both oral and intramuscular in two. </p> </section> </section> <section id="CD003124-sec-0057"> <h4 class="title">Excluded studies</h4> <p>We excluded 44 studies (see <a href="./references#CD003124-sec-0102" title="">Characteristics of excluded studies</a>) for different reasons: active control treatment, chronic disease, no control group, no placebo, no randomisation and/or type of outcome measures. </p> </section> </section> <section id="CD003124-sec-0058"> <h3 class="title">Risk of bias in included studies</h3> <p>Because the studies dated mainly from at least 15 to 40 years ago (median = 26 years) we were not successful in obtaining additional trial data. </p> <p>The risk of bias of the six studies included to evaluate efficacy is mentioned in the 'Risk of bias' table (<a href="#CD003124-fig-0001">Figure 1</a>; <a href="#CD003124-fig-0002">Figure 2</a>). One study had a 'low risk of bias' for all items except for 'incomplete outcome data' for which we judged the risk of bias as 'high' (<a href="./references#CD003124-bbs2-0005" title="NakayamaY , MaedaK , FuanabashiS , KubagawaT , SimanugiK , TatenoK , et al. Carbocysteine syrup in pediatrics: a clinical trial [Effets cliniques de s‐carboxymethylcysteine sous forme de sirop en pédiatrie (traduction)]. Japanese Journal of Pediatrics1977;10:1823. ">Nakayama 1977</a>). </p> <div class="figure" id="CD003124-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD003124-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD003124-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD003124-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD003124-sec-0059"> <h4 class="title">Allocation</h4> <p>Four studies did not report sufficient details on randomisation and allocation concealment to make meaningful conclusions (<a href="./references#CD003124-bbs2-0001" title="BellomoG , GiudiceS . Controlled study on the efficacy of a combination &quot;thiamphenicol‐acetylcysteine&quot; in oral administration in respiratory infections in pediatrics [Studio controllata sull'efficacia della combinazione &quot;tiamfenicolo‐acetilcisteina&quot; per via orale nel trattamento delle infezioni broncopolmonari dell'infanzia]. Clinical Pediatrics1972;54:30‐51. ">Bellomo 1972</a>; <a href="./references#CD003124-bbs2-0002" title="BiscattiG , BruschelliM , DamonteG , CapozziF . Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics [Ricerca controllata sugli effetti clinici dell'acetilcisteina per via orale nelle infezioni respiratorie in pediatria]. Minerva Pediatrica1972;24:1075‐84. ">Biscatti 1972</a>; <a href="./references#CD003124-bbs2-0003" title="FiocchiA , VignatiB , SalaM , ArancioR , BanderaliG , MarangioneP , et al. A new n‐acetylcysteine formulation in acute bronchopneumopathy in children [La n‐acetilcisteina nel trattamento delle broncopneumopatie acute in pediatria]. Giornale Italiano delle Malattie del Torace1989;43:327‐34. ">Fiocchi 1989</a>; <a href="./references#CD003124-bbs2-0006" title="ZaniniA , DodesniG . Lisomucil in pediatrics [Il lisomucil in campo pediatrico]. Clinica Europea1974;13:1‐12. ">Zanini 1974</a>). Only one study had low risk of bias for random sequence generation and allocation concealment (<a href="./references#CD003124-bbs2-0005" title="NakayamaY , MaedaK , FuanabashiS , KubagawaT , SimanugiK , TatenoK , et al. Carbocysteine syrup in pediatrics: a clinical trial [Effets cliniques de s‐carboxymethylcysteine sous forme de sirop en pédiatrie (traduction)]. Japanese Journal of Pediatrics1977;10:1823. ">Nakayama 1977</a>). For the last study the investigators did not respect the randomisation list, and therefore we classified it as having a high risk of bias (<a href="./references#CD003124-bbs2-0004" title="MalkaM , Lablache CombierB . Carbocysteine in the treatment of acute bronchitis in children [Interet d'un mucolytique, la carbocistéine, dans la bronchite aiguë de l'enfant]. Medicina Infantil1990;97:687‐92. ">Malka 1990</a>). </p> </section> <section id="CD003124-sec-0060"> <h4 class="title">Blinding</h4> <p>Four studies did not report sufficient details on blinding to make meaningful conclusions (<a href="./references#CD003124-bbs2-0001" title="BellomoG , GiudiceS . Controlled study on the efficacy of a combination &quot;thiamphenicol‐acetylcysteine&quot; in oral administration in respiratory infections in pediatrics [Studio controllata sull'efficacia della combinazione &quot;tiamfenicolo‐acetilcisteina&quot; per via orale nel trattamento delle infezioni broncopolmonari dell'infanzia]. Clinical Pediatrics1972;54:30‐51. ">Bellomo 1972</a>; <a href="./references#CD003124-bbs2-0002" title="BiscattiG , BruschelliM , DamonteG , CapozziF . Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics [Ricerca controllata sugli effetti clinici dell'acetilcisteina per via orale nelle infezioni respiratorie in pediatria]. Minerva Pediatrica1972;24:1075‐84. ">Biscatti 1972</a>; <a href="./references#CD003124-bbs2-0003" title="FiocchiA , VignatiB , SalaM , ArancioR , BanderaliG , MarangioneP , et al. A new n‐acetylcysteine formulation in acute bronchopneumopathy in children [La n‐acetilcisteina nel trattamento delle broncopneumopatie acute in pediatria]. Giornale Italiano delle Malattie del Torace1989;43:327‐34. ">Fiocchi 1989</a>; <a href="./references#CD003124-bbs2-0004" title="MalkaM , Lablache CombierB . Carbocysteine in the treatment of acute bronchitis in children [Interet d'un mucolytique, la carbocistéine, dans la bronchite aiguë de l'enfant]. Medicina Infantil1990;97:687‐92. ">Malka 1990</a>). For one study, we assessed a low risk of bias because all the blinding conditions were clearly mentioned and respected (<a href="./references#CD003124-bbs2-0005" title="NakayamaY , MaedaK , FuanabashiS , KubagawaT , SimanugiK , TatenoK , et al. Carbocysteine syrup in pediatrics: a clinical trial [Effets cliniques de s‐carboxymethylcysteine sous forme de sirop en pédiatrie (traduction)]. Japanese Journal of Pediatrics1977;10:1823. ">Nakayama 1977</a>). For the last study, authors "had noticed the better efficacy of one of the products in looking clinically at the therapeutic results" and so we assessed this as a high risk of bias (<a href="./references#CD003124-bbs2-0006" title="ZaniniA , DodesniG . Lisomucil in pediatrics [Il lisomucil in campo pediatrico]. Clinica Europea1974;13:1‐12. ">Zanini 1974</a>). </p> </section> <section id="CD003124-sec-0061"> <h4 class="title">Incomplete outcome data</h4> <p>In four studies, analyses were based on the data of all included patients, and therefore we assessed them as having a low risk of bias (<a href="./references#CD003124-bbs2-0002" title="BiscattiG , BruschelliM , DamonteG , CapozziF . Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics [Ricerca controllata sugli effetti clinici dell'acetilcisteina per via orale nelle infezioni respiratorie in pediatria]. Minerva Pediatrica1972;24:1075‐84. ">Biscatti 1972</a>; <a href="./references#CD003124-bbs2-0003" title="FiocchiA , VignatiB , SalaM , ArancioR , BanderaliG , MarangioneP , et al. A new n‐acetylcysteine formulation in acute bronchopneumopathy in children [La n‐acetilcisteina nel trattamento delle broncopneumopatie acute in pediatria]. Giornale Italiano delle Malattie del Torace1989;43:327‐34. ">Fiocchi 1989</a>; <a href="./references#CD003124-bbs2-0004" title="MalkaM , Lablache CombierB . Carbocysteine in the treatment of acute bronchitis in children [Interet d'un mucolytique, la carbocistéine, dans la bronchite aiguë de l'enfant]. Medicina Infantil1990;97:687‐92. ">Malka 1990</a>; <a href="./references#CD003124-bbs2-0006" title="ZaniniA , DodesniG . Lisomucil in pediatrics [Il lisomucil in campo pediatrico]. Clinica Europea1974;13:1‐12. ">Zanini 1974</a>). For one study, it was mentioned that not all the patients were included in the analysis (<a href="./references#CD003124-bbs2-0005" title="NakayamaY , MaedaK , FuanabashiS , KubagawaT , SimanugiK , TatenoK , et al. Carbocysteine syrup in pediatrics: a clinical trial [Effets cliniques de s‐carboxymethylcysteine sous forme de sirop en pédiatrie (traduction)]. Japanese Journal of Pediatrics1977;10:1823. ">Nakayama 1977</a>). </p> </section> <section id="CD003124-sec-0062"> <h4 class="title">Selective reporting</h4> <p>All studies were considered as having a low risk of reporting bias because they all mentioned relevant outcomes. </p> </section> <section id="CD003124-sec-0063"> <h4 class="title">Other potential sources of bias</h4> <p>None.</p> </section> </section> <section id="CD003124-sec-0064"> <h3 class="title" id="CD003124-sec-0064">Effects of interventions</h3> <section id="CD003124-sec-0065"> <h4 class="title">1. Efficacy</h4> <p>The six included trials involved 497 participants and compared cysteine derivatives with placebo (<a href="./references#CD003124-bbs2-0001" title="BellomoG , GiudiceS . Controlled study on the efficacy of a combination &quot;thiamphenicol‐acetylcysteine&quot; in oral administration in respiratory infections in pediatrics [Studio controllata sull'efficacia della combinazione &quot;tiamfenicolo‐acetilcisteina&quot; per via orale nel trattamento delle infezioni broncopolmonari dell'infanzia]. Clinical Pediatrics1972;54:30‐51. ">Bellomo 1972</a>; <a href="./references#CD003124-bbs2-0002" title="BiscattiG , BruschelliM , DamonteG , CapozziF . Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics [Ricerca controllata sugli effetti clinici dell'acetilcisteina per via orale nelle infezioni respiratorie in pediatria]. Minerva Pediatrica1972;24:1075‐84. ">Biscatti 1972</a>; <a href="./references#CD003124-bbs2-0003" title="FiocchiA , VignatiB , SalaM , ArancioR , BanderaliG , MarangioneP , et al. A new n‐acetylcysteine formulation in acute bronchopneumopathy in children [La n‐acetilcisteina nel trattamento delle broncopneumopatie acute in pediatria]. Giornale Italiano delle Malattie del Torace1989;43:327‐34. ">Fiocchi 1989</a>; <a href="./references#CD003124-bbs2-0004" title="MalkaM , Lablache CombierB . Carbocysteine in the treatment of acute bronchitis in children [Interet d'un mucolytique, la carbocistéine, dans la bronchite aiguë de l'enfant]. Medicina Infantil1990;97:687‐92. ">Malka 1990</a>; <a href="./references#CD003124-bbs2-0005" title="NakayamaY , MaedaK , FuanabashiS , KubagawaT , SimanugiK , TatenoK , et al. Carbocysteine syrup in pediatrics: a clinical trial [Effets cliniques de s‐carboxymethylcysteine sous forme de sirop en pédiatrie (traduction)]. Japanese Journal of Pediatrics1977;10:1823. ">Nakayama 1977</a>; <a href="./references#CD003124-bbs2-0006" title="ZaniniA , DodesniG . Lisomucil in pediatrics [Il lisomucil in campo pediatrico]. Clinica Europea1974;13:1‐12. ">Zanini 1974</a>). </p> <section id="CD003124-sec-0066"> <h5 class="title">1.a Analysis of included studies with acetylcysteine</h5> <p>Acetylcysteine was tested in three trials (<a href="./references#CD003124-bbs2-0001" title="BellomoG , GiudiceS . Controlled study on the efficacy of a combination &quot;thiamphenicol‐acetylcysteine&quot; in oral administration in respiratory infections in pediatrics [Studio controllata sull'efficacia della combinazione &quot;tiamfenicolo‐acetilcisteina&quot; per via orale nel trattamento delle infezioni broncopolmonari dell'infanzia]. Clinical Pediatrics1972;54:30‐51. ">Bellomo 1972</a>; <a href="./references#CD003124-bbs2-0002" title="BiscattiG , BruschelliM , DamonteG , CapozziF . Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics [Ricerca controllata sugli effetti clinici dell'acetilcisteina per via orale nelle infezioni respiratorie in pediatria]. Minerva Pediatrica1972;24:1075‐84. ">Biscatti 1972</a>; <a href="./references#CD003124-bbs2-0003" title="FiocchiA , VignatiB , SalaM , ArancioR , BanderaliG , MarangioneP , et al. A new n‐acetylcysteine formulation in acute bronchopneumopathy in children [La n‐acetilcisteina nel trattamento delle broncopneumopatie acute in pediatria]. Giornale Italiano delle Malattie del Torace1989;43:327‐34. ">Fiocchi 1989</a>) with a total of 209 participants. The first study included 59 patients with acute bronchitis or broncho‐pulmonary infections and compared oral administration of the antibiotic‐mucolytic combination (thiamphenicol glycinate acetylcysteinate) (n<sub>1</sub> = 30) with thiamphenicol alone (n<sub>2</sub> = 29) as an active control at the dose of 14 mg/kg/day of acetylcysteine with a duration of treatment of six days (<a href="./references#CD003124-bbs2-0001" title="BellomoG , GiudiceS . Controlled study on the efficacy of a combination &quot;thiamphenicol‐acetylcysteine&quot; in oral administration in respiratory infections in pediatrics [Studio controllata sull'efficacia della combinazione &quot;tiamfenicolo‐acetilcisteina&quot; per via orale nel trattamento delle infezioni broncopolmonari dell'infanzia]. Clinical Pediatrics1972;54:30‐51. ">Bellomo 1972</a>). There was total remission of febrile state, dyspnoea, "thoracic semeiologic alterations" (i.e., "wheezing breathing", rattling) and cough in both groups. However, there was a statistically significant more rapid remission in the group treated with the antibiotic‐mucolytic combination. For example, there was total remission of febrile state in the treated group after six days, but it took nine days for the recovery of all the patients in the placebo group (P = 0.03). </p> <p>The second study included patients with acute upper and lower respiratory tract infections (RTIs) and compared oral administration of acetylcysteine (n<sub>1</sub> = 25) and placebo (n<sub>2</sub> = 25) at a daily dose of 100 to 300 mg of acetylcysteine, depending on age, for six days (<a href="./references#CD003124-bbs2-0002" title="BiscattiG , BruschelliM , DamonteG , CapozziF . Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics [Ricerca controllata sugli effetti clinici dell'acetilcisteina per via orale nelle infezioni respiratorie in pediatria]. Minerva Pediatrica1972;24:1075‐84. ">Biscatti 1972</a>). All participants received some kind of antibiotic. The clinical parameters returned to normal in a statistically significant shorter time in the acetylcysteine group. For example, by the end of the treatment (six days), the remission of cough was total in the treated group whereas the cough persisted in 16% of the participants in the placebo group (risk difference (RD) ‐16%, 95% confidence interval (CI) ‐31% to ‐1%), risk ratio (RR) 0.11 (95% CI 0.01 to 1.95). </p> <p>The third study compared oral acetylcysteine (n<sub>1</sub> = 50) with placebo (n<sub>2</sub> = 50) at a daily dose of 20 mg/kg, subdivided into three daily administrations for 28 days in children with bronchitis or tracheitis (<a href="./references#CD003124-bbs2-0003" title="FiocchiA , VignatiB , SalaM , ArancioR , BanderaliG , MarangioneP , et al. A new n‐acetylcysteine formulation in acute bronchopneumopathy in children [La n‐acetilcisteina nel trattamento delle broncopneumopatie acute in pediatria]. Giornale Italiano delle Malattie del Torace1989;43:327‐34. ">Fiocchi 1989</a>). Participants received antibiotics if necessary. Clinical improvement was observed in the four groups by the end of the trial. In the subgroup of children with bronchitis, statistically significant differences in the clinical parameters (cough score, cough productivity and thoracic semeiologic alterations) were recorded favourably for the acetylcysteine treatment. For example, the median cough score (range = 0 to 3) decreased faster in the treated group with a difference before/after of 2.1 (2.20 to 0.10), whereas in the placebo group the median score dropped from 2.20 to 0.50 (P &lt; 0.05). </p> <p>In the subgroup of children with tracheitis, no statistically significant differences were noted on the various clinical parameters, except a statistically significant improvement of the cough score, with a difference before/after of 2.00 (2.10 to 0.10) in the acetylcysteine treatment subgroup and 1.60 (2.10 to 0.50) in the placebo group (P &lt; 0.05). We performed a comparison of the two groups (<a href="./references#CD003124-fig-0011" title="">Analysis 2.3</a>; <a href="./references#CD003124-fig-0012" title="">Analysis 2.4</a>; <a href="./references#CD003124-fig-0018" title="">Analysis 4.4</a>; <a href="./references#CD003124-fig-0019" title="">Analysis 4.5</a>; <a href="./references#CD003124-fig-0022" title="">Analysis 6.1</a>; <a href="./references#CD003124-fig-0023" title="">Analysis 6.2</a>): the treatment reduced the risk of "thoracic semeiologic alterations" by 83% (RR 0.17, 95% CI 0.03 to 0.99) (<a href="./references#CD003124-fig-0019" title="">Analysis 4.5</a>) and the RD at the end of the treatment was statistically significant: RD ‐14% (‐25% to ‐3%). The number needed to treat to benefit (NNTB) was eight (4 to 34). Regarding cough, the RD was ‐3% (‐13% to 7%) and the RR 0.67 (95% CI 0.16 to 2.76) (<a href="./references#CD003124-fig-0012" title="">Analysis 2.4</a>). At the end of the trial, productive cough was still present in three participants treated with acetylcysteine versus seven patients in the placebo group. The RD was not statistically significant though: RD ‐8% (‐20% to 3%) and the RR 0.41 (95% CI 0.11 to 1.56). </p> </section> <section id="CD003124-sec-0067"> <h5 class="title">1.b Analysis of included studies with carbocysteine</h5> <p>Carbocysteine was tested in three of the six included studies (<a href="./references#CD003124-bbs2-0004" title="MalkaM , Lablache CombierB . Carbocysteine in the treatment of acute bronchitis in children [Interet d'un mucolytique, la carbocistéine, dans la bronchite aiguë de l'enfant]. Medicina Infantil1990;97:687‐92. ">Malka 1990</a>; <a href="./references#CD003124-bbs2-0005" title="NakayamaY , MaedaK , FuanabashiS , KubagawaT , SimanugiK , TatenoK , et al. Carbocysteine syrup in pediatrics: a clinical trial [Effets cliniques de s‐carboxymethylcysteine sous forme de sirop en pédiatrie (traduction)]. Japanese Journal of Pediatrics1977;10:1823. ">Nakayama 1977</a>; <a href="./references#CD003124-bbs2-0006" title="ZaniniA , DodesniG . Lisomucil in pediatrics [Il lisomucil in campo pediatrico]. Clinica Europea1974;13:1‐12. ">Zanini 1974</a>) with a total of 288 participants. The first study included 106 participants with acute bronchitis, and compared oral administration of carbocysteine (n<sub>1</sub> = 49) with placebo (n<sub>2</sub> = 57) at a dose of 200 to 300 mg/day, depending on age, for seven days (<a href="./references#CD003124-bbs2-0004" title="MalkaM , Lablache CombierB . Carbocysteine in the treatment of acute bronchitis in children [Interet d'un mucolytique, la carbocistéine, dans la bronchite aiguë de l'enfant]. Medicina Infantil1990;97:687‐92. ">Malka 1990</a>). Both groups received antibiotics if necessary. The clinical symptoms (cough, expectoration, bronchial congestion, dyspnoea) and pulmonary function test abnormalities diminished in both groups. Significant differences between the two groups were observed for expectoration and pulmonary function tests. For example, after four days, expectoration was easier for 69% of the treated participants versus 49% of the participants of the placebo group (RD 23% (1% to 47%)). </p> <p>The second study included 152 participants with respiratory diseases (bronchial asthma or acute bronchitis) and compared oral administration of carbocysteine (n<sub>1</sub> = 74) with placebo (n<sub>2</sub> = 78) at a dose of 30 mg/kg/day, three to four times daily for seven days (<a href="./references#CD003124-bbs2-0005" title="NakayamaY , MaedaK , FuanabashiS , KubagawaT , SimanugiK , TatenoK , et al. Carbocysteine syrup in pediatrics: a clinical trial [Effets cliniques de s‐carboxymethylcysteine sous forme de sirop en pédiatrie (traduction)]. Japanese Journal of Pediatrics1977;10:1823. ">Nakayama 1977</a>). Both groups received bronchodilators, antibiotics and antihistamines if previously treated. The author reported improvement in clinical symptoms in both groups: global impression, cough, stridor, expectoration. The difference in improvement for overall assessment, stridor and expectoration was statistically significant in favour of the treatment group, but the data were available only for the outcome "overall assessment". The analysis of these data showed a RD of 17% (3% to 31%) and a NNTB of six (4 to 32). </p> <p>The third study included 30 participants with respiratory infections (such as bronchitis) and compared oral administration of carbocysteine (n<sub>1</sub> = 19) with placebo (n<sub>2</sub> = 11) at a dose of 100 to 400 mg/day according to age for five to nine days (<a href="./references#CD003124-bbs2-0006" title="ZaniniA , DodesniG . Lisomucil in pediatrics [Il lisomucil in campo pediatrico]. Clinica Europea1974;13:1‐12. ">Zanini 1974</a>) in participants hospitalised for acute respiratory infections. Participants in both groups received antibiotics if necessary. Improvement of clinical signs (cough, vomiting/dyspnoea, temperature, appetite, general condition) was observed in both groups, with significant improvement for cough, vomiting and dyspnoea in both groups, but the actual improvement of general condition was better in the placebo group. Though not significant, the RD was 12% (‐24% to 49%) in favour of the placebo group. </p> </section> <section id="CD003124-sec-0068"> <h5 class="title">1.c Pooled analysis</h5> <p>Because we could include very few studies, we have pooled the results of trials involving acetylcysteine and/or carbocysteine. We also considered primary endpoints that were similar but not exactly the same, for example, when the endpoint had close but slightly different dates. As a consequence, we used random‐effects models when both acetylcysteine and carbocysteine were involved and/or when the primary endpoints were not exactly the same. </p> <p>Five major endpoints could be considered for meta‐analysis: febrile state after six days (<a href="./references#CD003124-fig-0007" title="">Analysis 1.1</a>; <a href="./references#CD003124-fig-0008" title="">Analysis 1.2</a>), cough after six to seven days (<a href="./references#CD003124-fig-0009" title="">Analysis 2.1</a>; <a href="./references#CD003124-fig-0010" title="">Analysis 2.2</a>), dyspnoea after six to seven days (<a href="./references#CD003124-fig-0013" title="">Analysis 3.1</a>; <a href="./references#CD003124-fig-0014" title="">Analysis 3.2</a>), thoracic semeiologic alterations after five days (<a href="./references#CD003124-fig-0015" title="">Analysis 4.1</a>; <a href="./references#CD003124-fig-0016" title="">Analysis 4.2</a>; <a href="./references#CD003124-fig-0017" title="">Analysis 4.3</a>) and general condition after six to seven days (<a href="./references#CD003124-fig-0020" title="">Analysis 5.1</a>; <a href="./references#CD003124-fig-0021" title="">Analysis 5.2</a>). </p> <p>We calculated pooled RDs and when possible, pooled RRs to assess these outcomes. Febrile state after six days and cough after six to seven days were evaluated in three trials (<a href="./references#CD003124-bbs2-0001" title="BellomoG , GiudiceS . Controlled study on the efficacy of a combination &quot;thiamphenicol‐acetylcysteine&quot; in oral administration in respiratory infections in pediatrics [Studio controllata sull'efficacia della combinazione &quot;tiamfenicolo‐acetilcisteina&quot; per via orale nel trattamento delle infezioni broncopolmonari dell'infanzia]. Clinical Pediatrics1972;54:30‐51. ">Bellomo 1972</a>; <a href="./references#CD003124-bbs2-0002" title="BiscattiG , BruschelliM , DamonteG , CapozziF . Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics [Ricerca controllata sugli effetti clinici dell'acetilcisteina per via orale nelle infezioni respiratorie in pediatria]. Minerva Pediatrica1972;24:1075‐84. ">Biscatti 1972</a>; <a href="./references#CD003124-bbs2-0006" title="ZaniniA , DodesniG . Lisomucil in pediatrics [Il lisomucil in campo pediatrico]. Clinica Europea1974;13:1‐12. ">Zanini 1974</a>). The first two studies involved acetylcysteine and the last one, carbocysteine, and the outcome was not considered at exactly the same date (after six days or after an average of six days), so we used a random‐effects model. After six days, three participants were still febrile among the participants from the placebo group, whereas none presented fever in the treated group: the pooled RD was ‐5% (‐12% to 2%) (<a href="#CD003124-fig-0003">Figure 3</a>). Then, the RR was 0.21 (95% CI 0.02 to 1.77). Regarding cough, after six to seven days of treatment, the risk difference was ‐10% (‐19% to ‐1%) (<a href="#CD003124-fig-0004">Figure 4</a>) and the NNTB was 10 (6 to 101). The RR was 0.37 (95% CI 0.12 to 1.20). </p> <div class="figure" id="CD003124-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Febrile state (AC vs placebo), outcome: 1.1 Febrile state after 6 days." data-id="CD003124-fig-0003" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Febrile state (AC vs placebo), outcome: 1.1 Febrile state after 6 days. </p> </div> </div> </div> <div class="figure" id="CD003124-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 4 Cough (AC vs placebo), outcome: 4.1 Cough after 6 to 7 days." data-id="CD003124-fig-0004" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 4 Cough (AC vs placebo), outcome: 4.1 Cough after 6 to 7 days. </p> </div> </div> </div> <p>The assessment of the efficacy of acetylcysteine and carbocysteine to treat dyspnoea involved an additional trial (<a href="./references#CD003124-bbs2-0004" title="MalkaM , Lablache CombierB . Carbocysteine in the treatment of acute bronchitis in children [Interet d'un mucolytique, la carbocistéine, dans la bronchite aiguë de l'enfant]. Medicina Infantil1990;97:687‐92. ">Malka 1990</a>). Six participants treated complained of dyspnoea after six to seven days versus nine in the placebo group. The RD was ‐3% (‐9% to 3%) (<a href="#CD003124-fig-0005">Figure 5</a>) and the RR was 0.66 (95% CI 0.25 to 1.74). </p> <div class="figure" id="CD003124-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 3 Dyspnoea (AC or CC versus placebo), outcome: 3.1 Dyspnoea after 6 to 7 days." data-id="CD003124-fig-0005" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 3 Dyspnoea (AC or CC versus placebo), outcome: 3.1 Dyspnoea after 6 to 7 days. </p> </div> </div> </div> <p>We pooled data from two studies to evaluate the efficacy of acetylcysteine in the treatment of thoracic semeiologic alterations (<a href="./references#CD003124-bbs2-0001" title="BellomoG , GiudiceS . Controlled study on the efficacy of a combination &quot;thiamphenicol‐acetylcysteine&quot; in oral administration in respiratory infections in pediatrics [Studio controllata sull'efficacia della combinazione &quot;tiamfenicolo‐acetilcisteina&quot; per via orale nel trattamento delle infezioni broncopolmonari dell'infanzia]. Clinical Pediatrics1972;54:30‐51. ">Bellomo 1972</a>; <a href="./references#CD003124-bbs2-0002" title="BiscattiG , BruschelliM , DamonteG , CapozziF . Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics [Ricerca controllata sugli effetti clinici dell'acetilcisteina per via orale nelle infezioni respiratorie in pediatria]. Minerva Pediatrica1972;24:1075‐84. ">Biscatti 1972</a>). After three days, no treated participant was presenting that symptom versus three in the placebo group; the RD was 6% (‐13% to 2%) (<a href="#CD003124-fig-0006">Figure 6</a>). However, there was heterogeneity between the studies. After using a random‐effects model the RD was ‐5% (‐20% to 10%). </p> <div class="figure" id="CD003124-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 3 Thoracic semeiologic alterations (AC vs placebo), outcome: 3.1 Thoracic semeiologic alterations (after 3 days)." data-id="CD003124-fig-0006" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 3 Thoracic semeiologic alterations (AC vs placebo), outcome: 3.1 Thoracic semeiologic alterations (after 3 days). </p> </div> </div> </div> <p>We also assessed the efficacy on the general condition using the data from two studies involving carbocysteine (<a href="./references#CD003124-bbs2-0005" title="NakayamaY , MaedaK , FuanabashiS , KubagawaT , SimanugiK , TatenoK , et al. Carbocysteine syrup in pediatrics: a clinical trial [Effets cliniques de s‐carboxymethylcysteine sous forme de sirop en pédiatrie (traduction)]. Japanese Journal of Pediatrics1977;10:1823. ">Nakayama 1977</a>; <a href="./references#CD003124-bbs2-0006" title="ZaniniA , DodesniG . Lisomucil in pediatrics [Il lisomucil in campo pediatrico]. Clinica Europea1974;13:1‐12. ">Zanini 1974</a>). After seven days, 24 children were still presenting a deteriorated general condition in the treatment group and 32 in the placebo group. The RD was ‐7% (‐35% to 20%) and the RR was 0.78 (95% CI 0.31 to 1.95). </p> </section> <section id="CD003124-sec-0069"> <h5 class="title">1.d Subgroup analysis of infants under two years</h5> <p>Among the studies with acetylcysteine, <a href="./references#CD003124-bbs2-0001" title="BellomoG , GiudiceS . Controlled study on the efficacy of a combination &quot;thiamphenicol‐acetylcysteine&quot; in oral administration in respiratory infections in pediatrics [Studio controllata sull'efficacia della combinazione &quot;tiamfenicolo‐acetilcisteina&quot; per via orale nel trattamento delle infezioni broncopolmonari dell'infanzia]. Clinical Pediatrics1972;54:30‐51. ">Bellomo 1972</a> studied 22 children under one year of age and 28 children between one and five years of age, and <a href="./references#CD003124-bbs2-0002" title="BiscattiG , BruschelliM , DamonteG , CapozziF . Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics [Ricerca controllata sugli effetti clinici dell'acetilcisteina per via orale nelle infezioni respiratorie in pediatria]. Minerva Pediatrica1972;24:1075‐84. ">Biscatti 1972</a> studied 29 children under two years of age. However, it was not possible to obtain more information about possible differences in results in the different age groups. </p> <p>Among the studies with carbocysteine, <a href="./references#CD003124-bbs2-0005" title="NakayamaY , MaedaK , FuanabashiS , KubagawaT , SimanugiK , TatenoK , et al. Carbocysteine syrup in pediatrics: a clinical trial [Effets cliniques de s‐carboxymethylcysteine sous forme de sirop en pédiatrie (traduction)]. Japanese Journal of Pediatrics1977;10:1823. ">Nakayama 1977</a> studied children from one to 14 years old and <a href="./references#CD003124-bbs2-0006" title="ZaniniA , DodesniG . Lisomucil in pediatrics [Il lisomucil in campo pediatrico]. Clinica Europea1974;13:1‐12. ">Zanini 1974</a> studied 18 children under one year of age. However, it was not possible to obtain more information about possible differences in results in the children under two years of age. </p> </section> </section> <section id="CD003124-sec-0070"> <h4 class="title">2. Safety</h4> <p>Our search strategy identified 28 studies to evaluate safety, in addition to the six trials above (<a href="./references#CD003124-bbs2-0001" title="BellomoG , GiudiceS . Controlled study on the efficacy of a combination &quot;thiamphenicol‐acetylcysteine&quot; in oral administration in respiratory infections in pediatrics [Studio controllata sull'efficacia della combinazione &quot;tiamfenicolo‐acetilcisteina&quot; per via orale nel trattamento delle infezioni broncopolmonari dell'infanzia]. Clinical Pediatrics1972;54:30‐51. ">Bellomo 1972</a>; <a href="./references#CD003124-bbs2-0002" title="BiscattiG , BruschelliM , DamonteG , CapozziF . Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics [Ricerca controllata sugli effetti clinici dell'acetilcisteina per via orale nelle infezioni respiratorie in pediatria]. Minerva Pediatrica1972;24:1075‐84. ">Biscatti 1972</a>; <a href="./references#CD003124-bbs2-0003" title="FiocchiA , VignatiB , SalaM , ArancioR , BanderaliG , MarangioneP , et al. A new n‐acetylcysteine formulation in acute bronchopneumopathy in children [La n‐acetilcisteina nel trattamento delle broncopneumopatie acute in pediatria]. Giornale Italiano delle Malattie del Torace1989;43:327‐34. ">Fiocchi 1989</a>; <a href="./references#CD003124-bbs2-0004" title="MalkaM , Lablache CombierB . Carbocysteine in the treatment of acute bronchitis in children [Interet d'un mucolytique, la carbocistéine, dans la bronchite aiguë de l'enfant]. Medicina Infantil1990;97:687‐92. ">Malka 1990</a>; <a href="./references#CD003124-bbs2-0005" title="NakayamaY , MaedaK , FuanabashiS , KubagawaT , SimanugiK , TatenoK , et al. Carbocysteine syrup in pediatrics: a clinical trial [Effets cliniques de s‐carboxymethylcysteine sous forme de sirop en pédiatrie (traduction)]. Japanese Journal of Pediatrics1977;10:1823. ">Nakayama 1977</a>; <a href="./references#CD003124-bbs2-0006" title="ZaniniA , DodesniG . Lisomucil in pediatrics [Il lisomucil in campo pediatrico]. Clinica Europea1974;13:1‐12. ">Zanini 1974</a>). These 34 studies involved 2064 paediatric participants. Safety was evaluated using clinical, biological, radiographic or pulmonary function test parameters. Among these studies, 17 were controlled trials (including 14 randomised controlled trials (RCTs)), 16 were non‐controlled trials and the last one was a targeted pharmacovigilance study. The studies reporting adverse events were not comparable in terms of participants, interventions or adverse events, and so we judged pooling of the results to be inappropriate. </p> <section id="CD003124-sec-0071"> <h5 class="title">2.a Analysis of included studies with acetylcysteine</h5> <p>Twenty studies evaluated acetylcysteine, involving 1080 participants among which 831 were treated (<a href="./references#CD003124-bbs2-0009" title="BaldiniG , GucciM , TaroD , MemminiC . Controlled clinical study of a new Ambroxol formula in the treatment of infantile spastic bronchitis [Studio clinico controllato sull'attivita di una nuova formulazione di Ambroxol nella bronchite asmatiforme del bambino]. Minerva Pediatrica1989;41:91‐5. ">Baldini 1989</a>; <a href="./references#CD003124-bbs2-0012" title="BellomoG , FrigerioG , TirantelloG . Controlled study on the use of intramuscular acetylcysteine in acute respiratory infections in pediatrics [Ricerche controllate sull'impiego dell'acetilcisteina per via intramuscolare nelle infezioni respiratorie acute in pediatria]. Clinica Terapeutica1967;43:437‐58. ">Bellomo 1967a</a>; <a href="./references#CD003124-bbs2-0013" title="BellomoG , TirantelloG , GiudiceS . On the use of a combination of acetylcysteine with thiamphenicol glycinate in the systemic treatment of bronchopulmonary infections in children [Sull'uso di una combinazione dell'acetilcysteina con tiamfenicolo glicato nel trattamento sistemico delle infezioni broncopolmonari in eta' pediatrica]. Clinical Pediatrics1967;49:402‐24. ">Bellomo 1967b</a>; <a href="./references#CD003124-bbs2-0001" title="BellomoG , GiudiceS . Controlled study on the efficacy of a combination &quot;thiamphenicol‐acetylcysteine&quot; in oral administration in respiratory infections in pediatrics [Studio controllata sull'efficacia della combinazione &quot;tiamfenicolo‐acetilcisteina&quot; per via orale nel trattamento delle infezioni broncopolmonari dell'infanzia]. Clinical Pediatrics1972;54:30‐51. ">Bellomo 1972</a>; <a href="./references#CD003124-bbs2-0014" title="BellomoG , GiudiceS , GanciC . Comparative study of the efficacy of acetylcysteine by the oral and intramuscular routes in acute respiratory affections in pediatrics [Studio comparativo dell'efficacia dell'acetilcisteina per via orale ed intramuscolare nelle affezioni respiratorie acute in pediatria]. Minerva Pediatrica1973;25:844‐9. ">Bellomo 1973</a>; <a href="./references#CD003124-bbs2-0002" title="BiscattiG , BruschelliM , DamonteG , CapozziF . Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics [Ricerca controllata sugli effetti clinici dell'acetilcisteina per via orale nelle infezioni respiratorie in pediatria]. Minerva Pediatrica1972;24:1075‐84. ">Biscatti 1972</a>; <a href="./references#CD003124-bbs2-0017" title="BonerAL , VallettaEA , StoccheroL , RichelliC , BennatiD . Combined antibiotic plus mucolytic treatment of acute or recurrent pneumonia in children. Drugs Under Experimental and Clinical Research1984;10:627‐30. ">Boner 1984</a>; <a href="./references#CD003124-bbs2-0018" title="CamurriS , MarencoG . Clinical evaluation of the safety and efficacy of a new pharmaceutical formulation of bromhexine compared to N‐acetylcysteine in pediatric patients with acute bronchitis [Valutazione clinica dell'efficacia e della tollerabilita della nuova formulazione farmaceutica bromessina granulare nei confronti dell'N‐acetilcisteina granulare in piccoli pazienti affetti da bronchite acuta]. Gazzetta Medica Italiana1990;149:45‐8. ">Camurri 1990</a>; <a href="./references#CD003124-bbs2-0019" title="CaramiaG , BizzarriV , CompagnoniL , GregoriniS . Combined antibiotic plus mucolytic treatment in broncho‐pulmonary disease: cefuroxime plus acetylcysteine. Current Therapeutic Research, Clinical and Experimental1984;36:658‐63. ">Caramia 1984</a>; <a href="./references#CD003124-bbs2-0023" title="DanoG . Bronchospasm caused by acetylcysteine in children with bronchial asthma. Acta Allergologica1971;26:181‐90. ">Dano 1971</a>; <a href="./references#CD003124-bbs2-0003" title="FiocchiA , VignatiB , SalaM , ArancioR , BanderaliG , MarangioneP , et al. A new n‐acetylcysteine formulation in acute bronchopneumopathy in children [La n‐acetilcisteina nel trattamento delle broncopneumopatie acute in pediatria]. Giornale Italiano delle Malattie del Torace1989;43:327‐34. ">Fiocchi 1989</a>; <a href="./references#CD003124-bbs2-0027" title="GusbertiC , BellazziA , LonatiC , ModestiR . Clinical evaluation of a new synthetic derivative of acetylcysteine for treating respiratory inflammations in pediatric patients [Valutazione clinica di uno nuovo derivato sintetico dell'acido acetilsalicilico nella terapia di flogosi respiratorie di pazienti pediatrici]. Archivio di Medicina Interna1985;37:123‐9. ">Gusberti 1985</a>; <a href="./references#CD003124-bbs2-0030" title="JeanR , GardairF . Efficacy on expectoration of acetylcysteine nebulization in pediatric patients [Utilisation du Fluimucil antibiotic 750 en aérosols chez le nourisson et l'enfant son efficacité d'expectoration]. Laboratoires Zambon, Paris1982. ">Jean 1982</a>; <a href="./references#CD003124-bbs2-0031" title="LeupoldW von . Lung function in bronchial asthma during treatment with Mucosolvin [Die lungenfunktion bei asthma bronchiale unter der behandlung mit Mucosolvia]. Das Deutsche Gesundheitswesen1970;25:1400‐2. ">Leupold 1970</a>; <a href="./references#CD003124-bbs2-0032" title="Loscialpo RamundoD . On the use of the association of acetylcysteine and thiamphenicol glycinate in some pediatric pulmonary diseases [Sull'impiego associazone acetilcisteina‐tiamfenicolo glicinato in alcune forme di patologia polmonare pediatrica]. Clinical Pediatrics1968;50:43‐56. ">Loscialpo Ramundo 1968</a>; <a href="./references#CD003124-bbs2-0033" title="MayaudC , LentschnerC , BouchouchaS , MarsacJ . Thiamphenicol glycinate acetylcysteinate in the treatment of acute respiratory infections with mucostasis [L'acetylcysteinate de thiamphenicol glycinate dans le traitement des infections respiratoires aigues avec mucostase]. European Journal of Respiratory Diseases Supplement1980;61(111):70‐3. ">Mayaud 1980</a>; <a href="./references#CD003124-bbs2-0036" title="NikolicP , KoracD . The influence of acetylcysteine on respiratory functions in children with recurrent bronchitis. European Journal of Respiratory Diseases Supplement1980;61(111):141. ">Nikolic 1980</a>; <a href="./references#CD003124-bbs2-0040" title="RamenghiM , SabayiniG , MengoniM . Combined antibiotic plus mucolytic treatment for recurrent bronchial diseases in infancy. Current Therapeutic Research1984;36:664‐7. ">Ramenghi 1984</a>; <a href="./references#CD003124-bbs2-0044" title="SantangeloG , LombardoS , GiannottiG . A combination of cefuroxime and N‐acetyl‐cysteine for the treatment of lower respiratory tract infections in children. International Journal of Clinical Pharmacology, Therapy, and Toxicology1985;23:279‐81. ">Santangelo 1985</a>; <a href="./references#CD003124-bbs2-0046" title="TrastotenojoMS , HarsoyoN , SachroAD , SoemantriAG , SaidHW . Use of acetyl cysteine in respiratory tract disease in children. Paediatrica Indonesiana1984;24:1‐10. ">Trastotenojo 1984</a>). </p> <p>Nine of these studies were controlled trials in which the treatment was administered orally except in one study for which the route of administration was intramuscular. Control participants received either placebo (<a href="./references#CD003124-bbs2-0001" title="BellomoG , GiudiceS . Controlled study on the efficacy of a combination &quot;thiamphenicol‐acetylcysteine&quot; in oral administration in respiratory infections in pediatrics [Studio controllata sull'efficacia della combinazione &quot;tiamfenicolo‐acetilcisteina&quot; per via orale nel trattamento delle infezioni broncopolmonari dell'infanzia]. Clinical Pediatrics1972;54:30‐51. ">Bellomo 1972</a>; <a href="./references#CD003124-bbs2-0002" title="BiscattiG , BruschelliM , DamonteG , CapozziF . Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics [Ricerca controllata sugli effetti clinici dell'acetilcisteina per via orale nelle infezioni respiratorie in pediatria]. Minerva Pediatrica1972;24:1075‐84. ">Biscatti 1972</a>; <a href="./references#CD003124-bbs2-0003" title="FiocchiA , VignatiB , SalaM , ArancioR , BanderaliG , MarangioneP , et al. A new n‐acetylcysteine formulation in acute bronchopneumopathy in children [La n‐acetilcisteina nel trattamento delle broncopneumopatie acute in pediatria]. Giornale Italiano delle Malattie del Torace1989;43:327‐34. ">Fiocchi 1989</a>; <a href="./references#CD003124-bbs2-0046" title="TrastotenojoMS , HarsoyoN , SachroAD , SoemantriAG , SaidHW . Use of acetyl cysteine in respiratory tract disease in children. Paediatrica Indonesiana1984;24:1‐10. ">Trastotenojo 1984</a>), an active control treatment (<a href="./references#CD003124-bbs2-0009" title="BaldiniG , GucciM , TaroD , MemminiC . Controlled clinical study of a new Ambroxol formula in the treatment of infantile spastic bronchitis [Studio clinico controllato sull'attivita di una nuova formulazione di Ambroxol nella bronchite asmatiforme del bambino]. Minerva Pediatrica1989;41:91‐5. ">Baldini 1989</a>; <a href="./references#CD003124-bbs2-0018" title="CamurriS , MarencoG . Clinical evaluation of the safety and efficacy of a new pharmaceutical formulation of bromhexine compared to N‐acetylcysteine in pediatric patients with acute bronchitis [Valutazione clinica dell'efficacia e della tollerabilita della nuova formulazione farmaceutica bromessina granulare nei confronti dell'N‐acetilcisteina granulare in piccoli pazienti affetti da bronchite acuta]. Gazzetta Medica Italiana1990;149:45‐8. ">Camurri 1990</a>; <a href="./references#CD003124-bbs2-0027" title="GusbertiC , BellazziA , LonatiC , ModestiR . Clinical evaluation of a new synthetic derivative of acetylcysteine for treating respiratory inflammations in pediatric patients [Valutazione clinica di uno nuovo derivato sintetico dell'acido acetilsalicilico nella terapia di flogosi respiratorie di pazienti pediatrici]. Archivio di Medicina Interna1985;37:123‐9. ">Gusberti 1985</a>) or nothing (<a href="./references#CD003124-bbs2-0012" title="BellomoG , FrigerioG , TirantelloG . Controlled study on the use of intramuscular acetylcysteine in acute respiratory infections in pediatrics [Ricerche controllate sull'impiego dell'acetilcisteina per via intramuscolare nelle infezioni respiratorie acute in pediatria]. Clinica Terapeutica1967;43:437‐58. ">Bellomo 1967a</a>). If a concomitant treatment was authorised, for example, antibiotics, it was authorised for all participants. The controlled trials studied clinical or biological tolerance, or both. The biological tests consisted usually of full blood tests (haemoglobin (Hb), red blood count (RBC), white blood count (WBC) and platelets) and the monitoring of hepatic (bilirubin, serum glutamate‐oxaloacetate transaminase (SGOT), serum glutamate‐pyruvate transaminase (SGPT), alkaline phosphatase) and renal function (creatinine). In two studies, safety was also evaluated using radiographic (<a href="./references#CD003124-bbs2-0046" title="TrastotenojoMS , HarsoyoN , SachroAD , SoemantriAG , SaidHW . Use of acetyl cysteine in respiratory tract disease in children. Paediatrica Indonesiana1984;24:1‐10. ">Trastotenojo 1984</a>) or pulmonary function test parameters (<a href="./references#CD003124-bbs2-0003" title="FiocchiA , VignatiB , SalaM , ArancioR , BanderaliG , MarangioneP , et al. A new n‐acetylcysteine formulation in acute bronchopneumopathy in children [La n‐acetilcisteina nel trattamento delle broncopneumopatie acute in pediatria]. Giornale Italiano delle Malattie del Torace1989;43:327‐34. ">Fiocchi 1989</a>). The controlled trials all showed good clinical safety, except mild gastrointestinal tract adverse events (vomiting) in two participants (2%), leading to the withdrawal of one of them (<a href="./references#CD003124-bbs2-0003" title="FiocchiA , VignatiB , SalaM , ArancioR , BanderaliG , MarangioneP , et al. A new n‐acetylcysteine formulation in acute bronchopneumopathy in children [La n‐acetilcisteina nel trattamento delle broncopneumopatie acute in pediatria]. Giornale Italiano delle Malattie del Torace1989;43:327‐34. ">Fiocchi 1989</a>). </p> <p>In the other trials, the route of administration was oral in one study, intramuscular in five, inhaled in four, and both oral and intramuscular in one. Most of these studies authorised concomitant treatments, mainly antibiotics. All participants had equal access to these treatments, except in one trial (<a href="./references#CD003124-bbs2-0006" title="ZaniniA , DodesniG . Lisomucil in pediatrics [Il lisomucil in campo pediatrico]. Clinica Europea1974;13:1‐12. ">Zanini 1974</a>). Safety was evaluated using clinical and typically biological tests. Some studies also evaluated safety using radiographic (<a href="./references#CD003124-bbs2-0017" title="BonerAL , VallettaEA , StoccheroL , RichelliC , BennatiD . Combined antibiotic plus mucolytic treatment of acute or recurrent pneumonia in children. Drugs Under Experimental and Clinical Research1984;10:627‐30. ">Boner 1984</a>; <a href="./references#CD003124-bbs2-0019" title="CaramiaG , BizzarriV , CompagnoniL , GregoriniS . Combined antibiotic plus mucolytic treatment in broncho‐pulmonary disease: cefuroxime plus acetylcysteine. Current Therapeutic Research, Clinical and Experimental1984;36:658‐63. ">Caramia 1984</a>; <a href="./references#CD003124-bbs2-0030" title="JeanR , GardairF . Efficacy on expectoration of acetylcysteine nebulization in pediatric patients [Utilisation du Fluimucil antibiotic 750 en aérosols chez le nourisson et l'enfant son efficacité d'expectoration]. Laboratoires Zambon, Paris1982. ">Jean 1982</a>; <a href="./references#CD003124-bbs2-0032" title="Loscialpo RamundoD . On the use of the association of acetylcysteine and thiamphenicol glycinate in some pediatric pulmonary diseases [Sull'impiego associazone acetilcisteina‐tiamfenicolo glicinato in alcune forme di patologia polmonare pediatrica]. Clinical Pediatrics1968;50:43‐56. ">Loscialpo Ramundo 1968</a>; <a href="./references#CD003124-bbs2-0033" title="MayaudC , LentschnerC , BouchouchaS , MarsacJ . Thiamphenicol glycinate acetylcysteinate in the treatment of acute respiratory infections with mucostasis [L'acetylcysteinate de thiamphenicol glycinate dans le traitement des infections respiratoires aigues avec mucostase]. European Journal of Respiratory Diseases Supplement1980;61(111):70‐3. ">Mayaud 1980</a>; <a href="./references#CD003124-bbs2-0044" title="SantangeloG , LombardoS , GiannottiG . A combination of cefuroxime and N‐acetyl‐cysteine for the treatment of lower respiratory tract infections in children. International Journal of Clinical Pharmacology, Therapy, and Toxicology1985;23:279‐81. ">Santangelo 1985</a>) or pulmonary function test parameters (<a href="./references#CD003124-bbs2-0023" title="DanoG . Bronchospasm caused by acetylcysteine in children with bronchial asthma. Acta Allergologica1971;26:181‐90. ">Dano 1971</a>; <a href="./references#CD003124-bbs2-0031" title="LeupoldW von . Lung function in bronchial asthma during treatment with Mucosolvin [Die lungenfunktion bei asthma bronchiale unter der behandlung mit Mucosolvia]. Das Deutsche Gesundheitswesen1970;25:1400‐2. ">Leupold 1970</a>). In one study, the tolerance was not documented (<a href="./references#CD003124-bbs2-0036" title="NikolicP , KoracD . The influence of acetylcysteine on respiratory functions in children with recurrent bronchitis. European Journal of Respiratory Diseases Supplement1980;61(111):141. ">Nikolic 1980</a>). The main potential adverse event observed was broncho‐constriction induced by inhaled N‐acetylcysteine in children older than two years of age (<a href="./references#CD003124-bbs2-0023" title="DanoG . Bronchospasm caused by acetylcysteine in children with bronchial asthma. Acta Allergologica1971;26:181‐90. ">Dano 1971</a>; <a href="./references#CD003124-bbs2-0031" title="LeupoldW von . Lung function in bronchial asthma during treatment with Mucosolvin [Die lungenfunktion bei asthma bronchiale unter der behandlung mit Mucosolvia]. Das Deutsche Gesundheitswesen1970;25:1400‐2. ">Leupold 1970</a>). As a consequence, 11 children (31%) were withdrawn from one of these studies (<a href="./references#CD003124-bbs2-0031" title="LeupoldW von . Lung function in bronchial asthma during treatment with Mucosolvin [Die lungenfunktion bei asthma bronchiale unter der behandlung mit Mucosolvia]. Das Deutsche Gesundheitswesen1970;25:1400‐2. ">Leupold 1970</a>). This side effect was mainly explained by the trial authors by the high concentration (20%) of acetylcysteine. Whereas in another study, no such effect was reported with a lower concentration (10%) (<a href="./references#CD003124-bbs2-0032" title="Loscialpo RamundoD . On the use of the association of acetylcysteine and thiamphenicol glycinate in some pediatric pulmonary diseases [Sull'impiego associazone acetilcisteina‐tiamfenicolo glicinato in alcune forme di patologia polmonare pediatrica]. Clinical Pediatrics1968;50:43‐56. ">Loscialpo Ramundo 1968</a>). In the other uncontrolled trials clinical safety was very good except in one study where 12 participants (11%) complained of gastro‐intestinal tract disorders (nausea, vomiting, diarrhoea), but none were withdrawn (<a href="./references#CD003124-bbs2-0033" title="MayaudC , LentschnerC , BouchouchaS , MarsacJ . Thiamphenicol glycinate acetylcysteinate in the treatment of acute respiratory infections with mucostasis [L'acetylcysteinate de thiamphenicol glycinate dans le traitement des infections respiratoires aigues avec mucostase]. European Journal of Respiratory Diseases Supplement1980;61(111):70‐3. ">Mayaud 1980</a>). </p> </section> <section id="CD003124-sec-0072"> <h5 class="title">2.b Analysis of included studies with carbocysteine</h5> <p>Thirteen studies evaluated carbocysteine, involving 989 participants, among which 755 were treated (<a href="./references#CD003124-bbs2-0008" title="Anonymous . A study of tolerance of carbocisteine syrup in children [Etude de la tolérance clinique du sirop carbocistéine chez l'enfant]. Dossier d'autorisation de mise sur le marché, Laboratoires Alpharma, Aubervilliers, France1987. ">Anonymous 1987</a>; <a href="./references#CD003124-bbs2-0010" title="BanovcinP . Efficacy of carbocysteine in the treatment of bronchopneumonias in children. Prakticky Lekar1990;70:885‐7. ">Banovcin 1990</a>; <a href="./references#CD003124-bbs2-0011" title="BanovcinP , JakusovaL , RosslerovaV , MiklerovaM , PullmanR . Carbocysteine in the treatment of recurrent bronchitis in infants [Karbocystein v liecbe recidivujucich bronchitid u dojciat]. Ceskoslovenska Pediatrie1992;47:543‐6. ">Banovcin 1992</a>; <a href="./references#CD003124-bbs2-0016" title="BerniM , CollinaA , ZavattiniG . Ambroxol in bronchopulmonary pathology in children [Ambroxol nella patologia broncopolmonare del bambino]. Clinica Terapeutica1983;106:351‐5. ">Berni 1983</a>; <a href="./references#CD003124-bbs2-0020" title="CaredduP , BernocchiD , ScottiL , ManiniG , MezzopaneA . Therapeutic activity and tolerability of a new mucoregulating drug called nesosteine in the treatment of acute diseases of the respiratory apparatus. Controlled pediatric study vs carbocysteine [Attivita terapeutica e tollerabilita di un nuovo farmaco mucoregolatore denominato nesosteina nel trattamento di affezioni acute dell'apparato respiratorio studio pediatrico controllato vs carbocisteina]. Giornale Italiano Delle Malattie Del Torace1989;43:47‐52. ">Careddu 1989</a>; <a href="./references#CD003124-bbs2-0021" title="CastelloD , CostaG , deCandussioG . Modifications in catarrhal bronchitis secretion in paediatric age following treatment with S‐carboxymethyl‐cystein (viscosimetric study) [Modificazioni dell'escreato nella bronchite catarrale in eta pediatrica dopo trattamento con S‐carbossimetilcisteina (indagine viscosimetrica)]. Minerva Pediatrica1979;31:371‐80. ">Castello 1979</a>; <a href="./references#CD003124-bbs2-0025" title="GaudierB , LelongM . Carbocysteine to treat asthma in children [L'utilisation de la S‐Carboxy Methyl Cystéine (LJ 206) dans l'asthme de l'enfant]. Laboratoires Joullie, Paris1968. ">Gaudier 1968</a>; <a href="./references#CD003124-bbs2-0026" title="GinocchiG . Clinical effects of a mucolytic agent (Pol 65) in a pediatric statistical study [Effeti clinici di un mucoliyico (Pol 65) in una casistica pediatrica]. Settimana Medica1978;66:391‐408. ">Ginocchi 1978</a>; <a href="./references#CD003124-bbs2-0028" title="HenocqA , MoreauC , MalletE , SaugerF , Menibus CHde . Changes in IgA levels in nasal mucus after upper respiratory tract diseases in infants treated with carbocysteine [Modifications du taux IgA du mucus nasal au décours des affections des voies aériennes supérieures du nourrisson traitées par la carbocistéine]. Annales d'Oto‐Laryngologie et de Chirurgie Cervico Faciale1985;102:373‐5. ">Henocq 1985</a>; <a href="./references#CD003124-bbs2-0004" title="MalkaM , Lablache CombierB . Carbocysteine in the treatment of acute bronchitis in children [Interet d'un mucolytique, la carbocistéine, dans la bronchite aiguë de l'enfant]. Medicina Infantil1990;97:687‐92. ">Malka 1990</a>; <a href="./references#CD003124-bbs2-0034" title="MichaelP , HaaseW . Treatment of acute and chronic bronchitis. Therapeutic experience with Pulmoclase [Behandlung akuter und chronischer bronchitis. Therapeutische erfahrungen mit Pulmoclase]. Therapiewoche1986;36:4440‐5. ">Michael 1986</a>; <a href="./references#CD003124-bbs2-0005" title="NakayamaY , MaedaK , FuanabashiS , KubagawaT , SimanugiK , TatenoK , et al. Carbocysteine syrup in pediatrics: a clinical trial [Effets cliniques de s‐carboxymethylcysteine sous forme de sirop en pédiatrie (traduction)]. Japanese Journal of Pediatrics1977;10:1823. ">Nakayama 1977</a>; <a href="./references#CD003124-bbs2-0006" title="ZaniniA , DodesniG . Lisomucil in pediatrics [Il lisomucil in campo pediatrico]. Clinica Europea1974;13:1‐12. ">Zanini 1974</a>). </p> <p>The treatment was administrated orally. Eight trials were controlled. The control participants received either a placebo (<a href="./references#CD003124-bbs2-0004" title="MalkaM , Lablache CombierB . Carbocysteine in the treatment of acute bronchitis in children [Interet d'un mucolytique, la carbocistéine, dans la bronchite aiguë de l'enfant]. Medicina Infantil1990;97:687‐92. ">Malka 1990</a>; <a href="./references#CD003124-bbs2-0005" title="NakayamaY , MaedaK , FuanabashiS , KubagawaT , SimanugiK , TatenoK , et al. Carbocysteine syrup in pediatrics: a clinical trial [Effets cliniques de s‐carboxymethylcysteine sous forme de sirop en pédiatrie (traduction)]. Japanese Journal of Pediatrics1977;10:1823. ">Nakayama 1977</a>; <a href="./references#CD003124-bbs2-0006" title="ZaniniA , DodesniG . Lisomucil in pediatrics [Il lisomucil in campo pediatrico]. Clinica Europea1974;13:1‐12. ">Zanini 1974</a>), or an active treatment (<a href="./references#CD003124-bbs2-0010" title="BanovcinP . Efficacy of carbocysteine in the treatment of bronchopneumonias in children. Prakticky Lekar1990;70:885‐7. ">Banovcin 1990</a>; <a href="./references#CD003124-bbs2-0011" title="BanovcinP , JakusovaL , RosslerovaV , MiklerovaM , PullmanR . Carbocysteine in the treatment of recurrent bronchitis in infants [Karbocystein v liecbe recidivujucich bronchitid u dojciat]. Ceskoslovenska Pediatrie1992;47:543‐6. ">Banovcin 1992</a>; <a href="./references#CD003124-bbs2-0016" title="BerniM , CollinaA , ZavattiniG . Ambroxol in bronchopulmonary pathology in children [Ambroxol nella patologia broncopolmonare del bambino]. Clinica Terapeutica1983;106:351‐5. ">Berni 1983</a>; <a href="./references#CD003124-bbs2-0020" title="CaredduP , BernocchiD , ScottiL , ManiniG , MezzopaneA . Therapeutic activity and tolerability of a new mucoregulating drug called nesosteine in the treatment of acute diseases of the respiratory apparatus. Controlled pediatric study vs carbocysteine [Attivita terapeutica e tollerabilita di un nuovo farmaco mucoregolatore denominato nesosteina nel trattamento di affezioni acute dell'apparato respiratorio studio pediatrico controllato vs carbocisteina]. Giornale Italiano Delle Malattie Del Torace1989;43:47‐52. ">Careddu 1989</a>) or nothing (<a href="./references#CD003124-bbs2-0028" title="HenocqA , MoreauC , MalletE , SaugerF , Menibus CHde . Changes in IgA levels in nasal mucus after upper respiratory tract diseases in infants treated with carbocysteine [Modifications du taux IgA du mucus nasal au décours des affections des voies aériennes supérieures du nourrisson traitées par la carbocistéine]. Annales d'Oto‐Laryngologie et de Chirurgie Cervico Faciale1985;102:373‐5. ">Henocq 1985</a>). If a concomitant treatment was authorised, for example, antibiotics, it was authorised for all participants. The controlled trials used clinical and sometimes biological parameters to evaluate safety. The biological tests consisted of blood tests and/or the monitoring of hepatic and renal function. In two studies, safety was also evaluated using pulmonary function test parameters (<a href="./references#CD003124-bbs2-0004" title="MalkaM , Lablache CombierB . Carbocysteine in the treatment of acute bronchitis in children [Interet d'un mucolytique, la carbocistéine, dans la bronchite aiguë de l'enfant]. Medicina Infantil1990;97:687‐92. ">Malka 1990</a>; <a href="./references#CD003124-bbs2-0005" title="NakayamaY , MaedaK , FuanabashiS , KubagawaT , SimanugiK , TatenoK , et al. Carbocysteine syrup in pediatrics: a clinical trial [Effets cliniques de s‐carboxymethylcysteine sous forme de sirop en pédiatrie (traduction)]. Japanese Journal of Pediatrics1977;10:1823. ">Nakayama 1977</a>). Three studies did not document adverse events (<a href="./references#CD003124-bbs2-0010" title="BanovcinP . Efficacy of carbocysteine in the treatment of bronchopneumonias in children. Prakticky Lekar1990;70:885‐7. ">Banovcin 1990</a>; <a href="./references#CD003124-bbs2-0011" title="BanovcinP , JakusovaL , RosslerovaV , MiklerovaM , PullmanR . Carbocysteine in the treatment of recurrent bronchitis in infants [Karbocystein v liecbe recidivujucich bronchitid u dojciat]. Ceskoslovenska Pediatrie1992;47:543‐6. ">Banovcin 1992</a>; <a href="./references#CD003124-bbs2-0028" title="HenocqA , MoreauC , MalletE , SaugerF , Menibus CHde . Changes in IgA levels in nasal mucus after upper respiratory tract diseases in infants treated with carbocysteine [Modifications du taux IgA du mucus nasal au décours des affections des voies aériennes supérieures du nourrisson traitées par la carbocistéine]. Annales d'Oto‐Laryngologie et de Chirurgie Cervico Faciale1985;102:373‐5. ">Henocq 1985</a>). The overall clinical safety was good in the other trials, with few participants (n = 19; 13%) complaining of gastrointestinal tract disorders (nausea, vomiting, diarrhoea) (<a href="./references#CD003124-bbs2-0020" title="CaredduP , BernocchiD , ScottiL , ManiniG , MezzopaneA . Therapeutic activity and tolerability of a new mucoregulating drug called nesosteine in the treatment of acute diseases of the respiratory apparatus. Controlled pediatric study vs carbocysteine [Attivita terapeutica e tollerabilita di un nuovo farmaco mucoregolatore denominato nesosteina nel trattamento di affezioni acute dell'apparato respiratorio studio pediatrico controllato vs carbocisteina]. Giornale Italiano Delle Malattie Del Torace1989;43:47‐52. ">Careddu 1989</a>; <a href="./references#CD003124-bbs2-0004" title="MalkaM , Lablache CombierB . Carbocysteine in the treatment of acute bronchitis in children [Interet d'un mucolytique, la carbocistéine, dans la bronchite aiguë de l'enfant]. Medicina Infantil1990;97:687‐92. ">Malka 1990</a>), leading to the withdrawal or dropping out of two (1.9%) treated children and one (0.9%) among the control patients (<a href="./references#CD003124-bbs2-0004" title="MalkaM , Lablache CombierB . Carbocysteine in the treatment of acute bronchitis in children [Interet d'un mucolytique, la carbocistéine, dans la bronchite aiguë de l'enfant]. Medicina Infantil1990;97:687‐92. ">Malka 1990</a>). In one of these two studies (<a href="./references#CD003124-bbs2-0020" title="CaredduP , BernocchiD , ScottiL , ManiniG , MezzopaneA . Therapeutic activity and tolerability of a new mucoregulating drug called nesosteine in the treatment of acute diseases of the respiratory apparatus. Controlled pediatric study vs carbocysteine [Attivita terapeutica e tollerabilita di un nuovo farmaco mucoregolatore denominato nesosteina nel trattamento di affezioni acute dell'apparato respiratorio studio pediatrico controllato vs carbocisteina]. Giornale Italiano Delle Malattie Del Torace1989;43:47‐52. ">Careddu 1989</a>) the dose used was high (900 mg/day for children weighing around 25 kg). </p> <p>The other studies involved 501 paediatric participants. One study authorised antibiotics for all participants if necessary (<a href="./references#CD003124-bbs2-0021" title="CastelloD , CostaG , deCandussioG . Modifications in catarrhal bronchitis secretion in paediatric age following treatment with S‐carboxymethyl‐cystein (viscosimetric study) [Modificazioni dell'escreato nella bronchite catarrale in eta pediatrica dopo trattamento con S‐carbossimetilcisteina (indagine viscosimetrica)]. Minerva Pediatrica1979;31:371‐80. ">Castello 1979</a>) and another one authorised antibiotics in 33 children (75%) (<a href="./references#CD003124-bbs2-0026" title="GinocchiG . Clinical effects of a mucolytic agent (Pol 65) in a pediatric statistical study [Effeti clinici di un mucoliyico (Pol 65) in una casistica pediatrica]. Settimana Medica1978;66:391‐408. ">Ginocchi 1978</a>). All trials studied clinical tolerance. Biological parameters (<a href="./references#CD003124-bbs2-0026" title="GinocchiG . Clinical effects of a mucolytic agent (Pol 65) in a pediatric statistical study [Effeti clinici di un mucoliyico (Pol 65) in una casistica pediatrica]. Settimana Medica1978;66:391‐408. ">Ginocchi 1978</a>) and sputum viscosimetry (<a href="./references#CD003124-bbs2-0021" title="CastelloD , CostaG , deCandussioG . Modifications in catarrhal bronchitis secretion in paediatric age following treatment with S‐carboxymethyl‐cystein (viscosimetric study) [Modificazioni dell'escreato nella bronchite catarrale in eta pediatrica dopo trattamento con S‐carbossimetilcisteina (indagine viscosimetrica)]. Minerva Pediatrica1979;31:371‐80. ">Castello 1979</a>) were also used in two trials. Adverse events were observed in 13 participants (2.6%). These participants experienced gastrointestinal tract disorders (stomach pain, nausea, vomiting, diarrhoea) in two studies (<a href="./references#CD003124-bbs2-0025" title="GaudierB , LelongM . Carbocysteine to treat asthma in children [L'utilisation de la S‐Carboxy Methyl Cystéine (LJ 206) dans l'asthme de l'enfant]. Laboratoires Joullie, Paris1968. ">Gaudier 1968</a>; <a href="./references#CD003124-bbs2-0034" title="MichaelP , HaaseW . Treatment of acute and chronic bronchitis. Therapeutic experience with Pulmoclase [Behandlung akuter und chronischer bronchitis. Therapeutische erfahrungen mit Pulmoclase]. Therapiewoche1986;36:4440‐5. ">Michael 1986</a>), leading to the withdrawal of five participants (1.3%) in one study (<a href="./references#CD003124-bbs2-0034" title="MichaelP , HaaseW . Treatment of acute and chronic bronchitis. Therapeutic experience with Pulmoclase [Behandlung akuter und chronischer bronchitis. Therapeutische erfahrungen mit Pulmoclase]. Therapiewoche1986;36:4440‐5. ">Michael 1986</a>). </p> <p>Our search identified only one study designed to evaluate safety (<a href="./references#CD003124-bbs2-0008" title="Anonymous . A study of tolerance of carbocisteine syrup in children [Etude de la tolérance clinique du sirop carbocistéine chez l'enfant]. Dossier d'autorisation de mise sur le marché, Laboratoires Alpharma, Aubervilliers, France1987. ">Anonymous 1987</a>). This study was an open uncontrolled trial that involved 20 participants with acute upper and lower RTIs, including some infants. Participants received carbocysteine for six days at a dose of 200 mg per day via the oral route. No concomitant treatment was allowed, except antibiotics in one child. The safety was evaluated clinically by questioning parents and children. The only potentially adverse event reported (vomiting) occurred after the end of the treatment and involved only the child on antibiotics. </p> </section> <section id="CD003124-sec-0073"> <h5 class="title">2.c Subgroup analysis of infants under two years of age</h5> <p>Among the 22 studies that provided clear data on participants' ages, only 10 included participants under two years, involving 262 patients (68%) under this age (<a href="./references#CD003124-bbs2-0011" title="BanovcinP , JakusovaL , RosslerovaV , MiklerovaM , PullmanR . Carbocysteine in the treatment of recurrent bronchitis in infants [Karbocystein v liecbe recidivujucich bronchitid u dojciat]. Ceskoslovenska Pediatrie1992;47:543‐6. ">Banovcin 1992</a>; <a href="./references#CD003124-bbs2-0012" title="BellomoG , FrigerioG , TirantelloG . Controlled study on the use of intramuscular acetylcysteine in acute respiratory infections in pediatrics [Ricerche controllate sull'impiego dell'acetilcisteina per via intramuscolare nelle infezioni respiratorie acute in pediatria]. Clinica Terapeutica1967;43:437‐58. ">Bellomo 1967a</a>; <a href="./references#CD003124-bbs2-0013" title="BellomoG , TirantelloG , GiudiceS . On the use of a combination of acetylcysteine with thiamphenicol glycinate in the systemic treatment of bronchopulmonary infections in children [Sull'uso di una combinazione dell'acetilcysteina con tiamfenicolo glicato nel trattamento sistemico delle infezioni broncopolmonari in eta' pediatrica]. Clinical Pediatrics1967;49:402‐24. ">Bellomo 1967b</a>; <a href="./references#CD003124-bbs2-0014" title="BellomoG , GiudiceS , GanciC . Comparative study of the efficacy of acetylcysteine by the oral and intramuscular routes in acute respiratory affections in pediatrics [Studio comparativo dell'efficacia dell'acetilcisteina per via orale ed intramuscolare nelle affezioni respiratorie acute in pediatria]. Minerva Pediatrica1973;25:844‐9. ">Bellomo 1973</a>; <a href="./references#CD003124-bbs2-0002" title="BiscattiG , BruschelliM , DamonteG , CapozziF . Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics [Ricerca controllata sugli effetti clinici dell'acetilcisteina per via orale nelle infezioni respiratorie in pediatria]. Minerva Pediatrica1972;24:1075‐84. ">Biscatti 1972</a>; <a href="./references#CD003124-bbs2-0021" title="CastelloD , CostaG , deCandussioG . Modifications in catarrhal bronchitis secretion in paediatric age following treatment with S‐carboxymethyl‐cystein (viscosimetric study) [Modificazioni dell'escreato nella bronchite catarrale in eta pediatrica dopo trattamento con S‐carbossimetilcisteina (indagine viscosimetrica)]. Minerva Pediatrica1979;31:371‐80. ">Castello 1979</a>; <a href="./references#CD003124-bbs2-0022" title="ChalumeauM , CheronG , assathianyR , MoulinF , BavouxF , BreartG , et al. Mucolytic agents for acute respiratory tract infections in infants: a pharmacoepidemiologic problem? [Fluidifiants bronchiques dans les infections respiratoires aiguës du nourrisson: un problème pharmacoépidémiologique?]. Archives de Pédiatrie2002;9:1128‐36. ">Chalumeau 2002</a>; <a href="./references#CD003124-bbs2-0026" title="GinocchiG . Clinical effects of a mucolytic agent (Pol 65) in a pediatric statistical study [Effeti clinici di un mucoliyico (Pol 65) in una casistica pediatrica]. Settimana Medica1978;66:391‐408. ">Ginocchi 1978</a>; <a href="./references#CD003124-bbs2-0030" title="JeanR , GardairF . Efficacy on expectoration of acetylcysteine nebulization in pediatric patients [Utilisation du Fluimucil antibiotic 750 en aérosols chez le nourisson et l'enfant son efficacité d'expectoration]. Laboratoires Zambon, Paris1982. ">Jean 1982</a>; <a href="./references#CD003124-bbs2-0040" title="RamenghiM , SabayiniG , MengoniM . Combined antibiotic plus mucolytic treatment for recurrent bronchial diseases in infancy. Current Therapeutic Research1984;36:664‐7. ">Ramenghi 1984</a>). Among the 10 studies, only one was a good‐quality controlled trial (<a href="./references#CD003124-bbs2-0002" title="BiscattiG , BruschelliM , DamonteG , CapozziF . Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics [Ricerca controllata sugli effetti clinici dell'acetilcisteina per via orale nelle infezioni respiratorie in pediatria]. Minerva Pediatrica1972;24:1075‐84. ">Biscatti 1972</a>) and three were low‐quality controlled trials (<a href="./references#CD003124-bbs2-0011" title="BanovcinP , JakusovaL , RosslerovaV , MiklerovaM , PullmanR . Carbocysteine in the treatment of recurrent bronchitis in infants [Karbocystein v liecbe recidivujucich bronchitid u dojciat]. Ceskoslovenska Pediatrie1992;47:543‐6. ">Banovcin 1992</a>; <a href="./references#CD003124-bbs2-0012" title="BellomoG , FrigerioG , TirantelloG . Controlled study on the use of intramuscular acetylcysteine in acute respiratory infections in pediatrics [Ricerche controllate sull'impiego dell'acetilcisteina per via intramuscolare nelle infezioni respiratorie acute in pediatria]. Clinica Terapeutica1967;43:437‐58. ">Bellomo 1967a</a>; <a href="./references#CD003124-bbs2-0014" title="BellomoG , GiudiceS , GanciC . Comparative study of the efficacy of acetylcysteine by the oral and intramuscular routes in acute respiratory affections in pediatrics [Studio comparativo dell'efficacia dell'acetilcisteina per via orale ed intramuscolare nelle affezioni respiratorie acute in pediatria]. Minerva Pediatrica1973;25:844‐9. ">Bellomo 1973</a>). One hundred and seventy‐four participants (75%) under two years of age were included in these four trials; 26 were treated with carbocysteine (<a href="./references#CD003124-bbs2-0011" title="BanovcinP , JakusovaL , RosslerovaV , MiklerovaM , PullmanR . Carbocysteine in the treatment of recurrent bronchitis in infants [Karbocystein v liecbe recidivujucich bronchitid u dojciat]. Ceskoslovenska Pediatrie1992;47:543‐6. ">Banovcin 1992</a>) and 59 with acetylcysteine, including 14 in the single good‐quality controlled trial (<a href="./references#CD003124-bbs2-0002" title="BiscattiG , BruschelliM , DamonteG , CapozziF . Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics [Ricerca controllata sugli effetti clinici dell'acetilcisteina per via orale nelle infezioni respiratorie in pediatria]. Minerva Pediatrica1972;24:1075‐84. ">Biscatti 1972</a>). None of them had side effects. No side effect was reported in the other six trials. </p> <p>Our search strategy also identified a targeted pharmacovigilance study (<a href="./references#CD003124-bbs2-0022" title="ChalumeauM , CheronG , assathianyR , MoulinF , BavouxF , BreartG , et al. Mucolytic agents for acute respiratory tract infections in infants: a pharmacoepidemiologic problem? [Fluidifiants bronchiques dans les infections respiratoires aiguës du nourrisson: un problème pharmacoépidémiologique?]. Archives de Pédiatrie2002;9:1128‐36. ">Chalumeau 2002</a>). This study followed the spontaneous reporting to the French pharmacovigilance system of cases of paradoxically increased bronchorrhoea in infants receiving mucolytic agents. This prospective two‐month study was performed in the emergency departments of two paediatric teaching hospitals in Paris, France. During this period, six participants were diagnosed as having a paradoxically increased bronchorrhoea after having received acetylcysteine (n = 3) or carbocysteine (n = 3) for acute upper and lower respiratory infections. Participants were aged 2.5 to 7.5 months old. The median delay between treatment and the diagnosis of paradoxically increased bronchorrhoea was 4.5 days. The dose was on average 26 mg/kg/day, ranging from 20 to 35 mg/kg/day. Two children were hospitalised because of their respiratory state. Using the Naranjo scale for causality assessment, the causality between the exposure and the adverse reaction was considered possible or plausible (<a href="./references#CD003124-bbs2-0076" title="NaranjoCA , BustoU , SellersEM , SandorP , RuizI , RobertsEA , et al. A method for estimating the probability of adverse drug reactions. Clinical Pharmacology and Therapeutics1981;30:239‐45. [MEDLINE: 7249508] ">Naranjo 1981</a>). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD003124-sec-0074" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD003124-sec-0074"></div> <section id="CD003124-sec-0075"> <h3 class="title" id="CD003124-sec-0075">Summary of main results</h3> <p>We found a limited number of studies that evaluated the efficacy of acetylcysteine and carbocysteine as symptomatic treatments for acute upper and lower respiratory tract infections (RTIs) in paediatric patients without chronic broncho‐pulmonary disease (<a href="./references#CD003124-bbs2-0001" title="BellomoG , GiudiceS . Controlled study on the efficacy of a combination &quot;thiamphenicol‐acetylcysteine&quot; in oral administration in respiratory infections in pediatrics [Studio controllata sull'efficacia della combinazione &quot;tiamfenicolo‐acetilcisteina&quot; per via orale nel trattamento delle infezioni broncopolmonari dell'infanzia]. Clinical Pediatrics1972;54:30‐51. ">Bellomo 1972</a>; <a href="./references#CD003124-bbs2-0002" title="BiscattiG , BruschelliM , DamonteG , CapozziF . Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics [Ricerca controllata sugli effetti clinici dell'acetilcisteina per via orale nelle infezioni respiratorie in pediatria]. Minerva Pediatrica1972;24:1075‐84. ">Biscatti 1972</a>; <a href="./references#CD003124-bbs2-0003" title="FiocchiA , VignatiB , SalaM , ArancioR , BanderaliG , MarangioneP , et al. A new n‐acetylcysteine formulation in acute bronchopneumopathy in children [La n‐acetilcisteina nel trattamento delle broncopneumopatie acute in pediatria]. Giornale Italiano delle Malattie del Torace1989;43:327‐34. ">Fiocchi 1989</a>; <a href="./references#CD003124-bbs2-0004" title="MalkaM , Lablache CombierB . Carbocysteine in the treatment of acute bronchitis in children [Interet d'un mucolytique, la carbocistéine, dans la bronchite aiguë de l'enfant]. Medicina Infantil1990;97:687‐92. ">Malka 1990</a>; <a href="./references#CD003124-bbs2-0005" title="NakayamaY , MaedaK , FuanabashiS , KubagawaT , SimanugiK , TatenoK , et al. Carbocysteine syrup in pediatrics: a clinical trial [Effets cliniques de s‐carboxymethylcysteine sous forme de sirop en pédiatrie (traduction)]. Japanese Journal of Pediatrics1977;10:1823. ">Nakayama 1977</a>; <a href="./references#CD003124-bbs2-0006" title="ZaniniA , DodesniG . Lisomucil in pediatrics [Il lisomucil in campo pediatrico]. Clinica Europea1974;13:1‐12. ">Zanini 1974</a>). These trials showed some benefit from mucolytic agents, although differences were sometimes small, not statistically significant and/or of little clinical relevance. Considering the pooling of data, the effect of acetylcysteine or carbocysteine was not statistically significant except for cough after six to seven days. The treatment (acetylcysteine or carbocysteine) reduced the risk of cough by 63%. However, the number needed to treat to benefit (NNTB) was 10 with a large CI (6 to 101), suggesting a questionable effect size. Only one of the six trials was considered to have a low risk of bias (<a href="./references#CD003124-bbs2-0005" title="NakayamaY , MaedaK , FuanabashiS , KubagawaT , SimanugiK , TatenoK , et al. Carbocysteine syrup in pediatrics: a clinical trial [Effets cliniques de s‐carboxymethylcysteine sous forme de sirop en pédiatrie (traduction)]. Japanese Journal of Pediatrics1977;10:1823. ">Nakayama 1977</a>; <a href="#CD003124-fig-0002">Figure 2</a>). However, in the low risk of bias trial by <a href="./references#CD003124-bbs2-0005" title="NakayamaY , MaedaK , FuanabashiS , KubagawaT , SimanugiK , TatenoK , et al. Carbocysteine syrup in pediatrics: a clinical trial [Effets cliniques de s‐carboxymethylcysteine sous forme de sirop en pédiatrie (traduction)]. Japanese Journal of Pediatrics1977;10:1823. ">Nakayama 1977</a>, an overall criterion based on an improvement in global condition was used as an outcome, but this composite criterion has not been validated and may not be clinically relevant. No statistically significant difference was observed regarding most symptoms considered separately, especially expectoration and cough. It was not possible to make any evaluation about the subgroup of infants under two years of age, because none of the six studies that we included to evaluate efficacy mentioned the results for this age group separately. </p> <p>The overall safety of acetylcysteine and carbocysteine was good, with mainly minor gastrointestinal tract disorders in few participants (n = 46; 2%). These findings should not lead to the conclusion that mucolytic agents are well tolerated in paediatric patients. In fact, (i) the size of the low risk of bias trial was not sufficient to provide enough statistical power to detect any rare potentially severe adverse event, (ii) many high risk of bias trials did not provide detailed descriptions of the severity of adverse events and abnormal laboratory tests or reasons for treatment discontinuation separately for each intervention group, and (iii) very few children under two years of age were involved in the studies. RCTs of adequate sample size offer the only unbiased approach for assessing the frequency and severity of side effects from a given medication, but when that kind of evidence is lacking, other sources, such as pharmacovigilance and pharmaco‐epidemiology can be helpful. </p> <p>Regarding the safety of mucolytic agents in paediatric patients, attention should be paid to the youngest age group. In a targeted prospective pharmacovigilance study in two paediatric emergency departments, six infants (all younger than eight months old) were diagnosed with paradoxically increased bronchorrhoea during a two‐month period (<a href="./references#CD003124-bbs2-0022" title="ChalumeauM , CheronG , assathianyR , MoulinF , BavouxF , BreartG , et al. Mucolytic agents for acute respiratory tract infections in infants: a pharmacoepidemiologic problem? [Fluidifiants bronchiques dans les infections respiratoires aiguës du nourrisson: un problème pharmacoépidémiologique?]. Archives de Pédiatrie2002;9:1128‐36. ">Chalumeau 2002</a>). An analysis of the French pharmacovigilance system concerning adverse drug reactions to acetylcysteine and carbocysteine showed 59 respiratory adverse drug reactions in children younger than six years from 1989 to 2008 (30 children received carbocysteine, 28 received acetylcysteine and one child received both drugs at the same time). The respiratory adverse drug reactions reported were increased and/or prolonged cough, increased bronchorrhoea, worsening of respiratory distress, mucous vomiting and dyspnoea (<a href="./references#CD003124-bbs2-0073" title="MalletP , MourdiN , DubusJ‐C , BavouxF , Boyer‐GervoiseM‐J , Jean‐PastorM‐J , et al. Respiratory paradoxical adverse drug reactions associated with acetylcysteine and carbocysteine systemic use in paediatric patients: a national survey. PLoS One2011;6:e22792. ">Mallet 2011</a>). Fifty‐one children (86%) required hospitalisation or extended hospitalisation because of the adverse drug reactions. Outcome was favourable in all cases except for one patient in whom pleuropneumonia developed and a one‐year‐old girl who died of pulmonary oedema that was considered secondary to mucous vomiting according to the reporting physician. These side effects led to the withdrawal of the licence for carbocysteine and acetylcysteine in paediatric patients younger than two years of age in France and Italy in April 2010 (<a href="./references#CD003124-bbs2-0075" title="MourdiN , DubusJC , BavouxF , Boyer‐GervoiseM , Jean‐PastorMJ , ChalumeauM . Mucolytic drugs: towards a contraindication in infants. Archives de Pédiatrie2010;17:735‐6. ">Mourdi 2010</a>). </p> <p>This paradoxical reaction was also mentioned but not documented with references in some articles (<a href="./references#CD003124-bbs2-0068" title="HarrisRL , RileyHD . Reactions to aerosol medication in infants and children. JAMA1967;201:953‐5. ">Harris 1967</a>; <a href="./references#CD003124-bbs2-0030" title="JeanR , GardairF . Efficacy on expectoration of acetylcysteine nebulization in pediatric patients [Utilisation du Fluimucil antibiotic 750 en aérosols chez le nourisson et l'enfant son efficacité d'expectoration]. Laboratoires Zambon, Paris1982. ">Jean 1982</a>) and textbooks (<a href="./references#CD003124-bbs2-0051" title="Anonymous . Acetylcysteine. In: McVoyGK editor(s). American Hospital Formulary System Drug Information. Bethesda, USA: American Society of Health‐System Pharmacists Incorporation, 2000:472‐4. ">Anonymous 2000a</a>; <a href="./references#CD003124-bbs2-0052" title="Anonymous . Acetylcysteine. Anonymous. Drug Facts and Comparisons 2000. 4th Edition. Saint Louis, USA: Facts and Comparisons, 2000:677‐9. ">Anonymous 2000b</a>). The paradoxically increased bronchorrhoea could be explained by the effective action of mucolytic agents which increase bronchial mucous flow. This flow may exceed the capacity of spontaneous drainage of the infant which is limited by the small bronchial diameter and neuromuscular physiologic immaturity (<a href="./references#CD003124-bbs2-0085" title="WohlMEB . Developmental physiology of the respiratory system. In: ChernickV , BoatTF editor(s). Kendig’s Disorders of the Respiratory Tract in Children. Vol. 6th, Philadelphia, USA: WB Saunders Company, 1998. ">Wohl 1998</a>). This could also be explained by a dose‐related effect. No dose‐response trial has ever been performed for acetylcysteine, leading to a unique dose recommendation of 200 mg per day, whatever the weight of the child. According to the World Health Organization (WHO) standards (<a href="./references#CD003124-bbs2-0084" title="WHO Child GrowthStandards . Weight‐for‐age. http://www.who.int/childgrowth/standards/weight_for_age/en/ 2013 (accessed 1 April 2013). ">WHO 2007</a>), the median weight of a one‐month‐old infant is about 4.5 kg as opposed to 12.2 kg for a two‐year‐old. The recommended dose for the youngest infants is then three times higher than the dose recommended for the oldest (about 45 mg/kg/day versus 16 mg/kg/day). This may lead to dose‐related adverse events in very young infants. In the same way, no clinical research has been implemented to support the recommended dose of the marketing authorisation of carbocysteine (200 to 300 mg/day). The evaluation of drug safety should depend on age, considering that pharmacokinetics and pharmacodynamics in paediatric patients differ greatly from adults, especially in neonates and infants. Paradoxical side effects are not rare in these age groups (<a href="./references#CD003124-bbs2-0072" title="HughesJ , GillA , LeachHJ , NunnAJ , BillinghamI , RatcliffeJ , et al. A prospective study of the adverse effects of midazolam on withdrawal in critically ill children. Acta Paediatrica1994;83:1194‐9. ">Hughes 1994</a>) but a causal relationship is difficult to prove when a paradoxical side effect of a drug is suspected because of protopathic bias. The term <i>protopathic bias</i> is used if the first symptoms of the outcome of interest are the reasons for use of treatment (<a href="./references#CD003124-bbs2-0079" title="SalasM , HofmanA , StriekerBHC . Confounding by indication: an example of variation in the use of epidemiologic terminology. American Journal of Epidemiology1999;149:981‐3. ">Salas 1999</a>). This bias leads people to believe that when symptoms worsen during the course of a drug that is prescribed for a specific disease it may be related to the disease itself and not to the drug (<a href="./references#CD003124-bbs2-0063" title="Delgado‐RodriguezM , LlorcaJ . Bias. Journal of Epidemiology and Community Health2004;58:635‐41. ">Delgado‐Rodriguez 2004</a>; <a href="./references#CD003124-bbs2-0071" title='HorwitzRI , FeinsteinAR . The problem of "protopathic bias" in case‐control studies. American Journal of Medicine1980;68:255‐8. '>Horwitz 1980</a>). The only way to evaluate paradoxical side effects of drugs avoiding protopathic bias would be theoretically to study them in another unrelated disease. However, this is not possible in the case of carbocysteine because its only indications are RTIs. For acetylcysteine, in a multicentre, post‐marketing safety study, respiratory symptoms were reported in 2.2% of paediatric (n = 1905) patients receiving intravenous acetylcysteine for acetaminophen overdose between 1980 and 2005. Respiratory symptoms included bronchospasm, cough, wheezing, stridor, shortness of breath, chest tightness or respiratory distress (<a href="./references#CD003124-bbs2-0062" title="CumberlandPharmaceuticals . Acetadote(r) iv injection, acetylcysteine iv injection. Product information2008. ">Cumberland Pharmaceuticals 2008</a>). </p> </section> <section id="CD003124-sec-0076"> <h3 class="title" id="CD003124-sec-0076">Overall completeness and applicability of evidence</h3> <p>The external validity of this review is difficult to evaluate. On the one hand, it seems high given the various settings of the studies, the various types of participants, the various type of interventions and outcomes. On the other hand, the meaning of results observed in studies performed 40 years ago in patients with clinical conditions and general management that are very different from the current practices is questionable. </p> <p>The evaluation of the benefit‐risk ratio of mucolytic agents should take into consideration the fact that these medicines are prescribed for self limiting diseases (for example, acute cough, bronchitis). For example, in the <a href="./references#CD003124-bbs2-0001" title="BellomoG , GiudiceS . Controlled study on the efficacy of a combination &quot;thiamphenicol‐acetylcysteine&quot; in oral administration in respiratory infections in pediatrics [Studio controllata sull'efficacia della combinazione &quot;tiamfenicolo‐acetilcisteina&quot; per via orale nel trattamento delle infezioni broncopolmonari dell'infanzia]. Clinical Pediatrics1972;54:30‐51. ">Bellomo 1972</a> study, remission for all symptoms was complete in the placebo group within nine days at most. Regarding paediatric patients older than two years, no serious adverse events were reported in the available studies included in the present review. These studies suggest that acetylcysteine and carbocysteine may reduce frequency, intensity and duration of symptoms in acute upper and lower RTIs. For the patient group younger than two years, the benefit‐risk ratio is most probably negative according to available evidence for side effects in this age group. </p> <p>Our review has some implications for drug regulation agencies. Acetylcysteine and carbocysteine are licensed for use for the treatment of acute upper and lower RTIs in paediatric patients in many European countries. According to our review, this license is not supported by strong evidence in children older than two years of age and is not supported by any evidence in children under two years of age, considering some important concerns about safety (<a href="./references#CD003124-bbs2-0073" title="MalletP , MourdiN , DubusJ‐C , BavouxF , Boyer‐GervoiseM‐J , Jean‐PastorM‐J , et al. Respiratory paradoxical adverse drug reactions associated with acetylcysteine and carbocysteine systemic use in paediatric patients: a national survey. PLoS One2011;6:e22792. ">Mallet 2011</a>; <a href="./references#CD003124-bbs2-0075" title="MourdiN , DubusJC , BavouxF , Boyer‐GervoiseM , Jean‐PastorMJ , ChalumeauM . Mucolytic drugs: towards a contraindication in infants. Archives de Pédiatrie2010;17:735‐6. ">Mourdi 2010</a>). A re‐evaluation of the benefit‐risk ratio of these drugs by the drug regulation agencies of the countries where they are licensed is necessary, particularly in the age group younger than two years. </p> </section> <section id="CD003124-sec-0077"> <h3 class="title" id="CD003124-sec-0077">Quality of the evidence</h3> <p>The body of evidence identified allows a robust conclusion regarding patients younger than two years old. Indeed no study supports the use of acetylcysteine nor carbocysteine among this age group. For children older than two years, our conclusions are based on a small number of studies and patients, with an overall high risk of bias. Thus, the conclusions should be interpreted cautiously. </p> </section> <section id="CD003124-sec-0078"> <h3 class="title" id="CD003124-sec-0078">Potential biases in the review process</h3> <p>Given the effort that was made to contact all drug companies that manufacture acetylcysteine and carbocysteine, the high response rate obtained during this process (as shown by the numerous unpublished studies included) and the various contacts, we are confident that we analysed all relevant data in this review. </p> </section> <section id="CD003124-sec-0079"> <h3 class="title" id="CD003124-sec-0079">Agreements and disagreements with other studies or reviews</h3> <p>Our conclusions are in complete agreement with clinical practice guidelines for the management of cough in children (<a href="./references#CD003124-bbs2-0060" title="ChangAB , GlombWB . Guidelines for evaluating chronic cough in pediatrics. Chest2006;129(Suppl):260‐83. ">Chang 2006</a>; <a href="./references#CD003124-bbs2-0082" title="ShieldsMD , BushA , EverardML , McKenzieS , PrimhakR , British Thoracic Society Cough Guideline Group. BTS guidelines: recommendations for the assessment and management of cough in children. Thorax2008;63(Suppl 3):iii1‐15. ">Shields 2008</a>) and another systematic review (<a href="./references#CD003124-bbs2-0083" title="SmithSM , SchroederK , FaheyT . Over‐the‐counter (OTC) medications for acute cough in children and adults in ambulatory settings. Cochrane Database of Systematic Reviews2012, Issue 8. [DOI: 10.1002/14651858.CD001831.pub4] ">Smith 2012</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD003124-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD003124-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/full#CD003124-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD003124-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/full#CD003124-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Febrile state (AC vs placebo), outcome: 1.1 Febrile state after 6 days." data-id="CD003124-fig-0003" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Febrile state (AC vs placebo), outcome: 1.1 Febrile state after 6 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/full#CD003124-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 4 Cough (AC vs placebo), outcome: 4.1 Cough after 6 to 7 days." data-id="CD003124-fig-0004" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 4 Cough (AC vs placebo), outcome: 4.1 Cough after 6 to 7 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/full#CD003124-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 3 Dyspnoea (AC or CC versus placebo), outcome: 3.1 Dyspnoea after 6 to 7 days." data-id="CD003124-fig-0005" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 3 Dyspnoea (AC or CC versus placebo), outcome: 3.1 Dyspnoea after 6 to 7 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/full#CD003124-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 3 Thoracic semeiologic alterations (AC vs placebo), outcome: 3.1 Thoracic semeiologic alterations (after 3 days)." data-id="CD003124-fig-0006" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 3 Thoracic semeiologic alterations (AC vs placebo), outcome: 3.1 Thoracic semeiologic alterations (after 3 days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/full#CD003124-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Febrile state (AC or CC versus placebo), Outcome 1 Febrile state after 6 days." data-id="CD003124-fig-0007" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Febrile state (AC or CC versus placebo), Outcome 1 Febrile state after 6 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Febrile state (AC or CC versus placebo), Outcome 2 Febrile state after 6 days." data-id="CD003124-fig-0008" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Febrile state (AC or CC versus placebo), Outcome 2 Febrile state after 6 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-CMP-002-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Cough (AC or CC versus placebo), Outcome 1 Cough after 6 to 7 days." data-id="CD003124-fig-0009" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Cough (AC or CC versus placebo), Outcome 1 Cough after 6 to 7 days.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Cough (AC or CC versus placebo), Outcome 2 Cough after 6 to 7 days." data-id="CD003124-fig-0010" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Cough (AC or CC versus placebo), Outcome 2 Cough after 6 to 7 days.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Cough (AC or CC versus placebo), Outcome 3 Cough at the end of treatment (= 28 days)." data-id="CD003124-fig-0011" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Cough (AC or CC versus placebo), Outcome 3 Cough at the end of treatment (= 28 days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Cough (AC or CC versus placebo), Outcome 4 Cough at the end of treatment (= 28 days)." data-id="CD003124-fig-0012" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Cough (AC or CC versus placebo), Outcome 4 Cough at the end of treatment (= 28 days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-CMP-003-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Dyspnoea (AC or CC versus placebo), Outcome 1 Dyspnoea after 6 to 7 days." data-id="CD003124-fig-0013" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Dyspnoea (AC or CC versus placebo), Outcome 1 Dyspnoea after 6 to 7 days.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Dyspnoea (AC or CC versus placebo), Outcome 2 Dyspnoea after 6 to 7 days." data-id="CD003124-fig-0014" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Dyspnoea (AC or CC versus placebo), Outcome 2 Dyspnoea after 6 to 7 days.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-CMP-004-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Thoracic semeiologic alterations (AC versus placebo), Outcome 1 Thoracic semeiologic alterations after 5 days." data-id="CD003124-fig-0015" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Thoracic semeiologic alterations (AC versus placebo), Outcome 1 Thoracic semeiologic alterations after 5 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Thoracic semeiologic alterations (AC versus placebo), Outcome 2 Thoracic semeiologic alterations after 5 days." data-id="CD003124-fig-0016" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Thoracic semeiologic alterations (AC versus placebo), Outcome 2 Thoracic semeiologic alterations after 5 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Thoracic semeiologic alterations (AC versus placebo), Outcome 3 Thoracic semeiologic alterations after 5 days." data-id="CD003124-fig-0017" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Thoracic semeiologic alterations (AC versus placebo), Outcome 3 Thoracic semeiologic alterations after 5 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Thoracic semeiologic alterations (AC versus placebo), Outcome 4 Thoracic semeiologic alterations at the end of treatment (= 28 days)." data-id="CD003124-fig-0018" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Thoracic semeiologic alterations (AC versus placebo), Outcome 4 Thoracic semeiologic alterations at the end of treatment (= 28 days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Thoracic semeiologic alterations (AC versus placebo), Outcome 5 Thoracic semeiologic alterations at the end of treatment (= 28 days)." data-id="CD003124-fig-0019" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Thoracic semeiologic alterations (AC versus placebo), Outcome 5 Thoracic semeiologic alterations at the end of treatment (= 28 days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 General condition (CC versus placebo), Outcome 1 Bad general condition after 6 to 7 days." data-id="CD003124-fig-0020" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 General condition (CC versus placebo), Outcome 1 Bad general condition after 6 to 7 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 General condition (CC versus placebo), Outcome 2 Bad general condition after 6 to 7 days." data-id="CD003124-fig-0021" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 General condition (CC versus placebo), Outcome 2 Bad general condition after 6 to 7 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Cough productivity (AC versus placebo), Outcome 1 Cough productivity at the end of treatment (= 28 days)." data-id="CD003124-fig-0022" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Cough productivity (AC versus placebo), Outcome 1 Cough productivity at the end of treatment (= 28 days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Cough productivity (AC versus placebo), Outcome 2 Cough productivity at the end of treatment (= 28 days)." data-id="CD003124-fig-0023" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Cough productivity (AC versus placebo), Outcome 2 Cough productivity at the end of treatment (= 28 days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Appetite (CC versus placebo), Outcome 1 Appetite trouble at the end of treatment (5 to 9 days)." data-id="CD003124-fig-0024" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Appetite (CC versus placebo), Outcome 1 Appetite trouble at the end of treatment (5 to 9 days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Expectoration (CC versus placebo), Outcome 1 Expectoration at the end of treatment (= 7 days)." data-id="CD003124-fig-0025" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Expectoration (CC versus placebo), Outcome 1 Expectoration at the end of treatment (= 7 days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Expectoration (CC versus placebo), Outcome 2 Expectoration at the end of treatment (= 7 days)." data-id="CD003124-fig-0026" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Expectoration (CC versus placebo), Outcome 2 Expectoration at the end of treatment (= 7 days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Pulmonary function tests (CC versus placebo), Outcome 1 Alteration of the pulmonary function after 3 days." data-id="CD003124-fig-0027" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Pulmonary function tests (CC versus placebo), Outcome 1 Alteration of the pulmonary function after 3 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003124-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/urn:x-wiley:14651858:media:CD003124:CD003124-CMP-009-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_t/tCD003124-CMP-009-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Pulmonary function tests (CC versus placebo), Outcome 2 Alteration of the pulmonary function after 3 days." data-id="CD003124-fig-0028" src="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-009-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9 Pulmonary function tests (CC versus placebo), Outcome 2 Alteration of the pulmonary function after 3 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/media/CDSR/CD003124/image_n/nCD003124-CMP-009-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD003124-tbl-0001"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Characteristics of studies included to evaluate safety</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Methods</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participants</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Notes</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Allocation concealment</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0008" title="Anonymous . A study of tolerance of carbocisteine syrup in children [Etude de la tolérance clinique du sirop carbocistéine chez l'enfant]. Dossier d'autorisation de mise sur le marché, Laboratoires Alpharma, Aubervilliers, France1987. ">Anonymous 1987</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Case report</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20 children (1 to 14 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral carbocysteine <br/> 300 mg/day above 5 years <br/> 200 mg/day under 5 years <br/> 2 to 3 times daily for 6 days (except 1: 3 days) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough frequency and intensity, sputum quality and quantity</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>French</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not used</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0009" title="BaldiniG , GucciM , TaroD , MemminiC . Controlled clinical study of a new Ambroxol formula in the treatment of infantile spastic bronchitis [Studio clinico controllato sull'attivita di una nuova formulazione di Ambroxol nella bronchite asmatiforme del bambino]. Minerva Pediatrica1989;41:91‐5. ">Baldini 1989</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> Active treatment (ambroxol); <br/> participants received antibiotics if necessary </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28 children older than 2 years old</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral acetylcysteine <br/> 300 mg/day above 5 years <br/> 200 mg/day under 5 years <br/> For 10 days </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: expectoration, sputum viscosity, dyspnoea, cough, difficulty of expectoration. <br/> Biological: blood exam, monitoring of hepatic and renal function </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0010" title="BanovcinP . Efficacy of carbocysteine in the treatment of bronchopneumonias in children. Prakticky Lekar1990;70:885‐7. ">Banovcin 1990</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Controlled trial <br/> Active treatment (Ipecac syrup); <br/> antibiotics and vitamins for all participants </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18 children (6 to 15 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral carbocysteine <br/> 250 mg 3 times a day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PFT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Slovak</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0011" title="BanovcinP , JakusovaL , RosslerovaV , MiklerovaM , PullmanR . Carbocysteine in the treatment of recurrent bronchitis in infants [Karbocystein v liecbe recidivujucich bronchitid u dojciat]. Ceskoslovenska Pediatrie1992;47:543‐6. ">Banovcin 1992</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> Active treatment (Ipecac syrup); <br/> antibiotics for all participants </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51 children (6 to 24 months)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral carbocysteine <br/> 50 to 62.5 mg 3 times a day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical score: lung auscultation, fever, cough <br/> Biological: blood exam </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Slovak</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0012" title="BellomoG , FrigerioG , TirantelloG . Controlled study on the use of intramuscular acetylcysteine in acute respiratory infections in pediatrics [Ricerche controllate sull'impiego dell'acetilcisteina per via intramuscolare nelle infezioni respiratorie acute in pediatria]. Clinica Terapeutica1967;43:437‐58. ">Bellomo 1967a</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Controlled trial <br/> Control participants received no treatment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81 children (&lt; 8 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intramuscular acetylcysteine <br/> 25 to 50 mg/kg/day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, thoracic semeilogic alteration, fever</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0013" title="BellomoG , TirantelloG , GiudiceS . On the use of a combination of acetylcysteine with thiamphenicol glycinate in the systemic treatment of bronchopulmonary infections in children [Sull'uso di una combinazione dell'acetilcysteina con tiamfenicolo glicato nel trattamento sistemico delle infezioni broncopolmonari in eta' pediatrica]. Clinical Pediatrics1967;49:402‐24. ">Bellomo 1967b</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial <br/> Thiamphenicol for all participants </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39 children (16: &lt; 2 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intramuscular acetylcysteine <br/> 10 to 18 mg/kg/day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, thoracic semeilogic alteration, fever <br/> Biological: blood exam; X‐ray </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0001" title="BellomoG , GiudiceS . Controlled study on the efficacy of a combination &quot;thiamphenicol‐acetylcysteine&quot; in oral administration in respiratory infections in pediatrics [Studio controllata sull'efficacia della combinazione &quot;tiamfenicolo‐acetilcisteina&quot; per via orale nel trattamento delle infezioni broncopolmonari dell'infanzia]. Clinical Pediatrics1972;54:30‐51. ">Bellomo 1972</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> All participants received thiamphenicol with or without acetylcysteine </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>59 children (22: &lt; 1 year; 28: 1 to 5 years; 9: &gt; 5 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral acetylcysteine <br/> 13.8 mg/kg/day 2 to 4 times daily for 6 to 7 days average (maximum 14 days) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: duration of febrile state, dyspnoea, thoracic semeiologic alterations, cough</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0014" title="BellomoG , GiudiceS , GanciC . Comparative study of the efficacy of acetylcysteine by the oral and intramuscular routes in acute respiratory affections in pediatrics [Studio comparativo dell'efficacia dell'acetilcisteina per via orale ed intramuscolare nelle affezioni respiratorie acute in pediatria]. Minerva Pediatrica1973;25:844‐9. ">Bellomo 1973</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> Oral and intramuscular acetylcysteine; <br/> thiamphenicol for all participants </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50 children (35: &lt; 2 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral and intramuscular acetylcysteine <br/> 300 mg/day under 2 years <br/> 600 mg/day above </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, thoracic semeilogic alteration, fever</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0016" title="BerniM , CollinaA , ZavattiniG . Ambroxol in bronchopulmonary pathology in children [Ambroxol nella patologia broncopolmonare del bambino]. Clinica Terapeutica1983;106:351‐5. ">Berni 1983</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> Antibiotics if necessary </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 children (2 to 8 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral carbocysteine <br/> 200 to 300 mg </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, expectoration</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0002" title="BiscattiG , BruschelliM , DamonteG , CapozziF . Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics [Ricerca controllata sugli effetti clinici dell'acetilcisteina per via orale nelle infezioni respiratorie in pediatria]. Minerva Pediatrica1972;24:1075‐84. ">Biscatti 1972</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> All participants received some kind of antibiotic </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50 children (29: &lt; 2 years; 21: &gt; 2 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral acetylcysteine <br/> 100 mg/day under 2 years <br/> 200 mg/day between 2 and 4 years <br/> 300 mg/day above 4 years for 6 days </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, thoracic semeilogic alteration, temperature level <br/> Biological: ESR and leucocyte count </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian <br/> Possibly not comparable treatment because various antibiotics were used </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0017" title="BonerAL , VallettaEA , StoccheroL , RichelliC , BennatiD . Combined antibiotic plus mucolytic treatment of acute or recurrent pneumonia in children. Drugs Under Experimental and Clinical Research1984;10:627‐30. ">Boner 1984</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial <br/> Cefuroxime for all participants </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60 children (4 to 12 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intramuscular acetylcysteine <br/> 15 to 30 mg/kg/day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: temperature, cough, chest and abdomen pain, dyspnoea, wheezing <br/> Bacteriological: respiratory secretion cultures <br/> X‐ray </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>English</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0018" title="CamurriS , MarencoG . Clinical evaluation of the safety and efficacy of a new pharmaceutical formulation of bromhexine compared to N‐acetylcysteine in pediatric patients with acute bronchitis [Valutazione clinica dell'efficacia e della tollerabilita della nuova formulazione farmaceutica bromessina granulare nei confronti dell'N‐acetilcisteina granulare in piccoli pazienti affetti da bronchite acuta]. Gazzetta Medica Italiana1990;149:45‐8. ">Camurri 1990</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> Active treatment (bromhexine) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32 children (2 to 11 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral acetylcysteine <br/> 300 mg/day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, expectoration (difficulty, quantity and quality)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0019" title="CaramiaG , BizzarriV , CompagnoniL , GregoriniS . Combined antibiotic plus mucolytic treatment in broncho‐pulmonary disease: cefuroxime plus acetylcysteine. Current Therapeutic Research, Clinical and Experimental1984;36:658‐63. ">Caramia 1984</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial <br/> Cefuroxime for all participants </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 children (4 months to 13 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intramuscular acetylcysteine <br/> 20 to 30 mg/kg/day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, temperature, sputum viscosity, intrinsic sputum characteristics <br/> Bacteriological: respiratory secretion cultures <br/> X‐ray </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>English</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0020" title="CaredduP , BernocchiD , ScottiL , ManiniG , MezzopaneA . Therapeutic activity and tolerability of a new mucoregulating drug called nesosteine in the treatment of acute diseases of the respiratory apparatus. Controlled pediatric study vs carbocysteine [Attivita terapeutica e tollerabilita di un nuovo farmaco mucoregolatore denominato nesosteina nel trattamento di affezioni acute dell'apparato respiratorio studio pediatrico controllato vs carbocisteina]. Giornale Italiano Delle Malattie Del Torace1989;43:47‐52. ">Careddu 1989</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> Active treatment (nesosteine) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 children (5 to12 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral carbocysteine <br/> 900 mg/day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, expectoration <br/> Biological: blood exam </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0021" title="CastelloD , CostaG , deCandussioG . Modifications in catarrhal bronchitis secretion in paediatric age following treatment with S‐carboxymethyl‐cystein (viscosimetric study) [Modificazioni dell'escreato nella bronchite catarrale in eta pediatrica dopo trattamento con S‐carbossimetilcisteina (indagine viscosimetrica)]. Minerva Pediatrica1979;31:371‐80. ">Castello 1979</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Controlled trial <br/> Antibiotics if necessary </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13 children (1 of 15 months + 12: 2 to 12 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral carbocysteine; <br/> 3 spoons/day (2% under <br/> 4 years; 5% above <br/> 4 years) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: monitoring; <br/> viscosimetry </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0022" title="ChalumeauM , CheronG , assathianyR , MoulinF , BavouxF , BreartG , et al. Mucolytic agents for acute respiratory tract infections in infants: a pharmacoepidemiologic problem? [Fluidifiants bronchiques dans les infections respiratoires aiguës du nourrisson: un problème pharmacoépidémiologique?]. Archives de Pédiatrie2002;9:1128‐36. ">Chalumeau 2002</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Targeted pharmacovigilance study</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 children (&lt; 2 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19.5 to 34.6 mg/kg/day</p> <p>3 received oral carbocysteine <br/> 3 received oral acetylcysteine </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, sputum viscosity</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>French</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not used</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0023" title="DanoG . Bronchospasm caused by acetylcysteine in children with bronchial asthma. Acta Allergologica1971;26:181‐90. ">Dano 1971</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 children (5 to 17 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inhaled acetylcysteine <br/> 2 ml 10% + 2 ml 20% </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: monitoring; <br/> PFT </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>English</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0003" title="FiocchiA , VignatiB , SalaM , ArancioR , BanderaliG , MarangioneP , et al. A new n‐acetylcysteine formulation in acute bronchopneumopathy in children [La n‐acetilcisteina nel trattamento delle broncopneumopatie acute in pediatria]. Giornale Italiano delle Malattie del Torace1989;43:327‐34. ">Fiocchi 1989</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> All participants received antibiotics if necessary </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 children (all &gt; 2 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral acetylcysteine <br/> 20 mg/kg/day 3 times a day for 28 days </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, cough productivity and thoracic semeilogic alteration <br/> PFT </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian <br/> Side effects: 2 participants vomiting in acetylcysteine group, with 1 drop‐out </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0025" title="GaudierB , LelongM . Carbocysteine to treat asthma in children [L'utilisation de la S‐Carboxy Methyl Cystéine (LJ 206) dans l'asthme de l'enfant]. Laboratoires Joullie, Paris1968. ">Gaudier 1968</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50 children (&lt; 15 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral acetylcysteine; <br/> 2 spoons 2%/day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: monitoring (evolution of asthma)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>French</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0026" title="GinocchiG . Clinical effects of a mucolytic agent (Pol 65) in a pediatric statistical study [Effeti clinici di un mucoliyico (Pol 65) in una casistica pediatrica]. Settimana Medica1978;66:391‐408. ">Ginocchi 1978</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial <br/> Antibiotics in 33 children </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44 children (2 months to 13 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral carbocysteine <br/> 2 spoons/day under 5 years; 3 spoons/day above </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, expectoration, sputum viscosity <br/> Biological: blood exam </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0027" title="GusbertiC , BellazziA , LonatiC , ModestiR . Clinical evaluation of a new synthetic derivative of acetylcysteine for treating respiratory inflammations in pediatric patients [Valutazione clinica di uno nuovo derivato sintetico dell'acido acetilsalicilico nella terapia di flogosi respiratorie di pazienti pediatrici]. Archivio di Medicina Interna1985;37:123‐9. ">Gusberti 1985</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> Active treatment (acetylsalicylate of acetylcysteine 4%, 5 ml x 3) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 children (4 months to 13 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral acetylcysteine <br/> 200 mg 3 times a day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, expectoration (difficulty, quantity and quality), temperature <br/> Biological: blood exam </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0028" title="HenocqA , MoreauC , MalletE , SaugerF , Menibus CHde . Changes in IgA levels in nasal mucus after upper respiratory tract diseases in infants treated with carbocysteine [Modifications du taux IgA du mucus nasal au décours des affections des voies aériennes supérieures du nourrisson traitées par la carbocistéine]. Annales d'Oto‐Laryngologie et de Chirurgie Cervico Faciale1985;102:373‐5. ">Henocq 1985</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> Control participants received no treatment </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50 children (1 month to 4 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral carbocysteine <br/> 5 ml 2% per 5 kg/day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IgA level</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>French</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0030" title="JeanR , GardairF . Efficacy on expectoration of acetylcysteine nebulization in pediatric patients [Utilisation du Fluimucil antibiotic 750 en aérosols chez le nourisson et l'enfant son efficacité d'expectoration]. Laboratoires Zambon, Paris1982. ">Jean 1982</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial <br/> Thiamphenicol for all participants </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 children (&lt; 10 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inhaled acetylcysteine <br/> 200 mg/day under 3 months <br/> 400 mg/day above </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, expectoration, sputum viscosity, temperature <br/> Bacteriological <br/> X‐ray, PFT, bronchoscopy </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>French</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0031" title="LeupoldW von . Lung function in bronchial asthma during treatment with Mucosolvin [Die lungenfunktion bei asthma bronchiale unter der behandlung mit Mucosolvia]. Das Deutsche Gesundheitswesen1970;25:1400‐2. ">Leupold 1970</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36 children (7 to 16 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inhaled acetylcysteine <br/> 15 min: 18 participants at 20% and 18 participants at 10% </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: monitoring <br/> PFT </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>German</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0032" title="Loscialpo RamundoD . On the use of the association of acetylcysteine and thiamphenicol glycinate in some pediatric pulmonary diseases [Sull'impiego associazone acetilcisteina‐tiamfenicolo glicinato in alcune forme di patologia polmonare pediatrica]. Clinical Pediatrics1968;50:43‐56. ">Loscialpo Ramundo 1968</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial <br/> Thiamphenicol for all participants </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84 children (2 to 12 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inhaled acetylcysteine <br/> 1.5 ml 10% above 5 years <br/> 3 ml 10 % under (the first 5 days twice a day then once a day) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, fever <br/> Biological: blood exam <br/> X‐ray </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0004" title="MalkaM , Lablache CombierB . Carbocysteine in the treatment of acute bronchitis in children [Interet d'un mucolytique, la carbocistéine, dans la bronchite aiguë de l'enfant]. Medicina Infantil1990;97:687‐92. ">Malka 1990</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> All participants received antibiotics if necessary </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106 children (all &gt; 2 years); all participants received antibiotics if necessary</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral carbocysteine; <br/> 200 mg/day under 5 years <br/> 300 mg/day above for 7 days </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, expectoration, bronchial congestion, dyspnoea <br/> PFT </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>French <br/> 9 participants with side effects (in the carbocysteine group: 2 nausea, 3 diarrhoea, 1 stomach pain; in the placebo group: 1 nausea, 2 stomach pain) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0033" title="MayaudC , LentschnerC , BouchouchaS , MarsacJ . Thiamphenicol glycinate acetylcysteinate in the treatment of acute respiratory infections with mucostasis [L'acetylcysteinate de thiamphenicol glycinate dans le traitement des infections respiratoires aigues avec mucostase]. European Journal of Respiratory Diseases Supplement1980;61(111):70‐3. ">Mayaud 1980</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial <br/> Thiamphenicol for all participants </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>112 children (&lt; 8 years; 33: &lt; 1 year)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral and intramuscular acetylcysteine <br/> 50 mg/kg/day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: fever, expectoration (quality); <br/> Biological: blood exam <br/> Bacteriological: quality of sputum <br/> X‐ray </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>French</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0034" title="MichaelP , HaaseW . Treatment of acute and chronic bronchitis. Therapeutic experience with Pulmoclase [Behandlung akuter und chronischer bronchitis. Therapeutische erfahrungen mit Pulmoclase]. Therapiewoche1986;36:4440‐5. ">Michael 1986</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>374 children (mean: 5 years +/‐ 3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral carbocysteine; <br/> 500 mg/day under 4 years <br/> 750 mg/day above </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, sputum viscosity, expectoration, breathing</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>German</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0005" title="NakayamaY , MaedaK , FuanabashiS , KubagawaT , SimanugiK , TatenoK , et al. Carbocysteine syrup in pediatrics: a clinical trial [Effets cliniques de s‐carboxymethylcysteine sous forme de sirop en pédiatrie (traduction)]. Japanese Journal of Pediatrics1977;10:1823. ">Nakayama 1977</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> Patients received bronchodilators, antibiotics, antihistamine if previously treated </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152 children (0 to 18 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral carbocysteine; <br/> 30 mg/kg/day (in 3 to 4 doses a day for 7 days) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: overall assessment, cough, stridor, expectoration <br/> PFT </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>French</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adequate</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0036" title="NikolicP , KoracD . The influence of acetylcysteine on respiratory functions in children with recurrent bronchitis. European Journal of Respiratory Diseases Supplement1980;61(111):141. ">Nikolic 1980</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20 children (3 to 14 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral acetylcysteine <br/> 100 to 200 mg 3 times a day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical <br/> PFT </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>English</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0040" title="RamenghiM , SabayiniG , MengoniM . Combined antibiotic plus mucolytic treatment for recurrent bronchial diseases in infancy. Current Therapeutic Research1984;36:664‐7. ">Ramenghi 1984</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial <br/> Cefuroxim for all participants </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20 children (10 months to 2 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intramuscular acetylcysteine <br/> 15 mg/kg/day </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, rale, vesicular murmur, irritability, hypo‐alimentation <br/> Biological: blood exam <br/> Bacteriological: on pharyngotracheal aspirate </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>English</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0044" title="SantangeloG , LombardoS , GiannottiG . A combination of cefuroxime and N‐acetyl‐cysteine for the treatment of lower respiratory tract infections in children. International Journal of Clinical Pharmacology, Therapy, and Toxicology1985;23:279‐81. ">Santangelo 1985</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled trial <br/> Cefuroxim for all participants </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>103 children (2 months to 11 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intramuscular acetylcysteine; 20 to 30 mg/kg/day</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: monitoring <br/> Bacteriological: secretion cultures; X‐ray </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>English</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0046" title="TrastotenojoMS , HarsoyoN , SachroAD , SoemantriAG , SaidHW . Use of acetyl cysteine in respiratory tract disease in children. Paediatrica Indonesiana1984;24:1‐10. ">Trastotenojo 1984</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Controlled trial <br/> Antibiotics and bronchodilator if necessary </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60 children (2 months to 13 years)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral acetylcysteine 100 mg 3 times a day</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, findings on auscultation; <br/> Biological: blood exam <br/> X‐ray </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>English</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD003124-bbs2-0006" title="ZaniniA , DodesniG . Lisomucil in pediatrics [Il lisomucil in campo pediatrico]. Clinica Europea1974;13:1‐12. ">Zanini 1974</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT <br/> In treatment group 15 children received antibiotics + 4 inhaled acetylcysteine; in control group 8 children received antibiotics </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 children (18 &lt; 1 year; 12 &gt; 1 year)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral carbocysteine from 100 to 400 mg/day depending on age for 5 to 9 days</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical: cough, dyspnoea, temperature level, appetite, general condition</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Italian</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>RCT: randomised controlled trial <br/> PFT: pulmonary function tests <br/> ESR: erythrocyte sedimentation rate </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Characteristics of studies included to evaluate safety</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/full#CD003124-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003124-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Febrile state (AC or CC versus placebo)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Febrile state after 6 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.12, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Febrile state after 6 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.02, 1.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Febrile state (AC or CC versus placebo)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003124-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Cough (AC or CC versus placebo)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Cough after 6 to 7 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.19, ‐0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Cough after 6 to 7 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.12, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Cough at the end of treatment (= 28 days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.13, 0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Subgroup = bronchitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.25, 0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Subgroup = tracheitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.10, 0.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Cough at the end of treatment (= 28 days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.16, 2.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Subgroup = bronchitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.10, 2.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Subgroup = tracheitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.08, 19.09]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Cough (AC or CC versus placebo)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003124-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Dyspnoea (AC or CC versus placebo)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Dyspnoea after 6 to 7 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>245</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.09, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Dyspnoea after 6 to 7 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>245</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.25, 1.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Dyspnoea (AC or CC versus placebo)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003124-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Thoracic semeiologic alterations (AC versus placebo)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Thoracic semeiologic alterations after 5 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐0.13, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Thoracic semeiologic alterations after 5 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.20, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Thoracic semeiologic alterations after 5 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.01, 2.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Thoracic semeiologic alterations at the end of treatment (= 28 days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.25, ‐0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Subgroup = bronchitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.11 [‐0.27, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Subgroup = tracheitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.17 [‐0.32, ‐0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Thoracic semeiologic alterations at the end of treatment (= 28 days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.03, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Subgroup = bronchitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.03, 2.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Subgroup = tracheitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.01, 1.95]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Thoracic semeiologic alterations (AC versus placebo)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003124-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">General condition (CC versus placebo)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Bad general condition after 6 to 7 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>182</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.35, 0.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Bad general condition after 6 to 7 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>182</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.31, 1.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">General condition (CC versus placebo)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003124-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Cough productivity (AC versus placebo)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Cough productivity at the end of treatment (= 28 days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.20, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Subgroup = bronchitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.25, 0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Subgroup = tracheitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.25, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Cough productivity at the end of treatment (= 28 days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.11, 1.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Subgroup = bronchitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.10, 2.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Subgroup = tracheitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.04, 2.63]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Cough productivity (AC versus placebo)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003124-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Appetite (CC versus placebo)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Appetite trouble at the end of treatment (5 to 9 days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.29, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Appetite (CC versus placebo)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003124-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Expectoration (CC versus placebo)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Expectoration at the end of treatment (= 7 days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐0.31, 0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Expectoration at the end of treatment (= 7 days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.27, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Expectoration (CC versus placebo)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003124-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Pulmonary function tests (CC versus placebo)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Alteration of the pulmonary function after 3 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [‐0.14, 0.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Alteration of the pulmonary function after 3 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.75, 1.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Pulmonary function tests (CC versus placebo)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003124.pub4/references#CD003124-tbl-0010">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD003124.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD003124-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD003124-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD003124-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD003124-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD003124-note-0001">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003124\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003124\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003124\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003124\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003124\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003124\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003124\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003124\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003124\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003124\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003124\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003124\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003124\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003124\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003124\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003124\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003124\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003124\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ZDBB8PHY&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003124.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003124.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD003124.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD003124.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003124.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714238180"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003124.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714238184"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003124.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d69ce7c5bf3cd',t:'MTc0MDcxNDIzOC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 